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Crystallisation is an important unit operation in the processing of pharmaceuticals and 
other fine chemicals. This thesis presents research in the area of crystallisation and solid-
state chemistry and investigates methods towards optimising the physical and particle 
properties of organic solid forms. The work was carried out in the context of the EPSRC 
Centre for Innovative Manufacturing in Continuous Manufacturing and Crystallisation 
(CMAC). CMAC aims to accelerate the adoption of continuous manufacturing processes 
for the production of higher quality chemical products at lower cost and more sustainably. 
Chapters 1-3 present an introduction to the research area in crystallisation tackled, along 
with background theory and experimental methods employed. 
 
Crystal morphology is important for the ease of downstream processing in the production 
of pharmaceuticals and fine chemicals due to its impact on the bulk properties of a 
substance. Impurities can play a significant role in the final crystal morphology produced 
from crystallisation and can therefore be added intentionally (known as additives) to tune 
the morphology of a substance to a more desirable shape. Chapter 4 presents the 
discovery of a polymer-additive mediated effect on the crystal morphology of succinic 
acid; the effect of the additive is dependent on both the concentration of succinic acid and 
the polymer additive and a thorough investigation of these parameters at different scales 
is presented. A possible mechanism for the interaction of the polymer with the crystal 
surface is also described. Chapter 5 reports the transfer of the crystallisation of succinic 
acid carried out in Chapter 4 into the continuous environment using two different 
platforms. The system is used to characterise the design of a mesoscale segmented flow 
crystalliser as well as transferred to a well-established oscillatory flow platform. In the 
latter platform the additive effect of the polymer on the crystal morphology of succinic acid 
is successfully reproduced in the continuous environment. Chapter 6 explores the effect 
of a range of structurally similar additive candidates on the crystallisation of the Active 
Pharmaceutical Ingredient (API), isoniazid. As employed in Chapter 4, face indexing and 
analysis of the crystal structure are used to rationalise the effect of the additives.  
 
Chapter 7 and 8 detail small-scale molecular crystallisation studies in attempts to induce 
disordered or layered solid forms and understand orientational disorder. In Chapter 7 the 
production of a range of multi-component molecular complexes of the API piroxicam are 
reported. This includes a solvated system which shows interesting structural and thermal 
properties which have been studied in detail. Chapter 8 is concerned with studies of 
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1.1 Context of research 
Crystallisation is a vital step in the manufacture of many pharmaceuticals and fine 
chemicals, of which a high proportion are produced as crystalline solids. Control over the 
crystallisation process is important for the structural and particle attributes of a substance, 
enabling optimised function and physical properties to be achieved. Lack of 
understanding of the solid state behaviour of a substance can lead to unexpected phase 
transitions and result in altered properties such as stability and solubility: consequently, a 
material may not perform in the way anticipated. As well as the structural properties, 
optimisation of particle attributes such as particle size distribution and crystal morphology 
is important for the efficiency and ease of downstream manufacturing processes such as 
filtration and drying.  
 
The work presented in this thesis was carried out as part of the Doctoral Training Centre 
programme within the EPSRC Centre for Innovative Manufacturing in Continuous 
Manufacturing and Crystallisation (CMAC; see Section 1.3). 
 
1.2 Crystallisation 
A crystalline solid consists of molecules arranged in a regular array exhibiting long range 
order (see Chapter 2). Crystallisation methodology is key to the production of crystals 
with desired properties, and plays a role both in controlling the crystalline structure (often 
termed solid form control) and the macroscopic characteristics of the crystalline particle 
(particle attribute control). Although there are many crystallisation methods adopted, the 
work here concentrates on crystallisation from solution, the primary method currently 
adopted for the production of crystalline particles of pharmaceuticals and fine chemicals 
 2 
 
in a batch environment. Crystallisation methods can be of significant sophistication, but 
the basic process of crystallisation from solution can be described by three stages: 
generation of supersaturation, nucleation and crystal growth.  
 
1.2.1 Supersaturation 
Figure 1.1 shows a typical solubility curve as a function of temperature whereby an 
increase in solubility is observed as the temperature rises. At any given temperature on 
the curve the solution is saturated. A solution which lies below the equilibrium solubility 
line is termed undersaturated (existing crystals will dissolve) and a solution which lies 
above the equilibrium solubility line is supersaturated. A supersaturated solution therefore 
contains a greater concentration of dissolved solid than can ordinarily be accommodated 
at that temperature (i.e. greater solution concentration than the equilibrium saturation 
concentration).1 For crystallisation from solution to occur supersaturation needs to be 
generated (methods for generating supersaturation are outlined in Section 1.2.5); 
supersaturation is therefore considered the driving force for crystallisation.  
 
 





Above the solubility curve exists a metastable region in which the solution is 
supersaturated but within which it does not respond with spontaneous nucleation and 
only existing crystals will grow.3 The temperature at which spontaneous nucleation occurs 
for a given saturation concentration can be determined; this marks the limit of the 
metastable region (dotted black line on Figure 1.1), and is sometimes termed the 
metastable limit curve. The metastable zone width (MSZW) between these two curves is 
not always well defined and can vary depending on a number of conditions such as scale, 
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the cooling rate or the presence of impurities.4,5 A supersaturated solution whose 
composition lies beyond the metastable zone is termed labile and within this region 
spontaneous, uncontrolled nucleation is likely to occur.2  
 
A number of equations can be used to describe the supersaturation of a solution. By 
calculating the difference between the concentration of the solution (c) and the 
concentration of the solution at equilibrium saturation at the same temperature (c*) the 
concentration driving force can be determined2 (Equation 1.1). This value is used to 
describe supersaturation in this work. Supersaturation can also be described by the 
supersaturation ratio (S) of the two concentration values (Equation 1.2) or the relative 
supersaturation (Equation 1.3).6,7 




 Equation 1.2 
 σ =  
c − c∗
c∗
= 𝑆 − 1 Equation 1.3 
 
Thermodynamically, supersaturation can be described as the difference in chemical 




1.2.2 Nucleation  
Nucleation is defined as “the process of creating a new solid phase from a 
supersaturated homogeneous mother phase”2 and plays a decisive role in determining 
the molecular packing of a crystalline material.8 There are two types of nucleation: 
primary and secondary, outlined in Figure 1.2.  
 
Figure 1.2 - Schematic showing the types of nucleation differentiated by the absence or presence 





1.2.2.1 Primary nucleation 
Primary nucleation can be described as homogeneous or heterogeneous, distinguished 
based on the presence or absence of a solid interface. Homogenous nucleation is the 
spontaneous nucleation of a solid phase as a result of supersaturation alone (in the 
absence of any solid interface).3,9 While the mechanism behind nucleation is not fully 
understood, in current nucleation research two theories have been accepted for crystal 
nucleation from supersaturated solutions (Figure 1.3).10  
 
 
Figure 1.3 - The two alternative pathways for nucleation: (top) classical nucleation theory and 




First, classical nucleation theory (CNT) considers the addition of molecules to clusters 
until a critical size is reached to be able to sustain growth from solution. Clusters of this 
size are known as critical nuclei and their formation depends on overcoming the free 
energy barrier for the system11 (Figure 1.4). The maximum in the curve, at critical size zc, 
represents the size at which further growth of the cluster will lead to a decrease in free 
energy. Any cluster less than this size would only achieve a decrease in free energy by 
dissolution. The height of the free energy barrier depends on the level of supersaturation 
of the solution. As supersaturation increases, the height of the barrier and the value of the 
critical size decrease. Consequently, spontaneous nucleation is possible with increasing 
levels of supersaturation.2 
 
 






















Figure 1.4 - The free energy change as a function of cluster size (z), where zc represents the 





Alternative theories termed non-classical nucleation theories have also been 
explored.12,13 In the two-step mechanism,12 a highly disordered, liquid-like cluster is 
produced and once the nucleus reaches a certain critical size, crystalline order appears 
inside the liquid-like clusters.8  
 
In practice, homogenous nucleation is uncommon and primary nucleation more often 
occurs through heterogeneous nucleation.14 Heterogeneous nucleation is the 
spontaneous nucleation of a solid phase in the presence of a foreign surface such as 
dust, other impurities or the wall of the crystallisation vessel.15 This lowers the free energy 
barrier of nucleation by providing a surface on which material can be adsorbed. The 
presence of foreign surfaces can therefore induce nucleation at lower levels of 
supersaturation than for homogeneous nucleation.2,4 
 
1.2.2.2 Secondary nucleation 
Secondary nucleation describes the generation of new particles induced by the presence 
of suspended crystals of the solute.9 This mechanism usually occurs at lower 
supersaturations than for both types of primary nucleation.2,4 Secondary nuclei are 
formed in a number of different ways, most commonly through collision nucleation in 
which nuclei are formed by the collision of larger crystals with other crystals, the walls of 
the crystalliser or the impeller, resulting in smaller particles.2,3 The shear forces inflicted 
on a crystal by the solution flowing past can also be sufficient to produce secondary 




1.2.3 Crystal growth 
Upon reaching the critical size, addition of solute molecules from the supersaturated 
solution allows the crystal surface to undergo growth. The conditions and rate of crystal 
growth are important for the final product purity and crystal morphology.4 As in nucleation 
theory, there are several theoretical pathways by which a solute molecule adsorbs onto a 
crystal face from a supersaturated solution. The growth of crystal faces through the 
integration of growth units into the crystal lattice is dependent upon the strength and 
number of interactions likely to form between the crystal face and the growth unit.2 Crystal 
faces can be classified into three types depending on the number of interactions they can 
form with a growth unit, as proposed by Hartman and Perdok.16-18 There are three bonds 
possible at a kinked face, two bonds possible at a stepped face and one bond possible 
on a flat face (Figure 1.5). Crystal growth at a kinked face is the most energetically 
favourable type of bond, forming three interactions to an existing step rather than forming 
a new step.  
 
 
Figure 1.5 - A crystal surface showing growth units docking on a flat site (F), a step site (S) and a 
kink sites (K).  
 
Early crystal growth mechanisms considered the presence of an adsorbed layer of solute 
molecules on a crystal face. The Gibbs-Volmer theory postulates that growth units first 
adsorb onto the crystal surface, followed by diffusion on the surface to a step or kink site 
for incorporation. Thus, it is thought that crystals grow in a layer by layer fashion.4,7 This 
process can be described in terms of overcoming free energy barriers (Figure 1.6). 
 





In order to overcome ΔGdesolv the solute molecules must lose some of their solvent 
molecules to adsorb to the crystal surface, losing one degree of freedom (1). The growth 
unit then enters the adsorption layer where it overcomes the ΔGs,diff to migrate across the 
surface to a step position (2). Further desolvation then occurs to adsorb on a kink site 
(ΔGk) (or, less favourably, on a step site) (3).
2,7  
 
When crystalline materials contain sufficient kink and step sites on the surface, all 
approaching growth units will find a growth site. In this case, the growth rate is linearly 
proportional to supersaturation and this mechanism is known as continuous growth. 
When the crystal surface does not have enough step and kink sites to facilitate 
continuous growth steps must be created to accept the incoming growth units. One 
mechanism for step creation is described by two-dimensional nucleation at the surface. 
Growth units will form clusters on the flat surface which must reach critical size for growth 
of the layer to be completed.2,11 There are several models that describe the process of 
completing the layer. 
 
The mononuclear model assumes that following formation of the surface nucleus, it 
spreads across the surface at infinite velocity where the growth rate of each face is 
proportional to its area. This contrasts from the observed behaviour in which the largest 
faces are the slowest growing, eliminating the model as a possibility. In the polynuclear 
model, the spreading velocity is zero and the mechanism assumes that the nucleus does 
not spread, but the combination of several two-dimensional nuclei of critical size would 
eventually combine and cover the layer. The third model is known as the birth and spread 
model. This model allows a finite spreading rate independent of size and assumes 
nucleation occurs at any location on the surface and that there is no intergrowth between 
layers.4,11 In both of the latter models it can be seen that the rate-determining step in the 
two-dimensional nucleation mechanism is the surface nucleation rate; crystal growth is 
thus a discontinuous process.4,9 
 
In contrast, the Burton-Cabrera-Frank (BCF) model of crystal growth proposes that steps 
are self-generating as a result of screw dislocations in the crystal.4,11 The screw 
dislocation acts as a kink in the crystal and the new step grows over only a part of the 
surface, enabling the growth to wind up into a spiral towards self-perpetuating growth 
(Figure 1.7). This avoids the need for nucleation on the surface as an available 
adsorption site has been created spontaneously. This type of growth can result in growth 
rate dispersion in which different crystals and crystal surfaces have different growth rates 
due to the mechanism responding to specific dislocations on each crystal.2,11 As the 
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morphology of the crystal is dictated by the relative growth rates of the individual faces, 
this may result in differences in crystal morphology. 
 
 




The features of a growing crystal face such as the surface roughness (quantified by the 
α-factor) can be used to predict the growth mechanism adopted by the surface. Growth of 
a rough surface proceeds through continuous growth (α < 2) whereas growth of a smooth 
surface proceeds through a BCF mechanism (α > 5). Growth of a face of intermediate 
roughness may proceed through the birth and spread mechanism.7 Measurement of the 
growth rate of a face with respect to supersaturation can also give an indication of the 
growth mechanism, since the relationship predicted by each mechanism differs. A crystal 
face growing continuously will give a linear relationship between growth rate and 
supersaturation.2 A smooth crystal face growing at low supersaturation may undergo 
surface roughening at high supersaturation and/or temperature which can be related to a 
change in the growth mechanism of the face.20,21 This results in lost molecular selectivity 
and observation of rounded edges between different crystal faces (non-faceted 
growth).22,23 To maximise purity, supersaturation should be limited to maintain faceted 
growth. In non-faceted growth, the surface is less discriminating and may be more likely 
to accept impurities.  
 
1.2.4 Crystal morphology 
Crystal morphology represents the characteristic external shape of a crystal and is 
important for the function and physical properties of a material as well as the ease of 
downstream processing steps such as washing, filtration and compaction.4 For example, 
plate shaped crystals may be undesirable due to their tendency to pack as an 
impermeable layer on filter media resulting in poor efficiency in filtration and washing, 
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whereas block shaped crystals may filter more readily (Figure 1.8);2,24 block-like crystals 
are therefore generally more desirable for large scale processing. Specifically for 
pharmaceutical materials, crystal shape and size uniformity may also affect the 
dissolution properties of a drug and thus its bioavailability. 
 
 
Figure 1.8 - Diagram showing the effect of crystal morphology on filtration: block-like crystals filter 
well (left) whereas plate-shaped crystals filter less efficiently, packing as an impermeable layer 
(right). Adapted from [2]. 
 
The shape (morphology) of a crystal is governed by the relative growth rates of its 
individual faces. The growth of a face can be described as the rate of crystal growth 
along the direction perpendicular to the face – the (100) face thus “grows along” the  
a-direction, for example. A fast growing face will thus have a smaller area in comparison 
to a face that grows more slowly. Therefore, the morphology of a crystal is defined by its 
slowest growing faces. Large differences in the growth rates of individual faces will result 
in plate or needle-like crystals. The growth rate of each crystal face is affected by the 
internal molecular and crystal structure of the material as well as by external factors such 
as the choice of solvent, mixing conditions, degree of supersaturation, seeding and the 
presence of impurities such as structurally similar by-products.2 The crystallisation 
conditions can therefore sometimes be altered to optimise the crystal morphology.  
 
1.2.4.1 Prediction of crystal morphology 
The morphology of a crystal can be described as either the equilibrium or the growth 
morphology. The equilibrium shape is produced when the surface free energies of the 
crystal faces are minimised and is adopted when the crystal equilibrates with its 
surroundings. It is uncommon for crystals observed experimentally to adopt this shape 





The relationship between crystal morphology and crystal packing can enable prediction of 
a theoretical growth morphology. As stated above, the relative growth rates of the 
individual crystal faces govern the shape of the crystal. Early morphology prediction 
models related knowledge of the crystal packing or the energy of the crystal faces to the 
growth rates of individual crystal faces in order to construct a prediction of the crystal 
morphology.25 
 
The BFDH approach (used in this work) is based on the Bravais, Friedel, Donnay and 
Harker rule which assumes that the rate of crystal growth is inversely proportional to the 
interplanar spacing of a face (based on the underlying premise that molecules that are 
closer together as a result of this will have larger interaction energies).2 The BFDH model 
extends the prior work of Bravais and Friedel by adding the influence of space group 
symmetry elements such as screw axes and glide planes.26,27 However, this approach 
relies exclusively on knowledge of the crystal structure and therefore does not take into 
account the effect of the growth environment. The attachment energy model from 
Hartman and Perdok,16-18 later extended by Hartman and Bennema,28 states that the 
growth on the crystal surface proceeds by the addition of a layer containing the same 
crystal structure as the rest of the crystal and that the rate of growth perpendicular to a 
crystal face is proportional to its attachment energy. The attachment energy is defined as 
the energy released when one growth unit is attached to the surface of the crystal 
face.2,25 Crystal faces with a higher attachment energy have a faster growth rate and are 
therefore of lower morphological importance. 
 
Each of the BFDH and attachment energy models can be used to predict the crystal 
morphology of vapour-grown crystals, however, they cannot account for the effect of the 
growth environment in solution crystallisation, as they take no account of, for example, 
solvent interactions which can sometimes act to inhibit growth on crystal faces (Sections 
1.2.4.2 and 1.2.4.3).4,19 New models for crystal morphology prediction are continuing to 
be developed that take into account the effects of the growth environment; these may 
enable more accurate predictions of morphology.19,29-31 
 
1.2.4.2 Effect of solvent choice on crystal morphology 
The importance of incorporating solvent effects in morphology prediction models is 
emphasised by the fact that often in crystallisation different morphologies are produced 
from different solvents. Favourable interactions between solvent molecules and functional 
groups exposed on the surface of specific faces of the crystals may result in disruption of 
the growth rates of individual faces. Davey et al. studied the effect of solvent choice on 
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the crystal morphology of β-succinic acid whereby a plate-like morphology was produced 
from water and a needle-like morphology was produced from isopropanol. Examination of 
the crystal structure allowed functional groups to be identified at the slow growing faces. 
In crystallisation from water the slowest growing face features polar functional groups that 
would interact favourably with polar solvent molecules and thus result in slower growth 
rates of the face.2,32 Eddleston et al. recently reported the occurrence of triangular plate-
like crystals of theophylline form II from hydrophobic solvents containing hydrogen bond 
acceptor groups but no donor groups (hydrogen bonds are discussed in Section 1.5.1).33 
In contrast, crystallisation from solvents containing both hydrogen bond donor and 
acceptor groups produced lath-shaped crystals. The formation of triangular crystals was 
rationalised by considering the packing of the molecules in the crystal structure and the 
interaction of the solvent molecules with specific crystal faces.  
 
However, solvent-surface interactions must have enough stability to compete with the 
addition of solute molecules. In the case of sulfathiazole, its polymorphs show different 
morphologies, but each polymorph showed a similar morphology from all solvents 
studied.34 This suggested that morphology changes in that case are a result of different 
packing arrangements and any solvent-surface interactions did not inhibit the addition of 
sulfathiazole molecules to the fast growing faces. In contrast, the morphology of  
2,6-dihydroxybenzoic acid form I grown from toluene solution and chloroform solution is 
shown to differ significantly; rectangular plate-like crystals are produced from toluene 
whereas diamond shaped plates are produced from chloroform (Figure 1.9). Indexing of 
the crystal faces of 2,6-dihydroxybenzoic acid showed that the (310) face is prominent in 
the crystals produced from chloroform and absent in those produced in toluene. Analysis 
of the crystal packing showed that the surface of the (310) face exposes carbonyl and 
hydroxyl functionalities with which the chloroform solvent molecule can interact.35 
 
 






Similar studies were recently reported on the crystal morphologies of the α and β 
polymorphs of p-aminobenzoic acid where experimental morphologies from a range of 
solvents were compared with calculated morphologies.36 
 
1.2.4.3 Effect of impurities on crystal morphology 
The presence of impurities can also have a major effect on crystal growth. As with solvent 
molecules, impurities can compete with solute molecules by occupying adsorption sites 
on the crystal surface. This may cause defects,11 or inhibit or slow down growth on 
specific crystal faces by interacting preferentially with functional groups present on the 
surface of the face. A well-known example of this phenomenon is the case of the 
crystallisation of urea from water in the presence of biuret, a side-product in the synthesis 
of urea, with which it is structurally similar. In the absence of the impurity, urea 
crystallises in a needle-like morphology, but in the presence of biuret growth of the fast 
growing face is reduced, producing crystals with smaller aspect ratio.37,38 This disruption 
of growth is explained by the structural similarity of the biuret molecules, which facilitates 
competition for surface adsorption on the fast growing (001) face with the urea 
molecules. This inhibits hydrogen bonding of further urea molecules at such sites and 
slows down the overall growth rate of the face.38,39  
 
Another example of the impurity effect is that of benzoic acid on the growth of benzamide 
crystals from ethanol. In the absence of the impurity, plate-like crystals are produced. In 
the crystal structure of benzamide, a hydrogen bonded ribbon of benzamide molecules 
forms along the crystallographic b axis. The structural similarity of benzoic acid to 
benzamide and the presence of favourable hydrogen bond donor and acceptor groups 
allows it to occupy a site normally occupied by a benzamide molecule. This also prevents 
addition of further benzamide molecules in the chain (Figure 1.10). 
 
 
Figure 1.10 – A hydrogen bonded ribbon of benzamide molecules interrupted by a benzoic acid 
impurity preventing the addition of further benzamide molecules. Adapted from [40]. 
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This inhibits overall growth along the b axis resulting in production of needles rather than 
plate-like crystals.40,41 The presence of impurities can also influence the crystallisation in 
a range of other ways such as delaying nucleation,42-44 slowing down overall growth 
rates45 and affecting polymorphic form.46-50  
 
In some cases impurities are deliberately added to a crystallisation to engineer the growth 
of crystals with a desired morphology (by inhibiting growth of selected faces); these are 
known as additives. There is a broad array of examples in the literature of the effect of 
structurally similar additives, or size-matched additives with relevant functional groups, on 
crystal morphology24,51-54  and crystal size.43,55 However, significant quantities of these 
impurities may be required to yield the desired effect, and additives that show structural 
similarity to the target compound can be susceptible to inclusion into the crystal 
lattice.54,56,57 This is undesirable, especially if the additive compound is non-benign – in 
pharmaceuticals, for example, such additives may not be Generally Recognized As Safe 
(GRAS)58 and their incorporation into a resulting solid form would prohibit its potential use 
in any product.  
 
Control over crystal morphology can also be exerted by introducing impurities that are not 
structurally similar or size-matched to the target molecule, for example through use of 
polymer additives. Unlike the structurally similar case, polymer additives are unlikely to be 
incorporated into the final product due to their dissimilarity to the target material and their 
large size. The use of polymers in this context is also favoured by the fact that they are 
commonly used as excipients in drug formulations, and are thus a frequent component in 
pharmaceutical processing. There are a number of examples in which polymer additives 
have been shown to affect the crystallisation process: anti-solvent crystallisation of 
salbutamol sulfate in the presence of small quantities of a polyvinylpyrrolidone (PVP K25) 
was found to modify the crystal morphology from needle-like crystals to block-like crystals 
with a lower aspect ratio,59 while Vetter et al. reported the effect of Pluronic F127 on the 
crystal growth rates of Ibuprofen.45 A study into the effect of hydroxypropyl 
methylcellulose (HPMC) on the crystallisation of hydrocortisone acetate showed that, in 
the presence of the polymer, nucleation was delayed and habit modification to a wing-
shaped morphology was observed. The mechanism for inhibition of nucleation was 
described in terms of prevention of nucleation through the formation of drug-polymer 
interactions in solution. Mechanisms for the growth inhibition and resultant habit 
modification were also discussed. Growth is inhibited by adsorption of polymer molecules 
on the crystal surface through face-specific hydrogen bond interactions. In addition, 
accumulation of non-adsorbed polymer molecules at the boundary region may provide 
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resistance for the drug growth units to diffuse through the barrier and incorporate into the 
growth site.60 The influence of HPMC and other polymeric additives on the crystallisation 
of Ritonavir, Flutamide and Felodipine was also recently studied.61-65  
 
Several factors may be considered when selecting an additive for crystal growth inhibition 
such as structural similarity and the presence of functional groups which may interact 
favourably with the target compound. However, the design of such growth modifiers 
sometimes lacks such rationale and often relies on trial and error.39  
 
1.2.5 Crystallisation methods 
As noted above, in order for crystallisation from solution to occur, supersaturation must 
be generated and there are a number of techniques that can be used such as 
evaporation, cooling and the addition of an anti-solvent. Grinding (mechanochemical) and 
solution mediated (slurrying) methods can also be used to facilitate multi-component 
crystallisation. 
 
1.2.5.1 Evaporative crystallisation 
In evaporative crystallisation supersaturation is generated by removal of the solvent by 
evaporation at a fixed temperature. As the solvent evaporates the solution becomes more 
concentrated and passes through the metastable zone into the supersaturated region 
where nucleation and crystal growth occurs (Figure 1.11). Upon crystallisation, the solute 
concentration decreases, however as a result of the continual evaporation of the solvent, 
the concentration will increase back into the supersaturated region.   
 
 
Figure 1.11 - Generation of supersaturation by evaporation (arrow A) with the variation in solute 
concentration between the metastable and supersaturated regions depicted by the blue doubled 
headed arrow shown on the solubility diagram. 
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Evaporative crystallisation is often used as a screening method in materials discovery at 
small scales by altering variables such as the temperature and choice of solvent. Such 
variables affect the rate of crystallisation which can impact crystal size and shape. Often 
slow evaporation at controlled temperatures provides a good environment for single 
crystal growth. 
 
1.2.5.2 Cooling crystallisation 
In cooling crystallisation (without seeding) supersaturation is generated by cooling a 
saturated solution which reduces the solubility of the solute, driving the solution into the 
supersaturated region and resulting in nucleation and crystal growth (Figure 1.12).  
 
 
Figure 1.12 - Generation of supersaturation by cooling without seeding (arrow B) shown on a 
solubility diagram. 
 
Nucleation generates a drop in the solute concentration and if there is knowledge of the 
MSZW, the cooling profile can be controlled such that following nucleation, cooling 
continues within the MSZ where only growth is achieved. This strategy limits further 
primary nucleation leading to improved particle attributes. Cooling crystallisation is more 
commonly used in large scale pharmaceutical crystallisations. However, it requires there 
to be a significant solubility decrease with decreasing temperature in order to achieve a 
good yield.  
 
1.2.5.3 Anti-solvent crystallisation 
Another technique used to induce supersaturation is the addition of an anti-solvent. In this 
type of crystallisation, the solubility of the target compound decreases with the addition of 
a solvent in which the compound to be crystallised is insoluble / poorly soluble (the anti-
solvent). This drives the solution into the supersaturated region where crystallisation 
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occurs (Figure 1.13). Anti-solvent crystallisation is often used for substances which show 
little change in the solubility with temperature and can sometimes be used in combination 
with cooling to improve yield.66 It may also be used in order to avoid thermal degradation 
by avoiding the need for heating to elevated temperatures.  
 
 
Figure 1.13 - Generation of supersaturation via anti-solvent crystallisation (arrow C). 
 
1.2.5.4 Seeding 
Seeding is often implemented to improve the resulting particle size distribution and gain 
more control over the crystalline product such as the polymorphic form. Seeds of the 
substance are added to a solution in the metastable zone to result only in growth of the 
seed particles and suppression of spontaneous nucleation, inherently producing a narrow 
particle size distribution. The temperature at which the seeds are added is also important: 
addition of seeds in the undersaturated region will result in dissolution of the seeds 
(Figure 1.14, Point A) whereas addition of the seeds in the labile supersaturated region 
will cause secondary nucleation, with primary nucleation also occurring resulting in a 
broad particle size distribution (Figure 1.14, Point D). Addition of the seeds within the 
MSZ and close to the solubility curve (Figure 1.14, Point B) results in the situation where 
supersaturation is low and there is little secondary nucleation. This results in slow crystal 
growth and the production of larger crystals. Seeding close to the metastable limit  
(Point C, Figure 1.14) is at high supersaturation and induces secondary nucleation. Seed 






Figure 1.14 - Solubility diagram showing the importance of the seed addition temperature: in the 
undersaturated region (A), close to the solubility line (B), close to the metastable limit (C) and in 
the supersaturated region (D). Seed addition at position B would result in the narrowest particle 
size distribution. 
 
1.2.5.5 Ostwald ripening 
Ostwald ripening describes the growth of large particles at the expense of smaller 
particles. Large particles have a lower solubility than smaller particles which results in 
dissolution of the small crystals and their mass depositing on the larger particles. This 
increases the particle size of the larger crystals, decreasing the surface area : volume 
ratio thus minimising the Gibbs free energy.2,4 As the driving force for Ostwald ripening is 
the difference in solubility between the small and the large particles, the process can be 
accelerated by applying temperature fluctuations known as temperature cycling. This is 
sometimes utilised in crystallisation in order to obtain a more monodisperse particle size 
distribution.7 
 
1.2.5.6 Other methods for the preparation of multi-component crystalline 
complexes 
Synthesis of multi-component solid forms (discussed in Section 1.4) can sometimes be 
facilitated using mechanochemical methods.67,68 Dry or liquid-assisted grinding (LAG) 
methods are carried out manually using a mortar and pestle or using a mechanical ball 
mill. This avoids the need to identify a suitable solvent system and is often the first step 
carried out for co-crystal screening. The product of a mechanochemical experiment will 
usually be in polycrystalline form, and characterised using powder X-ray diffraction 
(PXRD). If PXRD indicates the production of new crystalline materials of interest, steps 
can be taken to grow single crystals of the system for full structural characterisation, 
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usually involving solution-based methods. Methods such as extrusion have been shown 
to be effective in the scale-up of mechanochemical synthesis of co-crystals.69,70 
 
Another method shown to be effective in producing multi-component materials is carried 
out by suspending the starting materials in a chosen solvent and stirring the slurry for a 
specific period of time.71-73 Upon suspension of starting materials in a solvent, they will 
each dissolve until reaching their individual solubility in the solvent system. Favourable 
interactions between the two components may result in the formation of a complex; 
nucleation and crystal growth of the complex will occur, depleting the solution 
concentration of the two individual components. Further dissolution of the starting 
materials will then occur due to the solution being undersaturated with respect to each 
component. Using the solution as a medium and when provided sufficient time and 
mobility, the remainder of the starting materials will convert to the complex.73  
 
 
1.3 Industrial Crystallisation 
Crystallisation is an essential unit operation in the manufacture of materials produced in 
solid form which makes up a large part of the pharmaceutical and fine chemicals industry. 
The equipment used in industrial crystallisation is vast in scope, from multi-purpose batch 
vessels to highly specialised and process-specific equipment.74 
 
1.3.1 Batch crystallisation 
The main platform currently employed for both production and purification of solids in the 
pharmaceutical, agrichemical and fine chemicals industries is the stirred tank reactor 
(STR). A STR is a jacketed batch vessel in which mixing is facilitated with a motor-
induced impeller. Although STRs are a well-established technology and offer the benefit 
of flexibility to different processes, there can be significant challenges in achieving 
homogenous processing conditions at large scales. In a STR, as scale increases, 
uniformity of mass and heat transfer in the vessel decreases, resulting in longer reaction 
times. Optimisation of mixing inside the vessel upon scale-up is therefore critical.66 
Varying conditions inside the vessel can sometimes result in inconsistent product 
attributes such as size distribution, polymorphic form and morphology which can have a 
direct impact on downstream processes such as filtration, drying and formulation as well 
as on the desired function of the material.5,75 STRs also occupy significant volumes of 
space and cleaning of the vessel between batches is a requirement, increasing reactor 




1.3.2 Continuous crystallisation 
There is significant interest in the application of continuous methods of crystallisation in 
the pharmaceutical and fine chemical industries in which feed solution is continually 
added to a crystalliser whilst continually removing product, minimising reactor downtime. 
Continuous crystallisation is of interest since it may overcome the difficulties that batch 
production brings. Improved heat and mass transfer can be accessed through use of 
continuous methods of crystallisation which may enable better control over particle 
attributes.11,76 Gaining control of these specific attributes will enable elimination of 
downstream corrective processes such as milling and granulation used to achieve 
uniform particle size in preparation for formulation.75 Continuous processes are also 
readily scaled-up simply through increasing the throughput and running the system for a 
longer period of time.77 Furthermore, a continuous mode of operation offers minimised 
reactor downtime and reduced environmental footprint through more efficient use of 
solvents, energy and space.5 Table 1.1 outlines the key differences between batch and 
continuous methods of operation.  
 
Table 1.1 - Table outlining the differences between batch and continuous methods. 
Batch Continuous 
Multi-purpose equipment that can be used 
for different processes 
Equipment is system dependent 
Significant process knowledge New technology – less process experience 
Non-uniform mixing 
Uniform mixing – improved heat and mass 
transfer 
Non-linear scale-up Linear scale-up 
Extended processing times 
Lower reaction time due to better 
temperature control 
Large footprint – high costs and large 
volumes of solvent used 
Reduced footprint – lower costs and lower 
volumes of solvent used 
 
There are various platforms designed to facilitate continuous crystallisation. A STR can 
be adapted to a single-stage mixed-suspension, mixed-product removal (MSMPR) 
crystalliser in which a feed solution or suspension is continuously fed into the vessel at 
the same rate at which the product suspension is withdrawn. The suspension of solids 
inside the vessel is well-mixed such that the composition is the same throughout. 
Therefore, product suspension has the same attributes as the suspension inside the 
volume of the crystalliser at the time of withdrawal, which can be described as 
unclassified withdrawal.9 MSMPR crystallisers can also be operated periodically which 
involves periodic solution addition and withdrawal of product slurry rather than continuous 
withdrawal.78,79 This allows for an equilibrium period in which no addition or withdrawal of 
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solution or slurry occurs and the suspension remains in the agitated vessel for a specific 
residence time. Additional vessels can also be included in the set-up and assembled in 
series (multi-stage MSMPR) in order to increase residence time (total time spent within 
the crystalliser) within the system. However, use of additional vessels increases inventory 
and running costs.5 
 
Continuous crystallisation can also be achieved using tubular flow platforms. One 
example is the continuous oscillatory baffled crystalliser (COBC) developed by NiTech 
Solutions.80 The COBC (Figure 1.15) is a jacketed tubular crystalliser containing equally 
spaced baffled cells in which oscillatory motion is superimposed on the net flow.5  
 
 
Figure 1.15 - Schematic of the COBC platform in the Wilson group laboratory at the University of 
Bath. 
 
A saturated solution is pumped into the system and supersaturation is generated by 
cooling through a temperature gradient along the length of the crystalliser. The tubing 
jackets allow for improved heat transfer and temperature control within the system 
compared to the MSMPR platform. Mixing is facilitated through the generation of eddies 
which result from the interaction of the flow with the baffles inside the crystalliser tubing. 
This results in uniform mixing within each cell and under optimised conditions, operation 
at plug flow at flows that would normally result in laminar flow in the absence of 
restrictions.5 In plug flow, the velocity of all the components in the tube is equal to the 
incoming flow ensuring uniform mixing in the radial direction and equal residence time for 
all components81 (Figure 1.16). Operation close to plug flow offers the benefit of uniform 
mixing and a highly reliable environment for the formation of crystals with consistent 
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properties. There is also potential for real-time monitoring of the crystallisation in the 
COBC, via ports that allow for in-line measurements using process analytical 
technologies (PAT). The COBC is described in more detail in Chapter 5. 
 
 
Figure 1.16 - Diagram showing the difference between laminar and plug flow; blue arrows indicate 
net movement of components within a tubular flow crystalliser. 
 
Other smaller scale tubular platforms are also being explored such as micro and 
mesoscale reactors. Microfluidic reactors offer the benefit of excellent heat and mass 
transfer due to their small internal diameters. However, one of the drawbacks of operating 
at this scale is the risk of sedimentation and blockages of the micrometre-sized 
channels.82 Mesoscale flow reactors operate at slightly larger internal diameters; some of 
which exploit segmented flow which creates individual segments of solution separated by 
air or a carrier fluid. This allows for each segment to act like a micro-batch reactor for 
crystallisation to occur under good mixing conditions through the generation of an internal 
fluid vortex within each segment. One example of a mesoscale platform is the KRAIC 
(Kinetically Regulated Automated Input Crystalliser) developed at the University of Bath 
which uses segmented flow to facilitate near plug flow conditions. A more detailed 
description of the KRAIC platform is presented in Chapter 5. 
 
Despite the benefits of a continuous mode of operation, uptake in the pharmaceutical 
industry has been slow.75 There are several challenges related to this inertia to change. 
Batch methods of operation have been used for many years and there is less process 
understanding regarding the use of continuous crystallisation methods; development of a 
process would therefore take more time and it would be perceived as higher risk. 
Furthermore, there is significant batch capability worldwide as well as a need to get new 
products to market as quickly as possible, while in some well-established processes there 
would be limited benefit from transfer to continuous modes of operation. However, as 
pharmaceutical companies are seeing low approval rates for new molecular entities,83 
there is increased focus on maximising revenue from existing portfolios of APIs, by 
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reducing manufacturing inefficiencies whilst maintaining high product quality.84 
Additionally, continuous manufacturing processes are well suited to facilitating the 
concept of personalised medicines.  
 
The pharmaceutical industry is strictly regulated and evidence is required for traceability 
of materials in continuous processes whereby in a batch operation, the existence of a 
batch simplifies quality control.11 However, the use of process analytical technologies 
(PAT) and employing the methodologies of Quality by Design, where quality is monitored 
on a continuous basis rather than on a post-production batch basis, are also key drivers 
in overcoming some of these barriers and decreasing the possibility of batch recalls.85 
 
The balance between nucleation and growth is critical in the design of a crystallisation 
process and has significant implications for e.g. the residence time of the crystallising 
system within a continuous crystallisation reactor. It is important to note that the 
crystallisation platform is selected based on the process required. This may depend on 
factors such as the nature of the substance and the quantity required as well as its 
crystallisation kinetics. In some cases, continuous modes of operation are not always 
suitable and crystallisation processes may be better suited to a batch mode of operation.  
 
The aim of research in the Centre for Innovative Manufacturing in Continuous 
Manufacturing and Crystallisation (CMAC) is to explore to what extent continuous 
technologies in crystallisation can give precise control over production of a specific solid 
form and to do so consistently and at the required scale for a manufacturing process.  
 
 
1.4 Crystal engineering 
The design of organic solids is known as crystal engineering, and represents a relatively 
new area in chemistry. Desiraju defines crystal engineering as “the understanding of 
intermolecular interactions in the context of crystal packing and in the utilisation of such 
understanding in the design of new solids with desired physical and chemical 
properties”.86 Crystal engineering relies on knowledge of the intermolecular interactions 
holding crystalline solids together (see Section 1.5, below). 
 
Unlike synthetic chemistry involving making and breaking covalent bonds, when studying 
crystal engineering, the nature of non-covalent interactions holding molecules together in 
the solid state are considered. Hydrogen bonding is frequently exploited in crystal 
engineering due to its strong, directional and, to some extent, predictable nature. 
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Hydrogen bonds also have the ability to act cooperatively, forming multiple bonds 
simultaneously.87 However, in crystal engineering, there are challenges in predicting 
where hydrogen bonds will form when a system contains multiple hydrogen bond donor 
and acceptor sites.88 Repetitive molecular recognition patterns adopted by certain 
functional groups, or supramolecular synthons,89 can be identified and those robust 
enough to make predictions about the self-assembly of molecules in the solid state are 
desirable.90 A method of describing such motifs named graph set notation was devised by 
Etter and co-workers88 (Figure 1.17) where G is a letter describing the type of hydrogen 
bonding pattern such as chains (C), non-cyclic dimers (D), rings (R) or intramolecular 
bonds (S). For example, a particularly abundant motif adopted in crystal structures is the 
hydrogen bonded carboxylic acid dimer (Figure 1.17). The cooperative nature of the 
hydrogen bonds and the stability of the interaction being insensitive to the nature of the 
rest of the molecule makes this motif (with graph set notation )8(
2
2R ) highly favourable in 
crystal structures of molecules containing this moiety.86  
 
 
Figure 1.17 - Diagram describing graph set notation and two examples of its application, (left) a 
carboxylic acid dimer and (right) an intramolecular hydrogen bond. 
 
By studying the complementarities between functional groups in a competitive 
environment, crystal engineering aims to encourage, by choice of an appropriate  
co-former molecule, the self-assembly of the desired solid form with specific interactions 








1.5 Intermolecular interactions 
Crystalline materials are held together by non-covalent interactions of varying strengths. 
A detailed understanding of hydrogen bonding and other intermolecular interactions is 
required in order to apply crystal engineering principles to the design of new solid 
forms.10,90 
 
1.5.1 Hydrogen bonding 
Hydrogen bonding is the dominant intermolecular interaction in many molecular systems 
and has been studied for over 100 years.91 In his book, The nature of the chemical bond, 
Pauling stated that “under certain conditions an atom of hydrogen is attracted by rather 
strong forces to two atoms, instead of only one, so that it may be considered to be acting 
as a bond between them”.92 He later deduced that the interaction had to be electrostatic 
in nature since “the hydrogen atom, with only one stable orbital, cannot form more than 
one pure covalent bond”. Pauling made the assumption that only if X and A are very 
electronegative, in an X-H...A interaction, would the partial positive charge on hydrogen, 
and the electrostatic attraction between H and A, be high enough to term the interaction a 
hydrogen bond. This suggested that hydrogen bonds are formed only between the most 
electronegative atoms such as N, O and F.93 
 
In contrast, Pimentel and McClellan (1960) stated that “a hydrogen bond exists between 
the functional group, X-H, and an atom or a group of atoms, A, in the same or different 
molecules when (a) there is evidence of bond formation, (b) there is evidence that this 
new bond linking X-H and A specifically involves a hydrogen atom already bonded to X”94 
This definition makes no assumption about the nature of A and X and allows 
consideration of the hydrogen bonding potential of other groups. For example, C-H, 
where X (equal to C in this case) is less electronegative than N, O and F but still remains 
more electronegative than hydrogen.93 
 
More recently, IUPAC defined a hydrogen bond as “an attractive interaction between a 
hydrogen atom from a molecule or a molecular fragment X–H in which X is more 
electronegative than H, and an atom or a group of atoms in the same or a different 
molecule, in which there is evidence of bond formation”.95 Other than electronegativity, 
this definition puts no restriction on X or A since there is evidence for many different types 
of acceptor and donor groups.  
 
Hydrogen bonds can vary in strength and can be classified in terms of the bond distance 
between donor and acceptor atoms as outlined by Jeffrey87 (Table 1.2). 
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Table 1.2 - Properties of strong, moderate and weak hydrogen bonds. 
 Strong Moderate Weak 
A-H…B interaction Mostly covalent Mostly electrostatic Electrostatic 
Bond lengths A-H ≈ H…B A-H < H…B A-H << H…B 
H…B (Å) ~1.2 - 2.5 ~1.5 - 2.2 2.2 - 3.2 
A…B (Å) 2.2 - 2.5 2.5 - 3.2 3.2 - 4.0 
Bond angles (°) 175 - 180 130 – 180 90 - 150 
Bond energy (kcal mol-1) 14 - 40 4 – 15 <4 
 
As well as forming interactions between molecules, intramolecular hydrogen bonds can 
also form between donor and acceptor groups of the same molecule depending on their 
geometry in relation to one another.93 This can alter the conformation of the molecule and 
thus affect its molecular packing. While hydrogen bonds commonly feature a single donor 
atom and acceptor atom, termed two-centre interactions, it is also possible for hydrogen 
bonds to arrange themselves in bifurcated or three-centred hydrogen bonds. These 
interactions involve one donor atom and two acceptor atoms or two donor atoms and one 
acceptor atom (Figure 1.18).87,93 
 
 
Figure 1.18 - (a) a two-centre hydrogen bond, (b) a bifurcated hydrogen bond with one donor atom 
and two acceptor atoms and (c) a bifurcated hydrogen bond with two donor atoms and one 
acceptor atom, where D is donor and A is acceptor. 
 
1.5.2 - interactions 
Structures that contain two or more aromatic rings that lie adjacent to one another often 
form interactions known as - interactions or -stacking.96 These interactions occur 
when attractive interactions between -electrons and the σ-framework are more 
favourable than repulsions between -electrons. One example of their existence is in the 
stacking of hydrogen bonded base pairs in DNA.97 Neighbouring aromatic rings can 
arrange themselves in different geometries (Figure 1.19), each of which can lead to 
significant -stacking interactions. The geometry of the interactions can be influenced by 
the substituents on the aromatic ring which alter the polarisation of the electron cloud. For 
example, the presence of an electron donating substituent on one of the rings will 




Figure 1.19 - (a) face-to-face -stacking, (b) offset -stacking, (c) edge -on or T-shaped -stacking. 
 
1.5.3 Weak interactions 
IUPAC defines van der Waals interactions as “the attractive or repulsive forces between 
molecular entities (or between groups within the same molecular entity) other than those 
due to bond formation or to the electrostatic interaction of ions with one another or with 
neutral molecules”.99 Van der Waals forces are relatively weak interactions in comparison 
to hydrogen bonds. The term broadly describes several types of weak interaction differing 
in the polarisability of the interacting entities. These include Keesom interactions, dipole-
induced-dipole interactions and dispersion interactions. 
 
Keesom or dipole-dipole interactions represent the interaction between two polar 
molecules and are reliant upon the orientation and distance of the two molecular entities. 
A polar molecule can also induce a dipole in a neighbouring non-polar molecule in a 
dipole-induced-dipole interaction. The presence of a nearby molecule with a permanent 
dipole induces polarity of the electron cloud of the non-polar molecule.97 In dispersion or 
London interactions, neighbouring non-polar molecules may attract one another as a 
result of small transient dipoles induced in each other.100 Although neither of the 
molecules possess a permanent dipole moment, variations in the instantaneous positions 
of their electrons results in attractive interactions between the two dipoles and a lowering 
of the potential energy of the pair.97 
 
Knowledge of these intermolecular interactions allows approaches such as crystal 
engineering to be used as a means of potentially predicting the ways in which molecules 
will link together in forming crystalline solids.  The principles of crystal engineering, and 
the harnessing of intermolecular interactions such as the hydrogen bond, are used 








1.6 Types of crystalline solids 
Crystalline solids can exist in several different forms as outlined in Figure 1.20.  
 
 




It is common for crystalline solids to exhibit polymorphism, in which the same component 
can adopt different packing arrangements forming different crystalline forms. McCrone 
defines a polymorph as “a solid crystalline phase of a given compound resulting from the 
possibility of at least two different arrangements of the molecules of that compound in the 
solid state”.101,102 As a result of the variation in the structural arrangement of molecules 
owing to the different intermolecular interactions present, polymorphs may possess 
different physical properties such as melting point, solubility and hardness.96  
 
A well-known example of polymorphism in a pharmaceutical material is that of 
paracetamol which exists in at least three polymorphic forms, of which two are the most 
common (Figure 1.21).  
 
 
Figure 1.21 - Crystal packing in two polymorphs of paracetamol: (a) herringbone form I viewed 
down the crystallographic a axis, (b) layered form II viewed down the crystallographic b axis. 
 
 
(a)                                                                 (b) 
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In form I the molecules pack in a herringbone arrangement whereas in form II the 
molecules pack in slipped layers; paracetamol is therefore an example of packing 
polymorphism. The ability of the molecules in the metastable form II to pack in layers 
allows this form to be more easily compressed into tablets than form I,103 while also being 
more soluble.46 
 
In the pharmaceutical industry, understanding polymorphism is essential when 
developing a new compound and high throughput polymorph screening is usually carried 
out utilising a range of crystallisation methods. Identification of the most stable form is 
important in order to avoid unexpected phase transitions during production or storage. 
One of the most well-known examples of the unexpected emergence of a new form is the 
case of the anti-retroviral compound, Ritonavir demonstrating the importance of solid form 
selection. Only one crystal form was initially identified and semi-solid capsules of the drug 
were produced and sold as Norvir, an effective treatment for HIV sufferers. However, two 
years later a new polymorph, form II, emerged following dissolution testing. As a result of 
its increased thermodynamic stability, form II had greatly reduced solubility compared to 
form I, with its enhanced stability causing difficulties in reproducing the more soluble 
metastable form I polymorph in production processes. Consequently, the drug was 
withdrawn from the market and it was necessary to reformulate Norvir. These factors 
resulted in huge losses of profit as well as threatening the supply of the treatment to the 
patients.104 This case is an example of conformational polymorphism in which compounds 
with conformationally flexible groups crystallise as distinct polymorphs. Conformational 
polymorphism can also be observed in the fenamic acid family of non-steroidal anti-
inflammatory drugs.105-107 
 
1.6.1.1 Thermodynamics of polymorphism 
The relative stability of a substance is governed by its free energy whereby the more 
stable substance has a lower free energy. In the case of polymorphism, the polymorph 
with the lowest free energy under defined conditions is the most thermodynamically 
stable form and other forms are known as metastable forms.108,109 Ostwald’s Law of 
Stages states that the least stable polymorph will nucleate first. Although kinetic factors 
may delay or prevent the transformation, less stable forms will be thermodynamically 
driven to transform into the most stable form.108 In some cases, solution-mediated phase 
transitions mean that the unstable phase may have converted to a more stable form prior 
to sampling and characterisation.3 Such transformation can sometimes be observed 




The thermodynamic behaviour of polymorphs can be described as enantiotropic or 
monotropic and these can be explained using energy-temperature diagrams as shown in 
Figure 1.22.14  
 
 
Figure 1.22 - Energy-temperature plots for enantiotropic and monotropic systems, where G is the 
free energy, T is the temperature, A, B and Liq refer to polymorphs A, B and the liquid phase and 
Tm and Tt refer to melting and transition point, respectively. 
 
Polymorphs are described as enantiotropic if the isobars of the two forms cross before 
crossing the isobar of the liquid phase. This results in a transition point where the 
polymorphs can undergo a reversible solid-state transition. At this transition point the free 
energies of the polymorphs are equal. Beyond the temperature of the transition point the 
isobar of the more stable polymorph B crosses the free energy isobar of the liquid and 
melting is observed. In the case of a monotropic relationship between polymorphs, 
polymorph A is more stable below the melting point of both polymorphs and so in this 
case the liquid isobar crosses the isobars of the solid forms before they cross each other. 
This means that the forms melt before they interconvert. It is important to identify whether 
a system displays enantiotropic or monotropic behaviour since it will affect processing 
decisions. If a polymorph is known to convert to a more stable form at low temperatures, 
this may affect the design of the crystallisation.14,109  
 
Enantiotropism and monotropism can also be related to the solubility of polymorphs; the 
solubility curves of the two solid forms cross in an enantiotropic system while they do not 
in a monotropic system (Figure 1.23). The temperature at which the solubility curves 
cross represents the temperature at which the phase transition occurs. In the monotropic 
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case the solubility curves do not cross and polymorph A is metastable with respect to 




Figure 1.23 - Solubility curves of two polymorphs of a substance with respect to temperature in an 
enantiotropic system (curves cross) and a monotropic system (curves do not cross). 
 
1.6.2 Co-crystallisation 
Crystallisation is not restricted to single-component systems and a range of  
multi-component solid-state systems can be prepared. A co-crystal can be described as a 
multiple-component system in which two distinct molecular components combine, usually 
via hydrogen bonded interactions, in their neutral forms.110 In these systems, the driving 
force for co-crystallisation is the formation of stronger hydrogen bonds between the two 
different components than hydrogen bonds in the individual single component systems.110 
As the molecular arrangement within the solid state plays a decisive role in the physical 
properties of a crystalline material, the presence of a second component in the crystal 
structure may lead to changes in the physical properties of the material.  
 
Co-crystals have become of interest in the pharmaceutical industry in recent years. 
Pharmaceutical materials are commonly manufactured in their crystalline form for stability 
and ease of characterisation. However, due to their ordered nature, crystalline forms are 
often less soluble than amorphous forms. Typically, drug molecules contain multiple 
hydrogen bond donor and acceptor groups so have high affinity for co-crystallisation with 
suitable co-former molecules with similar groups. Co-crystallisation of pharmaceutical 
materials is particularly desirable if it results in improved physical properties, such as 
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solubility and compressibility, when compared to the parent drug.110,111 Such improved 
properties come without compromising the structural integrity of the active pharmaceutical 
ingredient and may lead to improved bioavailability.112 However, preparation of systems 
in a multi-component environment can lead to challenges in isolating the desired solid 
form; as such crystallisation can sometimes yield a mixed-phase product.  
 
1.6.3 Salts 
As well as incorporation of a guest molecule or co-former in this way, the formation of 
multi-component systems in the form of a salt may also be possible if the target material 
contains acidic or basic groups. A salt forms when a proton is transferred from one 
molecule to another. The likelihood of proton transfer occurring can be determined using 
the difference in the pKa values of the acid and base components of the molecules as a 
guide. Proton transfer is likely to occur if ∆pKa is greater than or equal to three where 
∆pKa = pKa (base) – pKa (acid). If the ∆pKa is less than or equal to zero, a co-crystal may 
be expected to form. Within the intermediate region between zero and three, known as 
the salt-co-crystal continuum, it is difficult to predict whether a salt or neutral complex will 
form.113,114   
 
In the pharmaceutical industry salt formation is often investigated if a compound does not 
crystallise or displays poor physical properties such as solubility. Many pharmaceutical 
ingredients are thus manufactured as salts as a result of access to improved 
physicochemical properties without affecting the chemical effect of the drug.114 For 
example, ibuprofen lysine (marketed as, for example, Advil® and Nurofen®) is used for 
the treatment of the same conditions as ibuprofen. However, the lysine salt increases the 
water solubility of ibuprofen allowing for more rapid absorption by the body and 
subsequent onset of action and as a result is commonly used to treat migraines.  
 
1.6.4 Solvates and hydrates 
It is common for crystalline materials to incorporate solvent into their crystal lattice to form 
solvates, or hydrates in the case of incorporation of water. Identifying the ability of a 
potential active ingredient to form such so-called pseudopolymorphs is of practical 
importance in the process of manufacturing new substances. Hydrates may offer different 
properties to their anhydrous counterparts and although solvate formation is usually 
considered undesirable, especially in pharmaceutical materials, desolvation can 





1.6.5 Crystalline defects  
An important structural attribute in crystalline materials is the presence of defects in a 
crystal. In an ideal crystal structure (see Chapter 2), every asymmetric unit is equivalent 
and all of the unit cells are identical, but in a real system this is never the case and 
defects can be present. One type of crystal defect known as structural disorder occurs 
when a whole molecule, or parts of a molecule, in the structure adopt different 
orientations in different unit cells of the crystal. As the crystal structure shows the average 
asymmetric unit, the disorder is modelled as partially occupied sites representing two or 
more orientations of the molecule or part of the molecule.96,117 Put simply, IUPAC defines 
structural disorder as “any deviation from the ideal three-dimensional regularity of the 
crystal structure”.99 Disorder is most commonly observed in molecules that have 
symmetry, enabling them to take on multiple orientations or, as in polymorphism, in 
molecules with conformationally flexible groups of atoms. In the latter case, the molecule 
in the crystal structure lies partially in either conformation, for example in the crystal 
structure of salicylsalicylic acid.96,118 In this example, the hydroxyl group of the molecule 
occupies one ortho position in 72% of the molecules and the other ortho position in 28% 




Figure 1.24 - The two ortho positions of the hydroxyl group in the disordered structure of 
salicylsalicylic acid with their relative occupancy of disorder. 
 
Disorder can be divided into two categories known as static or dynamic disorder. Static 
disorder occurs when a molecule or part of a molecule occurs in one orientation or 
position in some unit cells and in another in other unit cells (as observed in the case of 
salicylsalicylic acid shown above). The amount of occupancy for each position is usually 
determined based on the distribution of electron density. Dynamic disorder occurs when 
the molecule or part of the molecule is constantly undergoing flux. This typically occurs in 
solvent molecules or alkyl chains.96 Static and dynamic disorder can be distinguished by 
comparing the X-ray thermal parameters for collections carried out at different 
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temperatures as large amplitudes of vibration observed in dynamic disorder can be 
reduced by cooling the sample to lower temperatures.117,118   
 
In some cases, the line between polymorphism and structural variation due to disorder is 
blurred. There are several examples in the literature that show disorder mistaken for 
polymorphism. In the case of eniluracil,120 differences in PXRD patterns of different 
crystalline samples were first interpreted as polymorphism. Two different PXRD studies 
produced crystal structures with different relative positions of bonds in the molecule. It 
was found that the solid forms were more accurately described in terms of different 
degrees of disorder rather than polymorphism after single crystal X-ray diffraction 
(scXRD) data were collected using different single crystals prepared using different 
crystallisation conditions.  
 
Disorder may have similar implications to polymorphism in product development. 
Disordered compounds with varying degrees of disordered components may display 
different physiochemical properties; resulting in batch to batch variations in many particle 
attributes of the bulk sample.118 Poor understanding of this phenomenon may have 
accounted for problems in developing a robust production process for eniluracil.120 
Therefore, identifying disorder may be fundamental for relating the structures to their bulk 
properties as well as the manufacturing properties and processability.121,122 However, 
there is limited literature on the link between crystalline disorder and the physical 





1.7 Research scope 
The underlying theme of the research presented in this thesis is the investigation of 
methods to alter physicochemical and bulk particle properties of organic solid forms 
through introducing a second component into the crystallisation (Figure 1.25). Alongside 
the material property modification, the work aims to investigate the production of such 
systems in both batch and continuous crystallisation environments in the context of the 
EPSRC Doctoral Training Centre for Innovative Manufacturing in Continuous 
Manufacturing and Crystallisation (CMAC). 
 
 
Figure 1.25 - Two types of multi-component environment in crystallisation explored in this work in 
seeking to improve properties of organic solid forms.  
 
The way in which molecules are arranged in the solid-state can affect the 
physicochemical properties of the substance as well as the overall shape (morphology) 
adopted by the crystals of the solid material, which will affect its bulk particle properties. 
Both can be affected by the presence of a second component in the crystallisation. A 
second component (additive) may affect growth of the single-component structure of the 
target material by forming interactions with certain faces of the growing crystal. This slows 
down the growth rate of the specific faces and consequently results in an altered overall 
morphology of the crystal, which may in turn affect the bulk particle properties such as 
flowability and bulk density. Alternatively, often if present in larger quantities, a second 
component (co-former) may interact favourably with the target material at the molecular 
level, for example through intermolecular hydrogen bonding interactions, and become 
incorporated into the structure. This results in nucleation and growth of a multi-
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component complex which may have different physiochemical properties to the single 
component structure.  
 
 
1.8 Thesis outline 
The research described in this thesis can be grouped into three main strands:  
(i) Investigation of the use of additives in crystallisation to alter crystal 
morphology and the implementation of such systems for production in the 
continuous environment (Chapters 4-6). Two systems were studied in this 
work. Succinic acid was selected as a model system with a plate-like 
morphology suggested as an interesting system by industrial partners. 
Secondly, isoniazid was selected as a pharmaceutically relevant substance 
which showed a poor morphology in terms of particle properties. 
 
(ii) Molecular-level investigations towards altering the physicochemical properties 
of a substance through the production of multi-component complexes 
(Chapter 7). The work, using the principles of crystal engineering targeted the 
production of disordered or layered solid forms as these attributes may 
introduce desired properties such as improved compressibility or enhanced 
solubility. Piroxicam was studied as prior work had shown the potential for this 
API to form solid forms displaying such structural attributes.  
 
(iii) In order to understand further the phenomenon of molecular disorder, a single-
component model system known to display disorder was studied. The level of 
orientational disorder in 5-chlorouracil was investigated with respect to the 
crystallisation conditions (Chapter 8). This understanding aimed to aid further 
studies into controlling disorder as a potentially important parameter in 














Theory of analytical methods 
 
The work presented in this thesis has been carried out using a range of analytical 
methods, for characterisation of solid products of crystallisation experiments.  Techniques 
used include a range of microscopies, crystallography, thermal analysis and 
spectroscopy. For the more detailed crystallisation studies carried out, in situ Process 
Analytical Technologies (PAT) were also used, which include a range of spectroscopies 
and light scattering methods. This chapter provides the theory behind the key analytical 
methods used.  
 
2.1 Microscopy 
2.1.1 Optical Microscopy 
Optical microscopy is a useful tool in support of other analytical techniques in solid-state 
chemistry; in the present work it has been used to examine the crystalline products of 
experiments. An optical microscope fitted with polarising lenses can be used to determine 
the crystallinity of a sample, observe the crystal morphology and assess the suitability of 
crystalline samples for X-ray diffraction. When viewed under polarising light, single 
crystals extinguish, becoming darker when rotated. Optical microscopy is also useful for 
observing the morphology, colour and size of crystals. In materials discovery, the crystal 
morphology can provide visual indication as to whether a crystal is a known solid form, if 
it has a distinct shape and size. Likewise a change in colour can indicate the formation of 
a previously unknown complex.  
 
2.1.2 Scanning Electron Microscopy (SEM) 
A scanning electron microscope is an instrument that can be used to obtain a more 
detailed image of a substance than optical microscopy, employing an electron beam 
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rather than light to illuminate the sample. In SEM, the sample is exposed to a focused 
beam of electrons resulting in ejection of electrons or X-rays from the sample which are 
detected and converted to a signal to produce an image. In this work, the images were 
produced from detection of secondary electrons, weakly bound electrons of atoms on the 
surface of the sample ejected upon impact of the SEM electron beam. As secondary 
electrons are ejected from the surface of the sample, their detection allows visualisation 
of the crystal morphology and surface structure. Samples for SEM must not contain any 
water since the instrument operates under vacuum. Furthermore, non-metallic samples 
must be pre-coated with a thin layer of a conductive substance such as gold or chrome 
using a sputter coater. This is to prevent the sample accumulating charge when scanned 




2.2.1 The crystalline state 
A crystalline solid consists of a periodic arrangement of matter repeated in all directions 
giving rise to a highly ordered structure exhibiting long range order.2,96,117 IUPAC defines 
crystallinity as “the presence of three-dimensional order on the level of atomic 
dimensions”.99 
 
If each structural unit in the regular array is represented by just a single point, a pattern of 
points all with the same surrounding environment can be generated. These points are 
named lattice points and the regular array of equivalent points is termed the lattice.117 
Linking up neighbouring lattice points in three-dimensions makes a volume which when 
repeated by translation, will produce the full three-dimensional crystal; this is termed the 
unit cell (Figure 2.1).  
 




There are multiple different choices possible for linking lattice points which gives rise to 
several possible shapes for the unit cell; however the unit cell with the highest internal 
symmetry is generally selected.96 The unit cell represents the smallest repeating unit of 
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the three-dimensional crystal lattice and is described by unit cell parameters. These 
consist of three axes a, b, c and three angles α, β, γ. The lengths of the axes for organic 
compounds are generally of the order of 3 to 40 Å.125 
 
In three-dimensional crystal structures, there are four different lattice types. The type of 
lattice depends on the position of the lattice points in the unit cell (Figure 2.2). The 
primitive (P) lattice type is the simplest with only one lattice point; therefore the only 
translational symmetry is that of the unit cell. The other lattice types, body centred (I), 
face centred (F) and centred (C), have additional lattice points contained within the unit 
cell volume, and thus show additional translational symmetry within the unit cell as well as 
the translational symmetry of the unit cell.126  
 
 




Assessing the possible symmetries for a lattice gives rise to seven possibilities for the 
shape of a unit cell; these are known as the seven crystal systems (Table 2.1).  
 
Table 2.1 - The unit cell restrictions for each of the seven crystal systems and the distribution of 
the lattice types. 
Crystal system Unit cell parameters Bravais lattice 
Cubic a=b=c   α=β=γ=90° P, I, F 
Hexagonal a=b≠c   α=β=90° γ=120° P 
Trigonal a=b≠c   α=β=90° γ=120° P 
Tetragonal a=b≠c   α=β=γ=90° P, I 
Orthorhombic a≠b≠c   α=β=γ=90° P, C, I, F 
Monoclinic a≠b≠c   α= γ=90° β≠90° P, C 
Triclinic a≠b≠c   α≠β≠γ≠90° P 
 
The combination of the lattice type and the seven crystal systems forms the 14 Bravais 
lattices to one of which all crystal structures belong. It is worth noting that not all of the 
combinations give rise to a different Bravais lattice. This is as a result of there being an 
alternative description that would effectively describe the lattice as one that is already 




2.2.2 Molecular symmetry 
The unit cell can be reduced further to asymmetric units that are related by symmetry 
operations within the unit cell.96 An asymmetric unit can be made up of several 
molecules, one molecule or part of a molecule depending on the symmetry present. 
There are multiple types of internal symmetry within the unit cell that are broadly 
described by two groups: non-translational and translational symmetry elements. Non-
translational symmetry elements describe a form of rotation of the object. There are four 
types: the inversion centre, reflection, rotation and rotation-inversion. As the name 
suggests, translational symmetry elements are identified by a translation. There are two 
types: screw axis and glide plane, each combining two symmetry elements. A screw axis 
combines a translation followed by a rotation, while a glide plane describes a translation 
followed by a reflection. The combination of the symmetry elements with the Bravais 
lattice is expressed as the space group of the crystal. Considering the full range of 
lattices and internal symmetry elements yields a total of 230 possible space groups.  
 
2.2.3 X-ray diffraction 
As a result of their long range order, crystalline materials have the ability to diffract X-rays 
to produce regular patterns, which provides a wealth of structural information. Interatomic 
bond distances lie in the region of 0.8 - 3.0 Å which is comparable to the wavelength of  
X-rays enabling the contents of a crystal to be probed at the atomic level. In the 
laboratory, Cu or Mo are typically used as X-ray tube target anode materials, providing 
characteristic X-rays of wavelengths 1.5418 and 0.71073 Å, respectively, for use in 
diffraction experiments.96,117,126 
 
In a diffraction experiment, a crystal is irradiated with X-rays and the interaction between 
the electrons in each atom and the incident X-ray beam causes the X-rays to diffract in all 
directions. The regularity of the crystalline structure gives rise to a diffraction pattern 
made up of distinct diffraction spots which is collected on an image plate or charge 
coupled device (CCD) detector. 
 
2.2.4 Bragg’s Law 
W. L. Bragg studied the conditions at which diffraction is observed and considered 
diffraction as a reflection from sets of planes within the crystal. Diffraction occurs when an 
X-ray interacts with lattice planes known as Miller planes with a characteristic spacing, d. 
Miller planes refer to families of parallel planes that are described by Miller indices, a set 
of three integer values (h k l), the separation of which are termed dhkl. The values 
represent the reciprocal of the intercepts of the plane with the crystallographic axes (a/h, 
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b/k and c/l) and are expressed as rational fractions. The path difference between the 
incident and diffracted X-rays can be calculated by considering X-rays reflected by two 
adjacent Miller planes separated by a distance of dhkl (Figure 2.3).  The path taken by the 
incident and diffracted beam is equal to the wavelength of the incoming X-ray beam, nλ 
and can be calculated as the sum of XY and YZ. If the angle of the incident beam to the 




Figure 2.3 - Bragg's Law for diffraction of X-rays from a set of parallel Miller planes.  
 
For constructive interference between these two beams to occur, this path difference 
must be equal to an integral number of wavelengths of the incident X-ray beam, nλ.96 
Therefore according to Bragg’s Law, diffraction spots occur when the incident X-ray 
wavelength satisfies the Bragg equation, 2dsinθ = nλ.  
 
Each diffraction spot can thus be identified with an hkl value, since each spot represents 
diffraction from a specific Miller plane. During the data collection process, we measure 
the intensities, Ihkl, of the diffracted beam from each set of Miller planes (hkl). The frames 
of data that make up the diffraction pattern are processed to produce observed structure 
factor magnitudes, |Fo (hkl)|.
96  
 
Structure factors are a mathematical description of the interaction of the incident  
X-rays with the atoms in a crystal lattice and are affected by atomic scattering factors, fj 
(Equation 2.2).96 The fj values account for the variation in scattering with the number of 
electrons in the atom and with the angle of scattering.117 All atoms have different electron 
clouds and consequently interact differently with X-rays. At low Bragg angles the 
scattering power is proportional to the number of electrons, but the scattering reduces at 
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higher Bragg angles (Figure 2.4), as the scattering from different parts of the electron 
cloud become less constructive due to its finite extent. This occurs more slowly for atoms 
with more electrons, and this, combined with the dependence of atomic scattering on the 
number of electrons, makes it less easy to locate lighter atoms, such as hydrogen atoms, 
in the diffraction map.96  
 
 
Figure 2.4 - Atomic scattering factors for hydrogen, carbon and fluorine, plotted against sinθ/λ.
127
 
The scattering factor for X-rays is related to the number of electrons in the scattering atom at 
sinθ/λ=0, then falls off with angle. 
 
The intensity, Ihkl, is proportional to the structure factor squared and this relationship is 
used to produce experimental structure factor values for each reflection (Equation 2.1). 
The structure factors are needed to determine the distribution of electron density in the 
unit cell, through relations 2.1-2.3 below.127  
 
𝐼ℎ𝑘𝑙




From the measured intensities, information is thus gained on the amplitude of the 
diffracted beam, however, the phase information cannot be determined, and this is 
needed in order to produce a three-dimensional image of the structure. This is known as 
the phase problem and is discussed below. 
 
The structure factors are related to the atomic positions and scattering factors, and can 
be calculated for each reflection hkl using Equation 2.2; during structure determination, 
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structure factors calculated from the known atomic positions can thus be calculated and 
compared with their corresponding Fo value.
125   
 
𝐹ℎ𝑘𝑙 =  ∑ 𝑓𝑗
𝑁
𝑗=1
𝑒𝑥𝑝[2𝜋𝑖(ℎ𝑥𝑗 + 𝑘𝑦𝑗 + 𝑙𝑧𝑗)] 
Equation 2.2 
 
The structure factor of each refection can also be related directly to the electron density 
at position (x,y,z) in the unit cell of the crystal structure by Fourier transformation117 
(Equation 2.3).  
 
𝜌𝑥𝑦𝑧 =  
1
𝑉





The electron density, 𝜌𝑥𝑦𝑧, is expressed in units of electrons per cubic angstrom (e Å
3), 
where V is the volume of the unit cell. All reflections in the diffraction pattern contribute to 
the electron density map. Evaluation of 𝜌𝑥𝑦𝑧 shows the variation of electron density in the 
unit cell and the atoms will be located where the electron density is concentrated.117 Once 
these atomic positions have been located, the phases of all the structure factors can be 
determined, but the problem remains that in order to calculate 𝜌𝑥𝑦𝑧 from Equation 2.3, an 
initial set of phases for at least some of the reflections Fhkl must be obtained. There are 
several ways of achieving this, now largely automated in crystal structure analysis.  
 
2.2.5 Structure solution 
During structure solution, a molecular model must be obtained that will represent the 
contents of the crystal lattice. However, the phase information lost during the diffraction 
experiment must be regenerated in order to do this (by allowing the electron density to be 
evaluated through Equation 2.3). Two approaches, direct and Patterson methods, aim to 
overcome the phase problem and produce an initial set of estimated phases. Once such 
a solution is achieved, an initial electron density map is produced. If sufficiently accurate 
initial phase information has been generated, this provides a representation of the 
distribution of electron density that is sufficiently good to allow atomic positions to be 
identified. Various methods can then be used to improve and extend the number of 
phases available, leading to full structure determination and refinement. 
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2.2.5.1 Patterson methods 
Patterson methods are commonly used for structures containing one atom or a small 
number of atoms that have significantly more electrons than the rest, named heavy 
atoms, so are often exploited in inorganic crystal structures. A Fourier transform of Fo
2 
with all the phases set to equal zero produces a Patterson map117 (Equation 2.4).  
 









A Patterson map is a map that shows the vectors between pairs of atoms in the structure, 
including atoms paired with themselves and thus consists of peaks which show where 
atoms lie relative to one another, but not where they lie relative to the unit cell origin. 
Patterson peaks are proportional in size to the product of the atomic numbers of the pair 
of atoms. Consequently, large peaks that stand out on the map can be attributed to 
vectors involving heavy atoms in the structure. It is then possible to find a set of atom 
positions for the heavy atoms. The origin (0, 0, 0) will always correspond to the largest 
peak on the map as it is made up of the vectors of atoms paired to themselves which 
have zero length. The peak height will therefore, be proportional to the sum of the 
squares of the atomic numbers of all the atoms.117,125 Once the heavy atoms have been 
found from a Patterson map, they can be used to obtain initial phases and the rest of the 
lighter atoms can be located in an iterative process using Equation 2.2 and Equation 2.3. 
Patterson methods are less appropriate for structures containing large numbers of atoms 
of equal atomic number as there are problems resolving overlapping peaks.  
 
2.2.5.2 Direct methods 
Direct methods are commonly used in small-molecule crystallography, often for crystal 
structures containing an organic molecule with no heavy atoms. However, as methods 
have become more advanced these increasingly automated methods have been used to 
solve more complex structures.96  
 
Structure solution using direct methods exploits phase relationships between the 
intensities of various observed reflections in order to overcome the phase problem.125 The 
initial strategy is based on a trial-and-error method which involves using normalised 
structure factors to ensure reflections measured at different θ values can be compared 
directly. Phases are then estimated for some of the strongest reflections (usually in a 
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parallel multiple solution method where sets of trial phases are assigned to reflections) 
and probable relationships between phases calculated. Constraints put restrictions on 
possible values for phases. These include that the value of electron density must never 
be negative and that the electron density maps must have high values at and near atomic 
positions but values close to zero elsewhere. The most probable phase set is then used 
to calculate an electron density map using a Fourier transform. The electron density map 
can then be examined and initial atom positions can be determined based on 
recognisable molecular features; these are used to generate an initial full set of estimated 
phases and the remainder of the atoms located in an iterative procedure using Equation 
2.2 and Equation 2.3. Once a structure has been solved it can be carried through the 
refinement process.96,117 
 
2.2.6 Structure refinement 
The most common method used to refine a crystal structure is the method of least 
squares.125 This method is used statistically to determine the fit between a model and the 
experimentally obtained data, with a specific value of certainty. In terms of crystal 
structure refinement, this provides a quantitative value as to the agreement between the 
structural model obtained during structure solution and the experimental diffraction 
dataset.96 
 
During the refinement process, the positions of the atoms and associated displacement 
parameters are optimised through an iterative process of fitting against the experimental 
data. This enables better agreement between the calculated structure factors and the 
observed structure factors. This is monitored by a residual index known as the R-value or 
R-factor (Equation 2.5). 
 
𝑅1 =  





The R-value is therefore related to the differences between the calculated and observed 
structure factor magnitudes and so the lower the R-value, the better the fit between the 
structural model and the experimental dataset. This provides an indication as to whether 
the refinements have reached convergence in which the structural model is at its best fit 




A weighted R-value is also calculated and reported which is often higher than the  
R-value, as it is based on the square of the structure factors and takes into account the 
errors in the diffraction experiment (Equation 2.6).  
 









Another statistical measure used to measure the quality of refinement is the goodness-of-
fit (GOOF) (Equation 2.7; n = number of reflections and p = number of parameters). The 
GOOF of the structure, S, when refined to convergence should have a value close to 1.  
 








2.2.7 Powder X-ray diffraction (PXRD) 
Crystals large enough for single crystal X-ray diffraction are not always present in the 
products of a crystallisation experiment; often a polycrystalline powder is formed from 
which a PXRD pattern can be obtained. PXRD is therefore frequently used as a 
fingerprinting tool to determine the composition of a sample.  
 
In a single crystal X-ray diffraction experiment, a complete diffraction pattern is obtained 
from one single crystal through measuring diffraction from the crystal as it adopts various 
orientations when rotated in the X-ray beam. In contrast, in a PXRD experiment the 
polycrystalline powder contains a large number of small, single crystallites lying in 
random orientations. Upon exposure to the sample the X-ray beam will therefore be 
diffracted in all directions and a cone of diffraction is produced for each Bragg reflection 
at an angle corresponding to its d-spacing and governed by Bragg’s Law.117 Each cone is 
made up of diffraction spots from many crystallites within the sample.126 A PXRD pattern 
is produced by plotting the ring intensity against the 2 angle and therefore instead of 
producing a three-dimensional diffraction pattern, a one-dimensional pattern is produced. 
The individual peak intensities may vary from those expected from the internal crystal 
structure, as effects such as preferred orientation can sometimes be present, increasing 
or decreasing the intensity of peaks. The peak positions are the most important feature 
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for the use of PXRD as a fingerprinting tool for identification of phases present in the solid 
sample; these reflect the unit cell dimensions, which are a critical parameter in phase 
identification. 
 
In cases where it is not possible to grow single crystals large enough for scXRD, it is 
sometimes possible to refine the structure from high quality powder data using a Rietveld 
refinement, providing a good starting structural model can be achieved.125 Rietveld 
refinement was not employed in this work. 
 
 
2.3 Thermal analysis 
2.3.1 Differential Scanning Calorimetry (DSC) 
DSC is commonly used as a method to understand the thermal properties of a substance, 
identify different solid forms and study their phase transitions in combination with other 
thermal techniques. A small quantity of sample is weighed into a sample pan and the 
heat flow required to keep the two pans at the same temperature is measured whilst 
heating the two pans at a set rate. Thermal events can thus be identified from the heat 
flows required to achieve this; for example, in the case of an exothermic event, less heat 
is required to increase the temperature of the sample pan relative to the reference pan. 
Thermal events are therefore shown as changes in heat flow with respect to temperature. 
As a result, the temperature at which exothermic and endothermic events occur can be 
identified as well as determination of the associated enthalpy of each thermal event 
through integration of the area under the curve.128,129 Typical thermal events that can be 
assessed using DSC are shown in Figure 2.5.  
 
 
Figure 2.5 - Graph showing typical thermal events in a DSC trace: (a) glass transition, 
(b) recrystallisation, (c) desolvation or phase transition and (d) melting.  
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2.3.2 Thermogravimetric Analysis (TGA) 
TGA is used to measure the change in mass of a sample as a function of temperature. In 
solid-state chemistry the technique is often used to determine the stoichiometry of 
solvates or hydrates and can also be used to study the decomposition of a material.129 
Combination of TGA with mass spectroscopy can allow for identification of degradation 
products. In TGA a known mass of sample is weighed into a sample pan (different types 
of pans can be used including aluminium and ceramic) and the mass is recorded as the 
temperature is increased at a programmable rate. A weak nitrogen flow is sometimes 
applied over the sample during the experiment to maintain an inert atmosphere.130 The 
percentage of mass change can be plotted with respect to temperature (Figure 2.6); this 
quantification allows, for example, events such as desolvation to be determined with a 
high degree of certainty.  
 
 
Figure 2.6 - Graph showing solvent loss in a typical TGA trace. 
 
2.3.3 Hot-stage Microscopy (HSM) 
Hot-stage microscopy is a useful thermal analytical tool in which the effect of temperature 
on a substance can be visualised and recorded. It is often used to complement DSC and 
TGA allowing for thermal events such as melting and phase transitions to be interpreted 
visually. HSM is also a useful tool for identifying properties such as colour change in 
thermochromic materials or the phenomenon of thermosalience in which crystals display 









2.4.1 Fourier Transform Infra-red spectroscopy (FTIR) 
Infra-red spectroscopy results from the absorption of infra-red light by a sample. The 
amount of infra-red light of each frequency that passes through the compound is 
measured as the percentage transmittance. Bonds are constantly vibrating and the 
incident beam can be absorbed by the sample when the incident frequency matches the 
frequency of vibration of the bond, which is therefore excited into a higher vibrational 
energy state. Specific bonds in a molecule thus absorb infra-red light at characteristic 
frequencies enabling the identification of functional groups from a spectrum of an 
unknown sample.  
 
Modern IR spectrometers often adopt Fourier transform techniques. Infra-red light passes 
through an interferometer which splits the beam from the sample into two beams. One 
beam reflects off a mirror which is fixed in place and the other beam reflects off a 
moveable mirror that can alter the path difference of the beam. When the two beams 
recombine their interference pattern is converted to a spectrum by applying a Fourier 
transformation. This method increases the sensitivity of the measurements and allows for 
all the frequencies to be collected simultaneously, decreasing the data collection time.97 
FTIR spectroscopy is a non-destructive and versatile technique in which only a small 
quantity of the liquid or solid sample is required.  
 
2.4.2 Raman spectroscopy 
Raman spectroscopy is another type of vibrational spectroscopy which involves shining a 
high energy incident beam (laser) on a sample and monitoring the light scattered by the 
molecules. Most of the scattered light emerges from the sample in the same frequency as 
the source, known as Rayleigh radiation. However, a small quantity of the scattered light 
emerges from the sample with lower or higher energy as a result of vibrational motions in 
the target material; this results in a change in frequency of the detected photons, and the 
resulting signals are named Stokes or anti-Stokes lines, respectively. Laser beams are 
required to provide highly monochromatic incident radiation for Raman spectrometers to 
observe the small shifts in the frequency of the low intensity scattered radiation.97  
 
Vibrational spectroscopy can sometimes be used to distinguish polymorphic forms by 
identification of subtle differences in their spectra. A bond that is involved in a hydrogen 
bond will vibrate differently than a free bond, creating a downshift in the frequency of the 
vibration. Polymorphs often exhibit different hydrogen bonding environments and thus 
different frequencies of relevant vibrational modes can be observed.  
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2.4.3 Process Analytical Technologies (PAT) 
In-line tools are increasingly being implemented to monitor reactions and crystallisations 
in real time. Use of PAT allows for spectroscopic data such as FTIR, UV-vis and Raman 
and other information to be collected during an experiment without the need for sampling 
from the reaction vessel for off-line analysis. In crystallisation, FTIR and UV-vis probes 
can be used to monitor the solution concentration of a compound over time. A Raman 
probe can be used to monitor changes in the solid form of a substance by observing 
subtle changes in the spectrum. Additional PAT methods such as Particle Vision and 
Measurement (PVM) and Focused Beam Reflectance Measurement (FBRM) can also be 
applied. PVM is used to observe the crystal shape, morphology and size as well as to 
monitor processes such as agglomeration. FBRM is a laser-based method used to 
monitor the particle counts per second based on the chord length distribution of particles 
in solution. In an FBRM probe a focused laser beam is rotated to allow for a circular path 
of laser light to interact with particles in a flowing suspension.131 Upon scanning across a 
particle, light is backscattered to a detector and the duration of each pulse of 
backscattered light is multiplied by the scan speed to calculate the distance across each 
particle. This distance is defined as the chord length. Thousands of particles are counted 
per second allowing for measurement of chord length distribution in real time.132 Chord 
length distribution describes the frequency at which particles of a particular chord length 
are detected and gives an indication of particle size.131 In this work in situ PAT 
incorporating FBRM, PVM and Raman probes were used to monitor the crystallisation of 











Techniques and instrumentation 
 
This chapter describes the routine techniques used in the preparation of crystalline 
materials as well as the instrumentation used for analysis and characterisation of the 
products. More detailed experimental information is provided in each chapter relevant to 
the particular materials studied. Additional analytical techniques were also used for 
individual materials studied; these are described in the chapter which describes the 
materials for which they were solely used. 
 
3.1 Solubility and metastable zone width (MSZW) measurements 
Knowledge of the solubility of the substance is an important parameter in crystallisation 
from solution, as well as being in many cases a key physical property of product solid 
forms, for example for APIs and their complexes. Solubility and MSZW determinations 
were carried out using the Crystal16 and Crystalline platforms from Technobis 
Crystallization Systems in the CMAC laboratory at the University of Strathclyde. 
 
Both platforms operate on the principle of using turbidity to detect the clear and cloud 
point temperatures of a solution. Varying concentrations of the substance are prepared 
into vials and the relevant solvent added. The transmissivity of the solution is then 
measured as the temperature is changed; this is used to indicate the clear and cloud 
points of the solution for each concentration. The clear point represents the temperature 
of dissolution; the temperature at which the solution becomes transparent (100% 
transmissivity) and the solid has all dissolved. The cloud point represents the temperature 
of recrystallisation; the temperature at which the percentage transmissivity of the solution 
begins to decrease. Data were analysed using the CrystalClear133 software in which the 
clear and cloud point temperatures can be determined for each solution (Figure 3.1). The 
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combination of these points from each solution prepared with different concentrations of 




Figure 3.1 - Determination of the clear (red) and cloud (blue) point temperatures with respect to 
transmissivity of a solution in the Technobis Crystallization Systems platforms. In this example, the 
clear point temperature lies at 40.5 °C and the cloud point temperature lies at 29.5 °C.  
 
The Crystal16 operates at 1.5 ml scale with magnetic bottom stirring and relies solely on 
turbidity to detect clear and cloud points for 16 vials in parallel. The Crystalline can 
operate at up to 8 ml scale with eight vials running in parallel and magnetically controlled 
overhead stirring can also be implemented. The Crystalline is also equipped with PAT 
capability in the form of in situ cameras and the capability for in situ Raman probes for 




3.2 Crystallisation platforms and methods 
3.2.1 Evaporative crystallisation  
Small scale evaporative crystallisation was used as an initial screening method in the 
preparation of multi-component molecular complexes and to obtain single crystals of 
sufficient size and quality for single crystal X-ray diffraction. It was also used in studies of 
the effect of additives on crystal morphology. The crystallisations were prepared in 7 ml 
glass vials in which milligram quantities of the substances were dissolved in a suitable 
solvent (usually the minimum quantity of solvent required for dissolution to be achieved). 
Sonication and a short period of heating were sometimes used to aid dissolution. Small 
holes were then pierced in the lids to allow for slow evaporation of the solvent and the 
vials were left to crystallise at controlled temperatures using temperature controlled hot-
plates (Figure 3.2). Crystallisations were also carried out at room temperature as well as 
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at 4 °C by placing the vials in the refrigerator. Multiple crystallisations were prepared in 
order to access different conditions for crystal growth; changes to the conditions were 
made by altering the solvent system, the stoichiometric ratios of the starting materials and 
the temperature of crystallisation.  
 
 
Figure 3.2 - Temperature controlled hot-plates for evaporative crystallisation. 
 
3.2.2 Cooling crystallisation 
Two platforms were used routinely in this work to carry out cooling crystallisation at small 
scale.  
 
3.2.2.1 Cambridge Reactor Design Polar Bear Plus Crystalliser 
The Polar Bear Plus crystalliser from Cambridge Reactor Design was used in this work 
for batch crystallisations at various scales. The crystalliser allows for programmable 
heating and cooling profiles and magnetic bottom stirring at different rates. The platform 
also allows for operation at different scales by the use of changeable inserts allowing for 
scales of 1 ml and 20 ml vials and 50 ml and 500 ml round bottomed flasks (Figure 3.3).  
 
 
Figure 3.3 - (left) The Polar Bear Plus crystalliser and (right) changeable inserts to allow for 




Overhead stirring was also implemented for crystallisations carried out using this platform 
by use of a magnetically controlled overhead stirrer from Technobis Crystallization 
Systems which was clamped above a 20 ml vial, or by using an overhead shaft and motor 
which was clamped above a round bottomed flask. The Polar Bear was also used for 
solution mediated (slurrying) crystallisations to enable temperature control and input of 
specific magnetic stirring speeds. 
 
3.2.2.2 ReactArray Microvate 
The ReactArray Microvate was also used for a number of cooling crystallisations; this 
device allows for programmable temperature regimes for rows of four 2.5 ml vials (Figure 
3.4). The compound was dissolved in a suitable solvent in the vial which was then placed 
in the reactor block with sealed lids. The cooling profile was set using the supplied 
computer software. Evaporation was also enabled in this device, by removing the lids of 
the vials for the relevant crystallisations.  
 
 




3.3 X-ray diffractometers 
3.3.1 Single X-ray diffraction 
During this work crystallographic data were collected using four in-house laboratory 
diffractometers: a Rigaku Oxford Diffraction (formerly Agilent Technologies) SuperNova, a 
Rigaku Oxford Diffraction Xcalibur, a Rigaku Oxford Diffraction Gemini A Ultra and, for a 
small number of data collections, a Rigaku R-AXIS/RAPID.  
 
The Rigaku R-AXIS/RAPID diffractometer has a four-circle goniometer and uses a sealed 
tube Mo-Kα source with a graphite monochromator. The diffractometer differs from the 
other three diffractometers in that it features an image plate detector while the others are 
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equipped with a Charged Coupled Device (CCD) area detector. The SuperNova 
diffractometer has a four-circle kappa goniometer and dual micro-focus sources (Mo-Kα 
and Cu-Kα) with a graphite monochromator and is equipped with an Eos S2 detector. The 
Xcalibur has a four-circle kappa goniometer, is also equipped with an Eos S2 detector 
and has a sealed tube Mo-Kα source with a graphite monochromator. The Gemini A Ultra 
diffractometer has a four-circle kappa goniometer and is equipped with a dual sealed tube 
source with a graphite monochromator (Mo-Kα and Cu-Kα radiation). The diffractometer 
has an Atlas CCD detector.  
 
Figure 3.5 shows a general set-up for a laboratory diffractometer (Rigaku Oxford 
Diffraction Xcalibur) with the main features highlighted. With the exception of the detector 
type, the general set-up for each of the diffractometers is the same. The four-circle 
goniometer can enable movement of the crystal through the diffractometer positions (κ, φ, 
ω, 2θ) required to collect a complete set of diffraction data. The distance between the 
sample and the detector can also be altered by movement of the detector.   
 
 
Figure 3.5 - A photograph of the Rigaku Oxford Diffraction Xcalibur diffractometer with the main 
features labelled. 
 
Each diffractometer utilises a liquid nitrogen flow device (either an Oxford Cryosystems 
Cryostream 700 or an Oxford Instruments CryoJetXL) in order to control the temperature 
of the sample during the data collection. In standard data collections the flow of nitrogen 
gas from the device is used to cool the sample. The device also incorporates the ability to 
heat the nitrogen gas and can thus be used to heat the sample to carry out data 









Data collection and processing was carried out using the CrysAlisPro134 software for the 
Rigaku Oxford Diffraction Gemini, Xcalibur and SuperNova diffractometers and the 
Rigaku CrystalClear 2.0135 software for the R-AXIS/RAPID diffractometer. When used, 
face indexing was carried out using the CrysAlisPro134 software. XPREP136 was also used 
in some cases to process data and verify space group assignment. All structures were 
solved by direct methods using SHELXS (-97 or -2013)137 and refined using SHELXL  
(-97 or -2013)138 within the WinGX139,140 program. Visualisation of the crystal structures 
and calculation of the BFDH morphology was carried out using Mercury 3.8.141 Specific 
experimental and special refinement details are reported within each chapter. 
 
A synchrotron source (Advanced Light Source, Lawrence Berkeley National Laboratory, 
Beamline 11.3.1) was also used to collect single crystal X-ray diffraction data for one of 
the crystal structures discussed in this work. This involved a variable temperature 
experiment, benefiting from the high intensity, rapid data collection times and enhanced 
sample environment available at the synchrotron beamline, and was carried out on behalf 
of the author. Use of the synchrotron allowed for the collection of high quality data from 
the high intensity of the synchrotron X-rays and also for data to be collected at 
temperatures higher than could be accessed using in-house laboratory diffractometers. In 
the experiment data were collected using a Bruker AXS D8 three-circle diffractometer, 
equipped with a Bruker AXS PHOTON 100 complementary metal-oxide semiconductor 
(CMOS) detector, using Si (111) monochromated radiation (λ = 0.9538 Å). The 
temperature of the sample was controlled using an Oxford Cryosystems Cryostream Plus. 
Data collection was carried out using the Bruker AXS APEX2142 software and data 
processing was carried out using the Bruker AXS APEX2142 with SADABS-2014/5143 
software packages. Further experimental information is provided in Chapter 7.  
 
3.3.2 Powder X-ray diffraction (PXRD) 
Routine PXRD data were collected in flat-plate mode using a Bruker D8 Advance 
laboratory diffractometer equipped with monochromatic Cu-Kα (λ=1.54056 Å) radiation in 
reflection geometry at 298 K. With the exception of samples of succinic acid, all samples 
were ground using a mortar and pestle to produce a microcrystalline powder prior to 
preparation for flat-plate analysis. Samples of succinic acid were prepared without 
grinding in order to prevent a polymorphic transformation (see Section 4.3.1).  
 
Variable temperature PXRD data were also collected at a synchrotron source (Diamond 
Light Source, Beamline I11) for one complex in order to study a phase transition; again 
this was carried out on behalf of the author. The microcrystalline sample was loaded into 
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a borosilicate glass capillary and secured in a brass holder using glue. The beamline 
uses Si (111) monochromated radiation with an energy of 15 keV (λ = ~0.826 λ), and is 
equipped with two detector arrays: the PSD (position-sensitive detector) is used for high 
throughput experiments and was used in this work, and the MAC (multi-analyser crystal) 
for high resolution. The sample temperature was controlled using an Oxford Cryosystems 
Cryostream Plus. Further experimental information is again detailed in Chapter 7.  
 
 
3.4 Thermal analysis 
3.4.1 Differential Scanning Calorimetry (DSC) 
DSC studies were performed using a Thermal Advantage Q20 DSC from TA Instruments, 
equipped with Thermal Advantage Cooling System 90 and operated with a dry nitrogen 
purge gas at a flow rate of 18 cm3 min1. 2-4 mg samples were placed in sealed Tzero 
aluminium pans and heated at a rate of 5 °C min1, to various maximum temperatures 
depending on the sample being studied. Data were collected using the software 
Advantage for Qseries version 5.4.0 © 2001-2011 TA Instruments-Waters LLC. Analysis 
of the data was carried out using TA Universal Analysis software.  
 
3.4.2 Thermogravimetric Analysis (TGA) 
In this work TGA was carried out by placing 2-5 mg of sample in a Perkin Elmer TGA4000 
with a nitrogen flow rate of 20 ml min1. The TGA data were accumulated while the 
temperature was ramped to 400 °C at a heating rate of 5 °C min1.  
 
3.4.3 Hot-stage Microscopy (HSM) 
HSM was carried out using a Mettler Toledo FP82 hot stage equipped with a Leica 
DM1000 microscope. Each crystal was subjected to a temperature program of 30 °C to 
various maximum temperatures depending on the sample at 5 °C min1 using the FP90 
Central Processor. The crystals were filmed using a Lumenera Infinity 2 microscopy 





3.5.1 Fourier Transform Infra-red spectroscopy (FTIR) 
The FTIR spectra in this work were recorded using a Perkin Elmer FTIR Spectrometer in 
the range 4000–500 cm−1 with an ATR sampling accessory at room temperature. 
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3.5.2 Raman spectroscopy  
Raman spectra in the succinic acid study were collected using a Thermo Scientific DXR 
Raman microscope (laser at 780 nm and OMNIC software version 8). For variable 
temperature Raman studies a Renishaw inVia Raman Microscope combined with a 
Mettler Toledo FP82 hot stage were used. 
 
3.5.3 1H Nuclear Magnetic Resonance (NMR) 
For all proton NMR studies in this work, samples were dissolved in a suitable deuterated 
solvent and an Agilent Technologies 500 MHz 1H-NMR instrument was used. The data 











Tuning crystal morphology of β-succinic 
acid using a polymer additive 
 
This chapter has been published in part as a journal article: 
A. R. Klapwijk, E. Simone, Z. K. Nagy and C. C. Wilson, Tuning Crystal Morphology of 
Succinic Acid Using a Polymer Additive. Cryst. Growth Des., 2016, 16, 4349-4359. 
 
Some of the other findings presented in this chapter are reported in the following paper: 
E. Simone, A. R. Klapwijk, C. C. Wilson and Z. K. Nagy, Investigation of the Evolution of 
Crystal Size and Shape during Temperature Cycling and in the Presence of a Polymeric 
Additive Using Combined Process Analytical Technologies. Cryst. Growth Des., 2017, 17, 
1695-1706. 
 
4.1 Introduction and aims 
In the context of this study, an additive is defined as a soluble, polymeric or structurally 
similar impurity deliberately added to a crystallisation with the aim of modifying crystal 
morphology or solid form. The aim of this work was to identify an additive compound 
which, when present in solution, results in changes in the crystal morphology of a target 
compound and to study the effect of the additive under various crystallisation conditions. 
As noted earlier, the avoidance of plate-like or thin needle morphologies is advantageous 
in processing, and an ideal additive would favour more isometric particles such as block 
shaped crystals. Succinic acid was selected as a relevant model target compound and 
various polymer additives were initially studied in order to select an additive system that 
can be seen to affect the morphology adopted. Indexing of the crystal faces using single 
crystal X-ray diffraction and analysis of the crystal structure were used as tools to 
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understand the mechanism by which the morphology change occurs. Ultimately, the aim 
is to move such an additive-mediated process into continuous crystallisation 
environments, discussed in Chapter 5 below. 
 
Succinic acid (Figure 4.1; SA) is a dicarboxylic acid used in the food industry and is a 
Generally Recognized as Safe (GRAS) compound144 commonly used as a co-former in 
multi-component crystallisation of APIs and other functional molecular systems.112,145,146 
SA was selected as a target system in this study as it grows into large plate-like crystals 
from water in which the morphology can be easily observed under the microscope and 
the morphology has previously been shown to be sensitive to crystallisation conditions, 
such as the choice of solvent.32,147  
 
 
Figure 4.1 - Chemical structure of succinic acid. 
 
There are two reported polymorphic forms of SA. The monoclinic β-form can be obtained 
from various solvents and is the stable form at ambient conditions. Above approximately 
137 °C the β-form converts to the high temperature triclinic α-form,148 which is metastable 
at room temperature.149,150 This polymorphic transition can be observed across a single 
crystal using hot-stage microscopy, as shown in Figure 4.2. The α-form of SA has 
previously been obtained by sublimation crystallisation151 and was also observed during 
milling experiments149,152 and through monodisperse droplet evaporation.150  
 
 
Figure 4.2 - Hot stage microscopy images of β-SA converting to α-SA. Images taken during the 
present work. 
 
The crystal morphology adopted by β-SA depends upon the solvent from which it is 




experiments described here of β-SA are from crystals grown in the current study) 
whereas crystallisation from isopropanol results in a more needle-like morphology.32,147  
 
 
Figure 4.3 - Microscope image of crystal morphology of SA crystallised from water. 
 
The faces of a β-SA crystal grown from aqueous solution were indexed using single 
crystal X-ray diffraction and the results correlate with those previously reported in the 
literature.147,153 In addition to the experimentally observed morphology, the BFDH 
morphology of β-SA was calculated. The observed and predicted morphologies are 
shown in Figure 4.4 with the crystal faces labelled with the corresponding Miller indices.   
 
 
Figure 4.4 - (left) Observed morphology of β-SA when crystallised from water and (right) predicted 




The predicted morphology correlates reasonably well with the observed morphology; all 
of the faces in the observed morphology are present in the predicted morphology. 
However, the overall shape of the predicted morphology is block-like and there are 
additional faces present in comparison with the observed plate-like morphology. This can 
partly be accounted for by the neglect of molecular-level solvent interactions in the BFDH 
model. As discussed in previous literature,32,51,154 in the crystal structure of β-SA the 
(100) face intercepts chains of SA molecules linked by hydrogen bonded carboxylic acid 
dimers (Figure 4.5). This makes the (100) face a polar face with which water molecules 
would be likely to interact, inhibiting growth along the direction perpendicular to this face 
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and suggesting why the (100) face is the largest, slowest growing face in crystallisations 
carried out from water and the final crystal shape is plate-like. The BFDH model does not 
account for such solvent interactions, which can have a large effect on the crystal 
morphology, and therefore may not always make accurate predictions of crystal shape.27  
 
 
Figure 4.5 - Packing arrangement of β-SA through the (100) face, showing the hydrogen bonded 
carboxylic acid dimers propagating the crystal structure perpendicular to this face. 
 
After initial crystallisation experiments, Pluronic P123 (PP123) was selected as the 
polymer additive to be used in this study. PP123 (Figure 4.6) belongs to a family of 
triblock co-polymers composed of a hydrophobic chain of poly(propylene glycol) (PPG) 
flanked by two hydrophilic chains of poly(ethylene glycol) (PEG) where the composition of 
PEG and PPG blocks is PEG20PPG70PEG20. Polyethylene glycol is widely used in many 
industrial applications and can be obtained in many different chain lengths. Pluronic F127 
(PF127) was also utilised in this study for comparison. This polymer contains the same 











4.2 Experimental information 
SA, PP123, PF127 and poly(propylene glycol) 4000 (PPG4000) were obtained from 
Sigma Aldrich. Poly(ethylene glycol) 1000 (PEG1000) was obtained from Alfa Aesar. 
Deionized water was used as the solvent for all crystallisations.  
 
4.2.1 Solubility and MSZW measurements 
Solubility and MSZW measurements of SA in water and in the presence of 0.5% PP123 
in water were carried out using the Technobis Crystallization Systems Crystalline at 3 ml 
scale. Vials containing different concentrations of SA and polymer were heated and 
cooled between temperature ranges of 5 °C and 70 °C using a heating/cooling rate of  
0.5 °C min1 using magnetic bottom stirring at 400 rpm and magnetically controlled 
overhead stirring at 700 rpm. The data were analysed using CrystalClear software.133  
 
4.2.2 SA and additive concentrations 
Table 4.1 outlines the concentrations of SA and PP123 used in the crystallisations from 
water. The dissolved polymer concentrations used are defined here, and for all other 
crystallisations in this chapter, as the percentage of the saturation concentration of SA by 
weight, expressed in g ml1 of water. These express the very low concentrations of 
polymer used, for example, for Tsat = 20 °C (0.06 g ml
1 of SA), 0.5% polymer 
concentration would be 0.00030 g ml-1, 0.25% would be 0.00015 g ml1 and 0.17% would 
be 0.00010 g ml1 of polymer; the Tsat concentrations are taken from the solubility curve 
detailed in the next section (Figure 4.14 below). It is known that Pluronic P123 assembles 
in micelles at low concentrations; the polymer concentrations used here are in the region 
where micellar formation is favoured, but it is unclear how this might influence the 
possible interaction with the growing crystal faces of the SA crystal.155 
 
Table 4.1 - Concentrations of SA and PP123 additive used, in mg ml
1








Concentration of PP123 (mg ml
1
) 
0.17% 0.25% 0.50% 1.0% 
20 60 0.10 0.15 0.30 0.60 
27 80 0.13 0.20 0.40 0.80 
30 90 0.15 0.23 0.45 0.90 
32 100 0.17 0.25 0.50 1.00 
34 110 0.18 0.28 0.55 1.10 
37 125 0.21 0.31 0.63 1.26 




4.2.3 Crystallisations at 1 ml scale 
The Cambridge Reactor Design Polar Bear Plus crystalliser was used for 1 ml scale 
screening crystallisations, which were carried out in 1.5 ml vials with magnetic bottom 
stirring at a stirring speed of 325 rpm. This set-up was also used for the crystallisations of 
SA at 1 ml scale in the presence of the PP123 additive. The experiments were carried out 
at seven saturation concentrations of SA (Tsat = 20, 27, 30, 32, 34, 37 and 40 °C) with 
four different concentrations of PP123 (0%, 0.17%, 0.25% and 0.5%). All 1 ml 
crystallisations were subject to a linear cooling profile from 10 °C above the saturation 
temperature of the given SA concentration to 5 °C with a cooling rate of 0.5 °C min1. The 
crystalline product was filtered at the end of the cooling profile and visual analysis carried 
out using optical microscopy. 
 
4.2.4 Initial crystallisations at 10 ml scale 
The Cambridge Reactor Design Polar Bear Plus crystalliser was used for the 10 ml 
cooling crystallisations, carried out in in 20 ml glass vials with each of overhead and 
magnetic bottom stirring. Crystallisations with overhead stirring at 10 ml scale, 
implemented using magnetically controlled overhead stirrers from Technobis 
Crystallization Systems, were carried out at four saturation concentrations of SA from 
water (Tsat = 20 , 27, 30 and 40 °C), with four concentrations of PP123 (0%, 0.17%, 
0.25% and 0.5%). Crystallisations from water with magnetic bottom stirring at a rate of 
325 rpm were carried out under a more limited set of conditions: with no polymer and 
0.17% of polymer for Tsat = 30 °C. Crystallisations from ethanol with overhead stirring 
were carried out at Tsat = 30 °C with 0% and 0.5% of PP123 additive.  All 10 ml 
crystallisations were subject to a linear cooling profile from 10 °C above the saturation 
temperature of the given SA concentration to 5 °C with a cooling rate of 0.5 °C min1. The 
crystalline product was filtered at the end of the cooling profile and visual analysis carried 
out using optical microscopy. 
 
4.2.5 Crystallisations at 200 ml scale 
Further experiments were carried out at 200 ml scale. The crystallisations were carried 
out in a 250 ml round bottom flask in the Cambridge Reactor Design Polar Bear Plus 
crystalliser. Overhead stirring was implemented by attaching a motor driven impeller to 
the platform and a stirring speed of 325 rpm was used (Figure 4.7). Experiments with 
magnetic bottom stirring were also carried out at this scale at 325 rpm. A saturation 
concentration of SA at 30 °C was used for all experiments with concentrations of 0% and 
0.17% PP123 investigated. The crystallisations were subject to a linear cooling profile 
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from 10 °C above the saturation temperature of the given SA concentration to 5 °C with a 
cooling rate of 0.5 °C min1. The crystalline product was filtered at the end of the cooling 
profile and visual analysis carried out using optical microscopy. 
 
 
Figure 4.7 - Experimental set up for 200 ml crystallisations with overhead stirring. 
 
4.2.6 Crystallisations at 350 ml scale 
The 350 ml cooling crystallisations were carried out at Loughborough University using a 
400 ml jacketed glass vessel equipped with overhead stirring at 325 rpm (PTFE pitch 
blade turbine). The set-up is shown in Figure 4.8 and Figure 4.9. The temperature was 
controlled using a PT-100 temperature probe connected to a Huber Ministat 230 
thermoregulator. A PAT array was used, consisting of an RXN2 Hybrid Raman analyser 
with immersion probe and 785 nm laser (Kaiser with iC Raman 4.1 software), D600L 
Lansentec Focused Beam Reflectance Measurement (FBRM) probe (equipped with 
control interface software version 6.7) and a particle vision and measurement (PVM) 
V819 probe (Mettler Toledo) with on-line image acquisition software (version 8.3). The 
pre- and post-processing of the data was carried out with Matlab R2013, iC Raman 4.1 
and Excel. The data from the FBRM and the Huber instrument are transmitted in real-time 
to the CryPRINS software (Crystallisation Process Informatics System). This software 
was used for real-time monitoring of the FBRM counts and the temperature, as well as 
input of a temperature profile. 
 
Different saturation concentrations of SA (Tsat = 20, 27, 30, 32, 34, 37 and 40 °C) in the 
presence of different concentrations of PP123 (0%, 0.17%, 0.25% and 0.5% of the 
saturation concentration of SA) were used. From each crystallisation a 6 ml sample was 
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taken at the end of each experiment for off-line analysis (PXRD, Raman and SEM 
imaging). At this scale up to six experiments were carried out consecutively such that at 
the end of each crystallisation, the contents were redissolved and additional quantities of 
SA and PP123 were added to the vessel to increase the concentration for the next 
experiment, also accounting for the 6 ml sample taken after each experiment. The feed 
solution was then replaced at the beginning of each day. All crystallisations were subject 
to a linear cooling profile from 10 °C above the saturation temperature of the given SA 
concentration to 5 °C with a cooling rate of 0.5 °C min1. The MSZW was determined at 
this 350 ml scale from the in situ FBRM data.  
 
 
Figure 4.8 - 400 ml stirred tank reactor with PAT used for 350 ml scale crystallisations. 
 
 




4.2.7 Additional crystallisations at 10 ml scale 
Additional studies investigating the cooling rate of the crystallisation, use of different 
polymer additives, and for washing / recrystallisation experiments were also carried out at 
10 ml scale with overhead stirring. For all experiments the crystalline product was filtered 
at the end of the cooling profile and visual analysis was carried out using optical 
microscopy. Experiments investigating the effect of the cooling rate on the crystal 
morphology of SA produced in the presence of PP123 were carried out at one saturation 
concentration of SA (Tsat = 30 °C) and four concentrations of PP123 (0%, 0.17%, 0.25% 
and 0.5%) with overhead stirring. All crystallisations were subject to a linear cooling 
profile from 10 °C above the saturation temperature of the given SA concentration to 5 °C 
with a cooling rate of 0.1 °C min1. 
 
Experiments performed using different polymer additives involved the use of Pluronic 
F127 (PF127) as well as the separate blocks of PP123: PEG1000 and PPG4000 as 
additives. Crystallisations in the presence of PF127 were carried out for SA concentration 
Tsat = 30 °C using 0.17% and 0.5% of polymer. Crystallisations carried out in the 
presence of PEG1000 were implemented for SA concentrations Tsat = 30 °C and 40 °C 
initially using 0.5% polymer. However, as no effect was observed, crystallisations with 1% 
of polymer were also carried out. Crystallisations carried out in the presence of PPG4000 
were implemented for SA saturation concentrations Tsat = 20, 27, 30 and 40 °C using 
0.17%, 0.25% and 0.5% of polymer. The same cooling profile was used as for the 
previous 10 ml crystallisations at a cooling rate of 0.5 °C min1. 
 
For the washing and recrystallisation experiments, crystals of a sample from a 350 ml 
scale experiment (Tsat = 50 °C; 0.5% PP123) were recrystallised from water at 10 ml 
scale for SA concentration Tsat = 30 °C using overhead stirring. A second sample was 
washed, in combination with filtration, with deionised water at 4 °C and then recrystallised 
after drying. This procedure was repeated with other crystals from the same sample but 
using diethyl ether as the washing solvent. Additionally, 1.5 g of crystals from the original 
morphology-modified sample were slurried in 10 ml of diethyl ether for one hour and the 
dry product recrystallised from water for SA concentration Tsat = 30 °C. The same cooling 
profile was used as for the previous 10 ml crystallisations at a cooling rate of  




4.2.8 Direct nucleation control (DNC) and temperature cycling experiments 
The DNC and temperature cycling experiments were carried out using the experimental 
set-up used for previous experiments at 350 ml scale at Loughborough University (Figure 
4.8). All DNC experiments were carried out from water at 350 ml scale with a SA 
concentration of 0.06 g ml1 (Tsat = 20 °C) and in experiments with the additive present an 
additive concentration of 0.5% was used. The initial cooling rate was 0.5 °C min1. Two 
set points of 100 and 200 counts/second were chosen for experiments with and without 
the additive present and set in the CryPRINS software. The value of total counts/second 
measured by the FBRM is sent to the CryPRINS software and temperature is decreased 
if the measured total counts/s is lower than the set point range, or increased if it is higher, 
causing small crystals to dissolve. In each case a sample was taken before and after 
DNC for visualisation of the crystal morphology.  
 
In the temperature cycling experiments a 350 ml solution (0.06 g ml1, Tsat = 20 °C) of SA 
in water was heated up to 30 °C and cooled to 10 °C at a rate of 0.5 °C min1. After 
nucleation the temperature cycling was started and experiments were stopped when the 
statistics from the FBRM and PVM reached a constant value (equilibrium state). A 
constant heating/cooling rate of +0.3 °C min1 was used and various parameters were 
investigated including the effect of the amplitude of the cycle where three different 
amplitudes were tested (4.5, 6 and 7.5 °C). The 4.5 °C amplitude temperature cycle 
experiment was repeated in the presence of the PP123 polymer additive in two 
concentrations (0.25% and 0.5%). 
 
4.2.9 Crystallisation of adipic acid 
Preliminary crystallisations of adipic acid (AA) were also carried out as part of this work. 
AA was obtained from Sigma Aldrich and deionised water was used as the solvent for all 
of the crystallisations. The solubility of AA was extracted from the literature.7,156 The 
crystallisations were carried out at 10 ml scale at four saturation concentrations of AA 
(Tsat = 20, 27, 30 and 40 °C) and one concentration of PP123 (0.5%) with overhead 
stirring. All crystallisations were subject to a linear cooling profile from 10 °C above the 
saturation temperature of the given AA concentration to 5 °C with a cooling rate of  
0.5 °C min1. The crystalline product was filtered at the end of the cooling profile and 




4.2.10 Characterisation methods 
Microscope images of crystals from 1 ml, 10 ml and 200 ml scale crystallisations were 
taken using a Leica DM1000 microscope equipped with an Infinity 2 microscopy camera 
at 4x magnification. In addition to the in situ PVM images, Raman spectra and images of 
the crystals from 350 ml scale crystallisations were obtained using a Thermo Scientific 
DXR Raman microscope (laser at 780 nm and OMNIC software version 8). All images 
were taken at 4x magnification. Scanning Electron Microscopy (SEM) images were 
obtained using a JEOL SEM6480LV SEM in which samples were coated with gold using 
an Edward Sputter Coater S15OB. 
 
Face indexing was carried out using a Rigaku Oxford Diffraction (formerly Agilent 
Technologies) Xcalibur diffractometer with Mo-Kα (λ=0.71073 Å) radiation. Unit cell 
screenings were carried out at 150 K with the temperature controlled using an Oxford 
Cryosystems Cryostream 700. Face indexing was then carried out using the CrysAlisPro 
171.37.33 software.134  Analysis of the crystal structure and morphology of β-SA and use 
of the BFDH morphology tool was carried out using Mercury 3.5.141 
 
MALDI-TOF mass spectrometry was carried out using a Bruker autoflex speed 
instrument. The samples were run using dithranol in THF as a matrix and NaTFA as a 
cationizing agent and data were acquired in reflectron positive mode. Samples of SA from 
a 350 ml scale experiment (Tsat = 50 °C; 0.5% PP123) and PP123 starting material were 
each dissolved in THF (5 mg ml-1) and spotted on a MTP384 polished steel plate and 
calibrated using PEG4000. Data were also collected for concentrations of 0.5 mg ml-1 and 
0.05 mg ml-1 of the PP123 starting material in order to determine the detection limit of the 
technique for the polymer. 
 
Experimental information for the DSC, PXRD, NMR and FTIR measurements undertaken 
are detailed in Chapter 3. 
 
 
4.3 Characterisation of SA starting material 
4.3.1 Polymorphism 
The two polymorphic forms of SA are distinguishable through PXRD; Figure 4.10 shows 
the diffraction patterns of each form calculated from single crystal data, along with 
experimental patterns from the SA sample used. Figure 4.10c shows the PXRD pattern of 
the starting material indicating that it is the β polymorphic form of SA.  
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Often samples are ground using a mortar and pestle in preparation for PXRD analysis in 
order to produce a more uniform particle size and shape and prevent preferred 
orientation effects in the diffraction pattern. However, care must be taken when applying 
this sample preparation method as sometimes dry grinding can induce changes in the 
solid form of the sample and subsequently produce misleading results. It was reported by 
Trask et al. that upon dry or liquid assisted (with a polar solvent) grinding of β-SA in a 
mechanical mill no polymorphic transformation is observed. However, it was also shown 
that grinding in a mechanical ball mill in the presence of several drops of a less polar 
solvent induces a transition to the metastable α-SA.152 In contrast to these findings, it was 
found in the present study that dry grinding of a sample of SA using a mortar and pestle 
for 5 minutes drove the partial transition from β-SA to α-SA. Moreover, within as little as 
30 seconds of grinding, peaks representative of the α-form were observed in the PXRD 
pattern. Diffraction peaks from the β-SA pattern remain dominant in the PXRD pattern; 
however, the presence of the additional low intensity peak at 22° 2 is characteristic of  
α-SA (Figure 4.10d). An additional experiment was carried out in which the sample was 
ground in a mortar and pestle for 20 minutes in attempt to drive the transition to 
completion. The peaks for β-SA remain dominant but in addition to the α-SA peak at 22° 
2, a weak peak characteristic of α-SA is evident at 27° 2 (Figure 4.10e).  
 
 
Figure 4.10 - PXRD patterns of SA: (a) calculated from the structure of the triclinic α-polymorph 
(CSD ref. code = SUCACB07), (b) calculated from the structure of the monoclinic β-polymorph 
(CSD ref. code = SUCACB02), (c) β-SA starting material, (d) after 5 minutes grinding and (e) after 
20 minutes grinding. 
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As a result of this observation all samples for PXRD analysis were prepared without 
grinding, although preferred orientation of varying degrees of severity was evident in 
these, due to the different crystal morphologies produced in this study. 
 
The polymorphic forms of SA are also distinguishable through Raman spectroscopy 
(Figure 4.11 and Figure 4.12).  
 
Figure 4.11 - Raman spectrum of α-SA. 
 
 








Differential scanning calorimetry (Figure 4.13) shows the melting of α-SA (onset:  
186.7 °C) which is followed by decomposition. The melting point of β-SA is not observed 
since the polymorphs are enantiotropically related and the β-form converts to the α-form 
prior to melting between 140-160 °C (as shown in the insert).  
 
 
Figure 4.13 - DSC trace of SA obtained from Sigma Aldrich, with the inset indicating the thermal 
event corresponding to the transformation from  to -SA. 
 
4.3.2 Solubility 
The solubility of β-SA was measured using turbidity and imaging in the Crystalline 
platform from Technobis Crystallization Systems in two solvents: water and ethanol 
(Figure 4.14).  
Figure 4.14 - Solubility curve of β-SA in (a) water and (b) ethanol with lines of fit based on a Van’t 




4.3.3 Crystal morphology 
The morphology of the SA raw material is non-uniform and exhibits rounded, irregular 
edges, as shown in Figure 4.15.  
 
 
Figure 4.15 - Microscope images showing crystal morphology of SA obtained from Sigma Aldrich. 
 
 
4.4 Identification of a polymer additive: initial crystallisations (1 ml scale) 
Initial 1 ml scale cooling crystallisations were carried out using magnetic bottom stirring in 
order to identify a suitable polymer additive to use in the planned morphology 
modification study. Experiments were carried out in water and in ethanol with two initial 
polymers selected; these were polyethylene glycol 200 (PEG200) and Pluronic P123 
(PP123), used at a starting concentration of 1% as well as a control with no polymer 
present.  
 
The PEG200 had very little effect on the resulting crystal morphology from both solvents 
and in crystallisations from ethanol, the presence of the PP123 additive also had little 
effect on the crystal morphology. In contrast, in aqueous solutions containing PP123, a 
large change in crystal morphology was observed: it was found that the presence of the 
PP123 additive at the high initial concentration used in this screening experiment 
effectively modified the crystal morphology of SA from plates to needles (Figure 4.16).  
 
 
Figure 4.16 - Microscope images of SA crystals from: (a) water, no additive, (b) water, 1% PP123, 
(c) ethanol, no additive and (d) ethanol, 1% PP123. 
(a) (b) (c) (d) 
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As a result of the obvious morphology change produced with the PP123 additive, 
investigations into the effect of this polymer on the crystallisation of SA were pursued and 
a broader range of parameters investigated.  
 
Preliminary investigations into the effect of PP123 on the morphology of SA were carried 
out by changing the concentration of SA and the concentration of PP123 at 1 ml scale 
with magnetic bottom stirring. Crystallisations were carried out with different 
concentrations of SA with 1.0% of PP123 present in solution. Figure 4.17 shows the 
crystals produced from these experiments. The images show that needle-like crystals are 
observed in each case, however, as the initial concentration of SA is increased, the 
crystals produced become broader and more rod-like.  
 
 
Figure 4.17 - Microscope images of SA crystals from crystallisation of different concentrations of 
SA in the presence of 1.0% PP123. 
 
The concentration of PP123 was also varied to observe whether a smaller concentration 
of polymer additive could be used to produce the same effect. Interestingly, with smaller 





Figure 4.18 - Microscope images of SA crystals from crystallisation in the presence of different 
concentrations of PP123. The SA concentration is 0.12 g ml
-1
 (Tsat = 35 °C) in all cases.   
 
The information obtained in these preliminary screening experiments was used to design 
the subsequent study. 
 
 
4.5 Cooling crystallisation from water (1 ml scale) 
As a result of the findings from the initial experiments, further analysis of the effect of the 
PP123 additive investigated concentrations of PP123 of 0-0.5% across a range of SA 
concentrations, at 1 ml scale. The crystal morphology was analysed using optical 
microscopy (Figure 4.19).  
 
Crystallisations of SA from water with no additive present in solution produced plate-like 
crystals which increased in size with increasing saturation concentration of SA. In the 
presence of the smallest quantity of polymer additive (0.17%), limited effect of the 
additive is apparent on the crystal morphology observed at low saturation concentrations 
of SA. However, at a SA concentration of above 0.10 g ml1 (Tsat = 32 °C), the crystal 
morphology becomes more block-like and at increasing saturation concentrations, the 
crystals become rod-like; this agrees with observations made in the initial experiments. 
When the concentration of PP123 in solution is increased a similar trend is observed, 
however needle-like crystals are produced at lower saturation concentrations of SA with 






Figure 4.19 - Microscope images of SA crystals crystallised at 1 ml scale. 
 
4.6 Effect of PP123 additive on solubility and MSZW at 3 ml scale 
4.6.1 Experiments with magnetic bottom stirring 
In experiments carried out at 1 ml scale, it was evident visually that solutions containing 
the PP123 additive nucleated at a lower temperature than those without the additive 
present. Solubility and MSZW measurements were thus carried out at 3 ml scale using 
magnetic bottom stirring with and without the polymer additive present in order to 
investigate this effect quantitatively. The solubility and cloud points were determined 
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using the combination of turbidity measurements and on-line imaging (Figure 4.20). It is 
clear that the presence of 0.5% PP123 additive in solution has no effect on the solubility 
of SA in water (Figure 4.20c). However, the cloud point results suggest that the addition 
of PP123 generates a shift in the MSZW of around 7-10 °C (Figure 4.20d) indicating an 
inhibiting effect of the additive on nucleation. The shift appears more prominent at low 
concentration of SA. A delay in nucleation has been observed in other studies into the 
effect of impurities on crystallisation.42,44,60,157 This may be a result of the impurity 
supressing the development of the nucleus of critical size.158 It was also confirmed 
through PXRD analysis that this shift was not due to nucleation of a different polymorphic 
form; the product remained the β-form. However, it should be noted that these 
measurements were performed at 3 ml scale and in small volumes primary nucleation is 
mainly a stochastic process. Findings by Kadam et al159 have shown significant variation 
in the nucleation temperature at small scale; therefore repeat determinations would be 
essential to establish if this temperature shift is statistically relevant.  
 
Figure 4.20 - Solubility and MSZW curves for SA in water at 3 ml scale with magnetic bottom 
stirring with (a) no PP123, (b) 0.5% PP123 and comparisons between (c) solubility with and 
without PP123 present and (d) MSZW with and without PP123 present. 
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Table 4.2 shows the nucleation temperature data for experiments without and with 0.5% 
PP123. The supersaturation ratio at nucleation does not change significantly with 
increased concentration of SA. In contrast, in the experiments with PP123 present the 
supersaturation ratio is higher at low concentrations of SA and falls as the concentration 
of SA increases.  
 


















20 0.059 12.60 0.04 1.56 
27 0.080 19.90 0.06 1.44 
32 0.099 22.80 0.06 1.54 
34 0.109 26.80 0.08 1.39 
35 0.120 29.50 0.09 1.34 
38 0.129 30.80 0.10 1.35 
39 0.139 31.60 0.10 1.40 
42 0.158 34.60 0.11 1.39 
45 0.180 40.00 0.15 1.23 
47 0.199 40.00 0.15 1.36 
49 0.217 43.30 0.17 1.28 
51 0.239 45.00 0.18 1.31 
53 0.258 45.40 0.19 1.39 
55 0.278 48.10 0.21 1.33 
      



















27 0.080 7.10 0.03 2.85 
30 0.090 8.90 0.03 2.90 
32 0.100 15.30 0.04 2.28 
34 0.110 16.00 0.05 2.42 
35 0.120 19.10 0.05 2.24 
38 0.130 21.40 0.06 2.16 
40 0.146 29.00 0.09 1.67 
44 0.170 31.40 0.10 1.73 
46 0.190 33.40 0.11 1.76 
48 0.210 38.20 0.13 1.56 
50 0.230 41.40 0.16 1.48 
 
 
4.6.2 Experiments with overhead stirring 
Solubility and cloud point determinations were also carried out at 3 ml scale with 
magnetically controlled overhead stirring (Figure 4.21). In contrast to the results obtained 
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with magnetic bottom stirring, the cloud points determined show significant spread, 
making it difficult to draw accurate conclusions on the effect of the additive on the 
nucleation temperature. This may be due to the geometry of the stirrer being positioned 
too high in the solution to suspend the volume of solution in the vial resulting in non-
uniform mixing conditions, a deduction supported by the non-uniform crystal morphology 
observed (Figure 4.23). Due to the apparatus being at another institution, repeat 
determinations were not possible in the timescales available. In contrast to the 
experiments with magnetic bottom stirring, no difference in MSZW is observed with 0.5% 
PP123 present (Figure 4.21c).  
 
 
Figure 4.21 - Solubility and MSZW curves for SA in water at 3 ml scale with overhead stirring with 
(a) no PP123, (b) 0.5% PP123 and comparisons between (c) MSZW with and without PP123 




4.7 Effect of PP123 additive on morphology at 3 ml scale 
On-line imaging was implemented for the duration of the heating and cooling profiles in 
the solubility and cloud point measurements at 3 ml scale. Images from crystallisations 
are shown in Figure 4.22 and Figure 4.23. 
 
4.7.1 Experiments with magnetic bottom stirring 
With magnetic bottom stirring (Figure 4.22), at low saturation (Tsat = 30 °C) the images 
suggest that there is no change in crystal morphology with 0.5% PP123 present. 
However, at higher saturation (Tsat = 40 °C) in the presence of polymer the SA crystals 
are elongated and needle-like whereas with no polymer present they remain non-uniform 
plates. These observations correlate with initial observations made in 1 ml scale 
crystallisations (Section 4.5). As the concentration of SA is increased to Tsat = 50 °C, the 
crystals grown in the presence of polymer are more rod-like. It is clear that in the 
presence of the PP123, the concentration of SA affects the morphology of the resulting 
crystals whereas with no polymer present the crystal shape is unchanged with increasing 




Figure 4.22 - On-line images from experiments with magnetic bottom stirring: (top) crystals of SA 
from Tsat = 30 °C, 40 °C and 50 °C with no polymer present; (bottom) crystals of SA from Tsat = 




4.7.2 Experiments with overhead stirring 
The images from the experiments carried out with overhead stirring are shown in  
Figure 4.23. It is clear that the mixing conditions were not optimal in these experiments as 
the crystal morphology and particle size is non-uniform. Although overhead stirring offers 
the benefit of lack of attrition of crystals at the bottom of the vessel, this outcome again 
highlights the importance of the geometry and height of the stirrer in the vessel. There is 
still, however, a clear change in crystal shape in the presence of 0.5% PP123 with 
overhead stirring; the crystals become more elongated as the saturation concentration of 
SA is increased. Due to the lower nucleation temperature with overhead stirring, 
crystallisation was not observed for the 0.5% PP123, Tsat = 30 °C experiments.  
 
 
Figure 4.23 - On-line images from experiments with overhead stirring: (top) crystals of SA from  
Tsat = 30 °C, 40 °C and 50 °C with no polymer present; (bottom) crystals of SA from  
Tsat = 32 °C, 40 °C and 50 °C with 0.5% PP123 present. 
 
 
4.8 Cooling crystallisation from water (10 ml scale)  
One of the limitations of working at 1 ml scale lies in the accuracy of weighing very small 
quantities of the PP123 additive into the 1.5 ml vials. This limits the ability to draw 
accurate conclusions about the effect of the different crystallisation conditions on the 
crystal morphology produced. The scale of the crystallisations was therefore increased to 
10 ml.  
 82 
 
Initial experiments at this scale were carried out using magnetic bottom stirring. A 
morphology change was observed when the additive was present, but with this mode of 
stirring the crystals were very non-uniform, both with and without the PP123 present 
(Figure 4.24). This suggests that the mixing conditions are non-uniform and crystal 
breakage may be occurring due to the abrasive action of the stirring bar.160  
 
Figure 4.24 - Microscope images of crystals produced with magnetic bottom stirring at 10 ml scale. 
 
As a result, subsequent crystallisations at this scale were carried out using overhead 
stirring (with the impeller positioned effectively in the solution for these experiments) with 
a range of SA and polymer additive concentrations investigated. The overhead stirring at 
this scale produced larger and more uniform particles than the magnetic bottom stirring, 
enabling more reliable analysis of trends in the crystal morphology with the different 
conditions. Microscope images of the crystals produced in the experiments carried out 
are shown in Figure 4.25. 
 
Figure 4.25 - Microscope images of product of crystallisations at 10 ml scale. 
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It is clear that the effect of the polymer is dependent on both the concentration of SA and 
the concentration of PP123 present. With no PP123 present in solution, SA crystallises 
from water in a non-uniform plate-like morphology, in agreement with previous 
reports.153,154,161 At a concentration of 0.5% PP123 and a low concentration of  
SA (Tsat = 20 °C) block-like crystals are produced, however they are relatively non-
uniform in terms of their morphology and size. This may be due to poor mixing; at higher 
concentrations of SA the morphology is more uniform. As the concentration of SA is 
increased to Tsat = 30 °C, the crystals remain block-like, however, the faces appear to 
have a more irregular surface. Crystallisation carried out at Tsat = 40 °C at 0.5% polymer 
yielded crystals of needle-like morphology. This trend of changing morphology with 
changing saturation of SA can also be observed at lower concentrations of PP123; the 
block-like crystals are accessible at higher saturations with lower concentration of PP123, 
with significantly improved uniformity in crystal size. As noted above, formation of block-
like crystals is very favourable in terms of ease of downstream processing of a solid form. 
Crystals of this favourable block-like morphology observed at low saturation 
concentrations of SA with overhead stirring were not previously observed with magnetic 
bottom stirring under the same conditions.  
 
It is interesting to note that very low concentrations of the PP123 additive are required to 
exert a large effect on the crystal morphology. Despite these substantial morphology 
changes, the polymorphic form of SA remained the β-form in all crystallisations, as 
confirmed by PXRD.  
 
 
4.9 Cooling crystallisation from ethanol (10 ml scale) 
Cooling crystallisations with overhead stirring were also carried out from ethanol at 10 ml 
scale in the presence of the PP123 additive at a saturation concentration of Tsat = 30 °C. 
As observed previously with magnetic bottom stirring, the polymer was found to have no 
effect on the crystal morphology on recrystallisation from ethanol (Figure 4.26).  
 
Figure 4.26 - Microscope images of crystallisations of SA from ethanol in the presence of different 




4.10 Cooling crystallisation from water (200 ml scale) 
Further scaling-up of the crystallisation was carried out and it was found to be possible to 
produce the desirable block-like crystals at 200 ml scale under the same conditions as at 
10 ml scale. Experiments were also carried out with magnetic bottom stirring for 
comparison and, as observed at 10 ml scale, the resulting crystals were smaller and non-
uniform in shape and size. 
 
Figure 4.27 - Microscope images of crystals produced at 200 ml scale. 
 
 
4.11 Scale-up of cooling crystallisation from water to 350 ml scale and 
implementation of Process Analytical Technologies (PAT) 
 
4.11.1 Aims 
This work was carried out in the Department of Chemical Engineering at Loughborough 
University in collaboration with Dr Elena Simone and Professor Zoltan Nagy. The aim was 
to scale up crystallisations of SA from water in the presence of PP123 (previously carried 
out at the University of Bath at smaller scales) and to implement PAT (FBRM, PVM and 
Raman) to monitor the crystallisation. Such PAT is used increasingly as it allows 
reactions and crystallisations to be monitored and provide real-time information. Use of 
PAT also enabled data to be collected on the nucleation temperature of the experiments, 
allowing for comparisons to be made with small scale crystallisations carried out in the 
Technobis Crystallization Systems Crystalline device. 
  
In this work several PAT tools were used in combination to follow the crystallisation 
(Figure 4.28). Particle vision and measurement (PVM) was used to observe the crystal 
shape and size in situ. Focused Beam Reflectance Measurement (FBRM) was used to 
detect the nucleation temperature and monitor the particle development. Raman 
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spectroscopy was used to detect any changes in solid form and provide an additional 
method of detecting the nucleation temperature.  
 
 
Figure 4.28 - A combination of PAT tools were used to follow up to six consecutive crystallisation 
experiments containing 0.17% PP123 with increasing concentration of SA; the FBRM, Raman and 
PVM measurements during six cycles are shown here (see experimental section for details of how 
the cycling was carried out). 
 
4.11.2 Raman analysis 
For the Raman measurements, a characteristic peak for each of the solute (840 cm1) 
and the solid (937 cm1) were identified (Figure 4.29). These peaks were used to detect 
the point of nucleation and dissolution in the crystallisation. Upon dissolution of the solid 
the solid peak decreases in intensity and the solute peak increases in intensity and vice 
versa for nucleation.  
 







































































































It is thus possible to produce a solubility curve using the Raman data. A SA solution was 
heated from 10 °C to 50 °C at 0.1 °C min1 and the Raman intensity of the solute peak 
was monitored as the solid dissolved (Figure 4.30, left). The Raman intensity of the solute 
peak was also plotted at four concentrations of SA (Figure 4.30, right), and these data 
related to produce the solubility curve; this is seen to be in reasonable agreement with 
that determined through imaging and turbidometric analysis in the Technobis 
Crystallization Systems Crystalline (Figure 4.31).  
 
 




Figure 4.31 - Comparison of SA solubility curve in water using Raman data and turbidometric 
analysis and imaging (Crystalline data). 
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4.11.3 Effect of PP123 additive on MSZW at 350 ml scale 
The MSZW of SA in water at 350 ml scale is shown in Figure 4.32a. The nucleation 
temperature was detected using the FBRM data. The results suggest that at this larger 
scale, the addition of PP123 in the range of concentrations studied (0.17%, 0.25% and 
0.50%) does not significantly change the cloud point. This is in contrast to the findings at 
smaller scale and may result from the different mechanisms of primary nucleation at the 
two scales. In small volumes primary nucleation is mainly a stochastic process which, for 
this case, seems to be inhibited by the additive. At larger scales, where primary 
nucleation mainly follows a deterministic mechanism, the additive seems not to have a 
significant effect.159 In Figure 4.32b the two MSZW curves in the absence of polymer, at  
3 ml and 350 ml, are shown together. At a temperature higher than 27 °C the two curves 
start to overlap while, at lower temperature, the cloud point at the small scale is higher 
compared to the larger scale. The opposite is true for the MSZW with PP123 present; the 
cloud point at the small scale is lower compared to the large scale (Figure 4.32c).  
 
 
Figure 4.32 - MSZW curves for SA in water at 350 ml scale with overhead stirring with (a) different 
concentrations of PP123 present and comparisons between (b) MSZW at 3 ml and 350 ml scale 
without PP123 present and (c) MSZW at 3 ml and 350 ml scale with PP123 present. 
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However, it should be noted that measurements of cloud point were carried out using 
different techniques for each scale (turbidity and on-line imaging for the 3 ml experiments, 
FBRM for the 350 ml experiments); therefore a fair comparison between the two sets of 
data is not possible. 
 
4.11.4 Crystal morphology at 350 ml scale 
Microscope images of the dry product from crystallisations carried out at 350 ml scale are 
shown in Figure 4.33 and Figure 4.34 and in situ images from the PVM probe are shown 
in Figure 4.35. The trend in the morphology change observed at this scale is similar to 
that described above for the 10 ml batch experiments. The morphology modification 
induced by the polymer additive is thus seen to be scalable. Additionally, a broader range 
of concentrations of SA were investigated at this scale allowing for more detailed analysis 
of the crystal morphology.  
 
As observed in the 10 ml crystallisations with overhead stirring, in the absence of polymer 
SA crystallises in non-uniform, diamond shaped plates (Figure 4.34). At higher 
temperatures (e.g. Tsat = 40°C) the resulting crystal faces are rounded and less  
well-defined than those of crystals produced at lower temperatures suggesting that the 
surfaces may have undergone roughening (see Section 1.2.3). Upon addition of 0.5% 
PP123 at low saturation of SA, crystals grow in a block-like morphology where the crystal 
faces appear to be growing at approximately equal rates. The shape of these block-like 
crystals is more uniform compared to those obtained in the equivalent 10 ml experiments. 
At higher saturations and high polymer concentration the shape of the crystals changes 
from block-like to needles. Figure 4.33 shows crystals obtained for Tsat = 30 °C, 0.5% 
polymer: the shape is still block-like but the surface of the crystals appears irregular, 
presumably because of the inhibiting effect of the polymer on growth. At higher saturation 
and the same polymer concentration (0.5%), the crystals grow as needles. Again, as 
observed in the 10 ml experiments, crystallisations carried out with a lower concentration 
of PP123 present showed the same trend in morphology change as the saturation of SA 
is increased. The block-like crystals can once again be accessed at higher saturation with 




Figure 4.33 - Microscope images of products of crystallisations at 350 ml scale with different 
concentrations of PP123 present. 
 
 
















































Figure 4.34 - Microscope images of products from crystallisations at 350 ml scale with no polymer.  
 
 
Figure 4.35 - PVM images from 350 ml crystallisations under different conditions. 
 
The calculated initial supersaturation ratio at nucleation, in crystallisations both with and 
without additive present, was found to be higher for low saturation concentrations of SA, 
decreasing as the saturation temperature rises (Table 4.3). This may explain why at high 
saturation concentrations, an enhanced effect of the additive was observed compared to 
lower saturation concentrations. At low supersaturation fewer crystals form, however with 
high initial concentrations more material is available in solution for the crystals to grow, 
which may explain why the particles obtained were considerably larger (or, in the case of 
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Tsat = 40°C 
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20 0.060 7.03 0.03 2.14 
27 0.080 12.89 0.04 2.07 
30 0.090 16.22 0.05 1.95 
32 0.100 20.11 0.06 1.78 
34 0.110 23.11 0.07 1.68 
37 0.125 26.94 0.08 1.58 
38 0.130 27.93 0.08 1.56 
40 0.145 31.52 0.10 1.47 
 




















27 0.080 12.66 0.04 2.10 
30 0.090 15.43 0.04 2.04 
32 0.100 18.66 0.05 1.91 
34 0.110 21.57 0.06 1.81 
37 0.125 25.36 0.07 1.70 
40 0.145 28.83 0.09 1.67 




















27 0.080 11.95 0.04 2.18 
30 0.090 15.93 0.05 1.98 
32 0.100 19.77 0.06 1.81 
34 0.110 22.71 0.06 1.71 
37 0.125 25.75 0.07 1.67 
40 0.145 32.00 0.10 1.44 
 




















27 0.080 13.07 0.04 2.05 
30 0.090 16.2 0.05 1.96 
32 0.100 20.39 0.06 1.75 
34 0.110 23.09 0.07 1.68 
37 0.125 27.06 0.08 1.57 
40 0.145 31.01 0.10 1.50 
 
NB. Tsat = 20 °C has been omitted for experiments with PP123; in these the temperature was held 




4.12 Effect of cooling rate on crystal morphology at 10 ml scale 
Preliminary investigations into the effect of the cooling rate on the crystal morphology 
produced in the presence of different concentrations of the PP123 additive were also 
carried out at the lower cooling rate of 0.1 °C min1 (the previous experiments having 
used a cooling rate of 0.5 °C min1). Figure 4.36 shows the morphology of the crystals 
produced at these two cooling rates, and it can be seen that at slower cooling rates, the 
polymer additive has an enhanced effect. For example, with a starting concentration of 
0.09 g ml1 of SA (Tsat = 30 °C) and 0.17% PP123, at a cooling rate of 0.5 °C min
1 block-
like crystals were produced. However, at the slower cooling rate with the same 
concentrations of SA and polymer additive, rod-like crystals were produced, resembling 




Figure 4.36 - Microscope images of SA crystals from experiments with a cooling rate of 
0.1°C min
1
. Relevant images from crystallisations carried out with a cooling rate of 0.5 °C min
1 
are also shown for comparison. 
 
It is postulated that at slower cooling rates nucleation may occur at higher temperatures 
and thus a lower supersaturation ratio would exist at nucleation. The supersaturation ratio 
in experiments carried out with the fast cooling rate at higher saturation concentrations of 
SA would be comparable with the supersaturation in experiments carried out with the 
slow cooling rate at lower saturation concentrations of SA. In order to investigate this 
postulate, direct measurement of the nucleation temperature would be required and a 
broader range of SA and additive concentrations studied, at a range of cooling rates. 
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4.13 Understanding the effect of the PP123 additive on crystal growth 
4.13.1 Indexing the crystal faces 
The crystal faces involved in the morphology change were identified via face indexing 
(Figure 4.37).  
 
 
Figure 4.37 - Faces of SA crystals: (a) plate-like crystals from crystallisations with no polymer; 
(b) block-like crystals from low saturation crystallisations and (c) rod or needle-like crystals from 
high saturation crystallisations. 
 
Upon addition of the PP123, the (100) face remains prominent. However, its prominence 
decreases with increased saturation concentration of SA and concentration of polymer as 
the crystal shape moves towards a needle-like morphology. This suggests that the growth 
rate in the direction of this face (along the crystallographic a axis) is faster than those of 
the other faces under these conditions. This is also evident in peak intensity changes due 
to preferred orientation in the experimental PXRD patterns (Figure 4.38).  
 





Figure 4.38 - PXRD of samples of each morphology showing preferred orientation. 
 
As described in Section 4.3.1, due to polymorphic transitions induced by the grinding 
process, the PXRD samples were prepared without grinding; the habit change is thus 
evident through preferred orientation. In the PXRD pattern for crystallisations in the 
absence of polymer, the (100) peak is more intense than in the PXRD pattern for the 
block-like crystals produced in the presence of polymer at low saturation concentrations 
of SA. Furthermore, in the pattern for the needle-like crystals produced in the presence of 
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the polymer at high saturation concentrations of SA, in which the (100) face is much 
diminished, the (100) peak is barely discernible. This change in crystal shape, and 
observed increase in the growth rate of the (100) face, suggests that the growth of the 
side faces is being inhibited by the presence of the PP123, slowing down growth in the 
direction perpendicular to the face and leading to needle-like growth along the (100) 
direction.  
 
Looking at the side faces, the (010) face is present in all of the morphologies, however it 
increases in size in crystals produced in the presence of the additives. It is also evident 
that in the presence of the PP123, the (111) faces become more dominant over the 
(011) faces. This face change can be observed in crystals obtained from crystallisations 
at low saturation of SA and low concentration of polymer which retain a plate like 
morphology but in which both the (011) and the (111) faces are present. Scanning 
electron microscopy (SEM) images show this (Figure 4.39b) and also that at higher 
saturation of SA only the (111) and (11̅1) faces are observed (Figure 4.39c). This 
suggests that the growth along the (111) and (11̅1) directions is being inhibited by the 
presence of the polymer, allowing these to become more prominent faces.  
 
 
Figure 4.39 - SEM images of SA crystals crystallised under the following conditions:  
(a) Tsat = 30 °C, no polymer; (b) Tsat = 20 °C, 0.25% PP123 (side view); (c) Tsat = 30 °C, 0.17% 
PP123; (d) Tsat = 30 °C, 0.5% PP123; (e) Tsat = 27 °C, 0.5% PP123; (f) Tsat = 40 °C, 0.5% PP123. 
 
The SEM images also reveal a more detailed picture of the surface of the crystals. On the 
block-like crystals the (100) face has a smooth surface, however, the (111), (11̅1), (010) 
and (01̅0) faces are more irregular, with well-defined steps. These irregularities are more 
 
(a) (b) (c) 
(d) (e) (f) 
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evident on the crystals produced from higher saturation experiments (Figure 4.39d). It is 
clear that these crystals remain single crystals; the crystals extinguish polarised light 
uniformly under a microscope. Diffraction patterns from these generally show single, 
sharp spots characteristic of single crystals but with some diffuse streaky spots also 
evident. Furthermore, the surface of the (100) face remains smooth and appears too 
uniform for the crystals to be agglomerates. The cause of this phenomenon is 
undetermined at present. 
 
4.13.2 Analysis of the crystal structure of β-SA 
The crystal structure of SA was analysed with respect to the results from the face 
indexing to investigate which functional groups of the molecule are present on the crystal 
surface that may be interacting with the polymer. In the crystal structure of β-SA, the 
molecules arrange themselves in hydrogen bonded chains linked by carboxylic acid 
dimers. The chains lie in two orientations, forming consecutive layers. One orientation 
runs parallel to the (111) plane, the other parallel to the (11̅1) plane (Figure 4.40). The 
only intermolecular interactions between these planes are short contact interactions 
between the layers of SA molecules. The hydrophobic CH2 groups lie on the surface of 
both the (111) and the (11̅1) faces suggesting that the polymer is interacting with these 
groups. These groups are also present on the surface of the (010) face which is slightly 
larger on crystals grown in the presence of the PP123 additive, suggesting that growth in 
the direction perpendicular to the (010) face may also be inhibited by the additive.  
 
  
Figure 4.40 - Packing arrangement of β-SA: (left) view along the (111) and (11̅1) planes and 
(right) view along the (010) plane. 
 
4.13.3 Additional experiments with PEG and PPG 
As noted above, PP123 is a triblock co-polymer comprising blocks of hydrophilic 
polyethylene glycol (PEG) and hydrophobic polypropylene glycol (PPG). To investigate 
which part of the polymer may be interacting with the surface of the growing crystals, 
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additional crystallisations were carried out at 10 ml scale with the individual blocks of 
PP123 (PEG and PPG) as additives; the resulting crystal morphologies from these 
experiments are shown in Figure 4.41.  
 
 
Figure 4.41 - Microscope images of SA crystals from crystallisations carried out with 
(top) PEG1000 and (bottom) PPG4000 at 10 ml scale. 
 
It was found that the presence of the hydrophilic block, PEG1000, had no effect on the 
morphology of SA even when the concentration of polymer was increased to 1%. In 
contrast, the crystallisations with the hydrophobic block, PPG4000, mostly resulted in 
block-like crystals with the same faces as the crystals produced from experiments at low 
saturation of SA or low concentration of PP123, as confirmed by microscopy and face 
indexing. This suggests a possible mechanism for the additive effect of PP123 in which 
the hydrophobic PPG4000 block of the co-polymer is interacting with the hydrophobic 
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faces of the crystals, on which the CH2 groups are present, causing inhibition of growth 
on these faces.   
 
Use of PPG4000 alone as an additive appears to have some additional benefits. In 
contrast to the experiments with PP123, the crystals produced at high saturation of SA 
remain block-like rather than needle-like, extending the concentration range over which 
the favourable block-like morphology can be obtained. At Tsat = 40°C and as the 
concentration of PPG is increased the surface of the crystals is increasingly more 
rounded suggesting that under these conditions the crystals may be growing via a 
continuous growth mechanism. 
 
Crystallisation in the presence of Pluronic F127 (PF127) was also carried out at 10 ml 
scale. PF127 has a shorter PPG and longer PEG block than PP123. As observed with 
the PEG1000, PF127 had no effect on crystal morphology, indicating again that the PPG 
block is important in the morphology change. 
 
 
Figure 4.42 - Microscope images of SA crystals from crystallisations carried out with PF127 at  
10 ml scale. 
 
 
4.14 Investigating the purity of the crystalline product 
The aim of crystallisation in the presence of additives is to improve the shape of the 
crystals whilst the additive remains in solution. In crystallisation in the presence of 
structurally similar additives the solution is designed to remain undersaturated with 
respect to the additive meaning that the additive will stay in solution and should not be 
present in the final solid product after filtration.  Although some polymer additives offer 
the benefit of being non-toxic and are often used as excipients in pharmaceutical 
formulations, it is important to understand whether any additive is left behind in the 
product. The additive may adhere to the surface of the crystals meaning that washing 
steps may be required to remove the compound. Several techniques were used in order 
to investigate whether the polymer additive was present in the product of the 
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crystallisations carried out here. Both analytical methods and a non-quantitative method 
of recrystallising the product after washing steps to observe residual effects on crystal 
morphology were employed. 
 
4.14.1 Analytical methods 
FTIR spectra of samples crystallised with and without additive present were recorded 
(Figure 4.43); these display no differences from each other, or correlation with the 
spectrum produced from the PP123 polymer. The polymorphic form of the product from 
each crystallisation was analysed using PXRD and Raman spectroscopy; the latter are 





Figure 4.43 - FTIR spectra for (a) PP123, SA samples crystallised (b) without and (c) with PP123 





Figure 4.44 - Raman spectra of SA crystallised (top) without and (bottom) with PP123 present in 
solution; the spectra are consistent with -SA. 
 
DSC and NMR were also used (Figure 4.45, and Appendix A4.1), as well as MALDI-TOF 
mass spectroscopic analysis (Appendix A4.2), again showing no evidence of the 





Figure 4.45 - Differential scanning calorimetry for SA samples crystallised (a) without and (b) with 
PP123 present in solution. 
 
The small quantity of polymer initially added to the crystallisation (1.15 mg ml1) was 
within the defined detection limit (0.05 mg ml1) of the MALDI-TOF method. That the 
polymer was not detected in the samples suggests that the polymer is not incorporated 
into the crystal lattice. However, it may be present on the surface of the crystals, but in 
lower concentrations than those detectable by the method (< 0.05 mg ml1).  
 
As a result of the limited success of using analytical techniques, an alternative approach 
was also adopted that involves washing experiments, using the presence of morphology 




4.14.2 Recrystallisation and slurrying experiments 
A series of preliminary crystallisation experiments were carried out on a sample 
previously crystallised from solution containing the highest concentration of PP123 
additive (and whose morphology had been modified to rod-like (Figure 4.46)) to assess 
whether trace amounts of PP123 were present in the crystals or on their surfaces. In 
theory, if no polymer is left behind on the crystals, subsequent recrystallisation of the 
sample from water would result in crystals of the original plate-like morphology. 
 
Recrystallisation of this sample from water produced crystals of block-like morphology 
(Figure 4.46 I), indicating that PP123 may remain on the surface of the crystals, in 
quantities smaller than those detectable by the analytical techniques implemented  
(Figure 4.43, Figure 4.44, Figure 4.45 and Appendix A4.1-A4.2). As a result of this 
observation, a number of washing experiments were carried out. Recrystallisation of 
samples that had been repeatedly washed with cold water, in combination with filtration, 
again continued to produce the morphology-modified crystals (Figure 4.46 II). Washing 
with water also resulted in a significant decrease in crystal yield due to dissolution. This 
suggests that a small quantity of the polymer still remains bound to the crystal surfaces of 
the SA following dissolution or washing in a polar solvent. When this method was 
repeated with a less polar solvent (diethyl ether), however, the resulting crystals were 
less block-like (Figure 4.46 III) indicating that diethyl ether washing is removing residual 
polymer from the crystal surfaces.  Slurrying of the crystals in diethyl ether for one hour 
prior to recrystallisation from water was found to be a more successful washing technique 
than washing with filtration. Washing by reslurrying the product in a solvent allows crystal 
agglomerates, which may entrap mother liquor, to break up whereas channelling may 
occur by washing on a filter so not all of the crystals have contact with the washing 
solvent.162 The crystals resulting from the slurry-washing experiments were of plate-like 
morphology as previously observed in the crystallisations of SA with no polymer present 
(Figure 4.46 IV). This experiment was repeated and again resulted in crystals of plate-like 
morphology (Figure 4.46 V). Thus the non-polar solvent had the effect of removing the 
polymer from the crystal surfaces, suggesting it is acting as a competitor for the  
polymer-crystal surface hydrophobic binding interaction. This also supports the 
conclusion that PP123 is not incorporated in the crystals of SA, and that the residual 





Figure 4.46 - Microscope images of SA crystals from washing experiments: (a) washing with 
filtration with cold water, (b) washing with filtration with diethyl ether, (c) slurrying in diethyl ether 
and (d) repeat of slurrying in diethyl ether. 
 
 
4.15 Further experiments carried out at 350 ml scale 
4.15.1 Direct nucleation control (DNC) experiments 
Feedback control strategies can be effective in improving crystal quality and size 
uniformity by controlling the number of nuclei present in the system.163-165 Such a strategy 
is implemented by maintaining the number of particle counts detected by the FBRM 
probe during a crystallisation process constant by heating and cooling the solution. If the 
particle counts are higher than the target number of counts, the control software reacts by 
































particles. If the number of counts is too low the temperature is decreased to enable 
growth of the existing particles and nucleation of new particles. This process continues 
until the crystallisation reaches the set point of counts per second.  
 
An automated DNC strategy for crystallisation of SA from water was implemented using 
the CryPRINS software, based on FBRM data. Additional DNC experiments were also 
carried out in the presence of the PP123 polymer to observe the combined effect of the 
additive and the DNC strategy on the crystal morphology. These initial DNC experiments 
were carried out in collaboration with Dr Elena Simone and Professor Zoltan Nagy at 
Loughborough University following on from the scale-up work detailed in Section 4.11. An 
additional, more detailed and optimised DNC study on this system was carried out 
subsequently by Dr Elena Simone.166  
 
4.15.1.1 DNC with no additive present 
Figure 4.47 and Figure 4.48 show the results from the two experiments with set points 
200 and 100 particle counts/second, respectively. The results show that with no additive 
present, two heating/cooling cycles were required to reach each set point.  
 
 
Figure 4.47 - Graph showing the temperature profile (black) used for the DNC experiment of SA 
crystallised with no additive present with an FBRM set point of 200 counts/sec (red). Data from the 




































































































Figure 4.48 - Graph showing the temperature profile (black) used for the DNC experiment of SA 
crystallised with no additive present with an FBRM set point of 100 counts/sec (red). Data from the 
Raman and PVM probes are also shown (blue and orange, respectively). 
 
Upon inspection of the crystal morphology before and after DNC it can be concluded that 
the DNC process has generated large, plate-like crystals of more uniform morphology 
than those observed without DNC (Figure 4.49). Face indexing was also used to confirm 
the morphology was the same as that observed with no DNC (Figure 4.50). 
 
 
Figure 4.49 - Microscope images of crystals obtained from DNC experiments with no additive. 
 
 




































































































4.15.1.2 DNC with 0.5% PP123 additive present 
DNC was also carried out on crystallisations containing 0.5% PP123 present in solution 
(Figure 4.51 and Figure 4.52). When comparing the results from these experiments with 
those with no additive present it is evident that more cycles are required for the particle 
counts to reach the same set point in the presence of the additive (in both cases of 200 
and 100 counts/second, three cycles were required to reach the set point). This may be a 
result of the inhibiting effect of the PP123 additive on the growth of the crystals increasing 
the cycles required to reach the desired number of particle counts.  
 
 
Figure 4.51 - Graph showing the temperature profile (black) used for the DNC experiment of SA 
crystallised with 0.5% PP123 present with an FBRM set point of 200 counts/sec (red). Data from 
the Raman and PVM probes are also shown (blue and orange, respectively). 
 
 
Figure 4.52 - Graph showing the temperature profile (black) used for the DNC experiment of SA 
crystallised with 0.5% PP123 present with an FBRM set point of 100 counts/sec (red). Data from 
the Raman and PVM probes are also shown (blue and orange, respectively). 
 
Figure 4.53 shows the crystal morphology produced from the DNC experiments with 0.5% 









































































































































































































however, they are more rod-like than those produced without DNC; in the latter the 
crystals are block-like in the presence of polymer additive. Indexing of the faces of the 
crystals from the DNC experiments showed that the dominant faces remain the same as 
those observed in the absence of DNC and the same face change is observed from when 
no additive is present.  Thus the combination of DNC and polymer additive is affecting the 
relative rates of face growth, while generating a similar trend of morphology modification. 
 
 
Figure 4.53 - Microscope images of crystals obtained from DNC experiments with 0.5% PP123 
additive present in solution.  
 
 
Figure 4.54 - Indexing of crystal from DNC crystallisation in the presence of 0.5% PP123 additive. 
 
4.15.2 Temperature cycling experiments 
Temperature cycling with no feedback control can also be used as a strategy to obtain 
improved particle shape and narrow size distributions, though it is often less efficient in 
process terms. Heating and cooling cycles allow for dissolution of fines and growth of 
larger particles to produce narrow particle size distributions.167 In addition, temperature 
cycling may impact the shape of the crystals since different faces have different relative 
growth and dissolution rates.  
 
The crystallisation experiments presented in this section were carried out by Dr Elena 
Simone at Loughborough University using the SA system in which prior collaborative 
work had been carried out (Section 4.11 and Section 4.15.1). The work is presented here 
as the outcomes of the experiments were analysed by the author in terms of the particle 
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morphology and indexing of the crystal faces. Results from temperature cycling 
experiments are presented in more detail in Simone et al.166 
 
Crystallisations of SA with temperature cycling were carried out with and without the 
PP123 additive present in solution. In the initial experiment with no additive present, 
following nucleation at 10 °C heating and cooling cycles of 4.5 °C were applied. After a 
period of two consecutive days, an equilibrium state was identified using the PAT data. 
Figure 4.55 shows an overlay of the temperature profile and the total counts per second 
from the FBRM probe over the two day period of temperature cycling. The total counts 
per second from the FBRM probe decreases until it reaches a constant value of 50 
counts per second. 
 
Figure 4.55 - Temperature profile and total counts per second recorded from the FBRM statistics 
during temperature cycling over a period of two days.  
 
During and after the experiment, samples were taken from the vessel and microscopy 
was used to observe the effect of the temperature cycling on the crystal morphology.  
Figure 4.56 shows the crystal morphology after temperature cycling. In contrast to the 
DNC experiments, temperature cycling with no additive present in solution resulted in a 
significant change in the shape of the SA crystals to square bipyramidal shaped crystals. 
 
 
Figure 4.56 - Microscope image of square bipyramidal morphology produced from temperature 
cycling experiments with no additive present. 
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In addition, the crystals were examined in more detail using face indexing. The 
temperature cycling appears to promote the growth of the (110) and (11̅0) faces over the 
(100) which is prominent in the plate-like crystals produced prior to temperature cycling 
(Figure 4.57).  
 
 
Figure 4.57 - Face indexing of SA crystals produced in the presence of no additive before (left) 
and after (right) temperature cycling. 
 
It is also interesting to note that the final equilibrium shape produced in the temperature 
cycling experiments is more comparable with the shape calculated by the BFDH method 
than any other morphology presented herein. The (100) face present in the BFDH shape 
is accompanied by the (110) and (1̅10) faces present in the crystals produced from 
temperature cycling which are not present in the original morphology (Figure 4.58).  
 
 
Figure 4.58 - BFDH morphology of β-SA. 
 
The equilibrium shape could also be obtained using larger cycling amplitudes in which the 
time required to reach steady state was reduced. Larger heating and cooling cycles 
enables more rapid dissolution of the smaller particles and quicker adjustment to the 






Temperature cycling was also carried out with the PP123 additive present in solution; the 
time required for the particle counts per second to reach a constant value was greater in 
the presence of the additive and the equilibrium square bipyramidal shape was not 
observed. Instead, rod-like crystals were produced which, in addition to the longer time 
required to reach equilibrium, may be a result of the inhibiting effect of the additive on the 
growth of SA. Analysis of the rod-like crystals was also carried out using face indexing 
which showed the morphology to be the same as that produced in the additive 
experiments with no temperature cycling.  
 
Significant differences were thus observed between the morphology obtained using DNC 
and using temperature cycling without DNC, specifically with no polymer present. In the 
preliminary DNC experiments presented here, the predicted equilibrium shape was not 
produced and instead, large plate shaped crystals formed.  
 
It should also be noted that, in practical terms with respect to the potential implementation 
of morphology modification strategies in industrial processing contexts, the need for 
repeat crystallisation cycles may be unfavourable. The polymer additive effect has been 
found in a single cooling run and offers a certain degree of control over particle size and 
shape (via polymer concentration, SA concentration and cooling rate) in the SA 
crystallisations presented here. However, in terms of particle size uniformity, the 
combination of the use of additives and temperature cycling techniques may enable 
access to desirable morphologies in more narrow size distributions. 
 
 
4.16 Application of PP123 additive to other dicarboxylic acids 
The aim of this experiment was to observe the possible effect of the PP123 polymer 




Figure 4.59 - The structure of adipic acid. 
 






Figure 4.60 - Microscope images of AA crystallised from water (Tsat = 40 °C). 
 
In the presence of PP123 additive the AA crystals become increasingly elongated at high 
saturation concentration of AA (Figure 4.61). The crystallisations at low saturation  
(Tsat = 20 °C) show a variable crystal morphology suggesting that the mixing rate was not 
sufficient to establish uniform mixing conditions. The needle-like crystals observed at  
Tsat = 40 °C are comparable with those produced under the same conditions with SA.  
 
 
Figure 4.61 - Microscope images of AA crystallisations carried out in the presence of 0.5% of 
PP123 additive. 
 
The results from these additional crystallisations indicate that the PP123 polymer additive 





In this work the presence of very small quantities of a polymer additive (Pluronic P123) 
have been shown to be effective in reproducibly modifying the crystal morphology of SA 
from plates to blocks when grown from aqueous solutions. The production of block-like 
crystals is more desirable in terms of ease of downstream processing and despite the 
large change in crystal morphology the solid form remains β-SA in all cases.  
 
The additive effect was investigated at various batch scales from 1 ml to 350 ml. The 
effect of the polymer is shown to be dependent on both the concentration of SA and the 
concentration of polymer in solution. At high saturation of SA or high concentration of 
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polymer, needle-like crystals are produced whereas at low saturation of SA or low 
concentration of polymer, more desirable block-like crystals are produced. Fine tuning of 
the crystallisation conditions enabled identification of the conditions required to produce 
the most desirable block-like morphology. Block-like crystals are shown to be produced at 
scales from 10 to 350 ml scale, where overhead stirring can be implemented. The chosen 
method of mixing and geometry of the impeller was found to be crucial in terms of the 
crystal shape and uniformity; experiments with magnetic bottom stirring resulted in 
needles at high saturation and non-uniform crystals at low saturation. In addition to the 
concentration of SA and concentration of additive, the effect of cooling rate was also 
investigated. It was found that at slower cooling rates, a more enhanced effect of the 
additive was observed. 
 
Where the nucleation temperature could be measured accurately using in-line analysis 
(turbidity or FBRM), it was found in all cases that, in the presence of the polymer additive 
PP123, a decrease in the supersaturation ratio with increasing saturation concentration of 
SA was observed. At low supersaturation fewer crystals formed but the high initial 
concentrations of SA mean that more material is available in solution for the crystals to 
grow, enabling the production of larger (or longer for needles) crystals compared to those 
produced at low saturation temperatures. On-line and in-line analysis also allowed for 
investigation of the effect of the polymer additive on the nucleation temperature. It was 
found that, at 3 ml scale, the additive appeared to widen the MSZW by 7-10 °C, whereas 
at 350 ml scale the additive had little effect on the nucleation temperature.  
 
Experiments were also carried out to investigate the mechanism by which the polymer is 
affecting crystal growth. Further experiments using the individual blocks of the triblock co-
polymer suggest that the PPG block of the polymer interacts with the interface of the 
growing crystal via hydrophobic interactions. Face indexing of the crystals produced and 
subsequent analysis of the crystal structure of β-SA showed that the faces being inhibited 
are hydrophobic faces, which are likely to interact with the PPG block of the triblock co-
polymer. Interestingly, when the PPG block alone was used as the additive in high 
concentrations or at high saturation of SA, block-like crystals were produced whereas 
with PP123, needle-like crystals would be produced under these conditions. This 
extension of the concentration range over which the favourable block-like crystals are 
produced is a significant benefit in terms of the goal of this work; to produce particles 




A range of analytical techniques were implemented to investigate whether the polymer 
was present in the final filtered product. However, the techniques used did not show the 
presence of any polymer at their level of sensitivity. To investigate this further, an 
alternative experimental method to deduce the presence of residual trace amount of 
polymer was implemented; using morphology-modification as a diagnostic of the 
presence or absence of polymer. Multiple recrystallisation and washing experiments were 
carried out which showed that polymer was present on the surface of the crystalline 
product. This derivative technique was successful in the identification of quantities of 
polymer smaller than those detectable by the analytical techniques previously employed. 
Washing the crystals in a low polarity solvent allowed for removal of the residual polymer 
present, in particular slurry-washing was shown to the most effective method for 
achieving this.  
 
Additives can be effective in modifying crystal morphology; however one of the limitations 
of this method is the addition of an impurity into the system which will require extra 
washing steps to remove. Direct nucleation control (DNC) and temperature cycling are 
presented as an alternative method of obtaining improved crystal size distributions and 
different morphologies. Implementation of DNC was effective in modifying the size of the 
crystals but not their shape. In the absence of the PP123 additive, large plate-like crystals 
were produced whereas large rod-like crystals were produced in the presence of the 
PP123 additive showing that the additive effect was reproduced with DNC methods. 
Unlike in the DNC experiments, temperature cycling of SA in the absence of additives 
produced a square bipyramidal shaped equilibrium morphology which was analysed by 
indexing the crystal faces and found to be more in agreement with the BFDH-predicted 
morphology. Temperature cycling with the additive present resulted in the rod-like 
morphology produced previously. It is also noted that these additive-free methods have 
the disadvantage of requiring repeat crystallisations, which may be unfavourable in terms 
of implementing efficient processes. However, combining the use of additives with such 
methods may enable access to desirable morphologies in more narrow size distributions. 
 
Initial studies into application of the PP123 additive to the crystallisation of adipic acid, a 
longer chain dicarboxylic acid than SA, were also carried out. Under the conditions 
explored, the additive had a similar influence on the crystal shape as SA where needle-
like crystals were produced. This indicates that the polymer-additive effect may be 
















Continuous crystallisation of succinic acid 
 
Traditionally, batch methods of crystallisation have been utilised in the pharmaceutical 
and fine chemical industries. Unlike others, these industries have not kept pace with 
advances in continuous modes of operation, relying heavily on the use of stirred tank 
reactors which, as noted above, can bring batch to batch variations and limited control 
over particle attributes.75 In recent years, there has been significant drive towards 
developing continuous methods of crystallising pharmaceuticals and other fine chemicals 
due to the opportunity to exploit improved mixing and heat transfer and other benefits the 
mode of operation may offer (discussed in Chapter 1). This chapter explores the use of 
two continuous crystallisation platforms for the cooling crystallisation of succinic acid (SA) 
from water, including continuous runs with polymer additives present, with the capability 
to modify morphology as discussed in Chapter 4.  
 
Part of the work presented in this chapter has been published as a journal article: 
K. Robertson, P.-B. Flandrin, A. R. Klapwijk and C. C. Wilson, Design and Evaluation of a 




5.1 Crystallisation in segmented flow 
5.1.1 Introduction and aims 
There are multiple existing platforms designed to facilitate crystallisation processes in 
flow at large macro-volume scale, such as continuous oscillatory baffled crystallisers 
(COBCs) and mixed-suspension, mixed-product removal (MSMPR) crystallisers. 
Reactors that enable production at micro-volume scales such as microreactors have been 
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studied significantly for enabling chemical reactions in flow168 and have also been applied 
to the synthesis of nanometre sized particles.169 However due to the narrow internal 
diameter of such reactors they are often deemed unsuitable for the processing of larger 
sized particles where problems with blockages are likely to occur.168 As a result there has 
been significant interest in tubular mesoscale reactors with larger internal diameters than 
microscale for the processing of solids without the need for large quantities of starting 
materials. Such mesoscale crystallisers often employ segmented flow – immiscible fluid, 
or gas, and a saturated feed solution are independently pumped into the system creating 
discrete segments (or slugs) of each phase. The barrier between the segments helps to 
prevent back-mixing and create homogeneity in the crystallisation conditions in each 
slug.170 Control of the flow rates of the two feeds can optimise the segment size and thus 
maximise the efficiency of mixing.171 The solution segments then flow through the reactor 
where mixing within the segments is facilitated by generation of an internal fluid vortex by 
the non-slip boundary between the immiscible phases.172,173 Segmented flow can be 
operated with air or with a suitable liquid immiscible with the crystallisation solvent, known 
as the carrier fluid, as shown in Figure 5.1. 
 
 
Figure 5.1 - Diagram comparing air and liquid segmentation. 
 
In air segmentation, the solution flow is interrupted by the presence of slugs of air and 
several studies have reported the use of this method in combination with cooling 
crystallisation within the solution segments.171,174 However, use of air segmentation 
(Figure 5.1, left) leaves the solution exposed to the walls of the crystalliser which may 
result in problems in the crystallisation of a compound which has a high affinity to 
nucleate on the walls of the tubing; the resulting fouling may ultimately promote the 
formation of blockages. In contrast, liquid segmentation overcomes this issue by 
generating slugs of solution which are separated from the walls of the reactor with a 
carrier fluid with suitable wetting properties (Figure 5.1, right), avoiding solid build-up on 
the crystalliser walls. Several studies have reported the precipitation of solids using this 
method.170,175 However, one of the main challenges of using liquid segmentation is 
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separation of the carrier fluid from the product at the end of the crystalliser tubing; this is 
tackled in the present work. 
 
The Kinetically Regulated Automated Input Crystalliser (KRAIC) is a mesoscale flow 
reactor designed by Dr Karen Robertson and developed in the Wilson group at the 
University of Bath (Figure 5.2). It is a versatile platform which can be used for many 
functions such as cooling and anti-solvent crystallisation as well as chemical synthesis in 
flow. In the configuration used here, a single, continuous, stream of solution is segmented 
by a flow of immiscible carrier fluid and cooled through passive insulated temperature 
controlled regimes. This results in nucleation and growth of crystals prior to separation of 
carrier fluid and filtration of product. 
 
 




The KRAIC is constructed from 15 m of fluorinated ethylene propylene (FEP) tubing with 
an internal diameter of 3.2 mm which is assembled in three progressively elevating coils. 
The solution and carrier fluid are independently pumped using gear pumps from 
temperature controlled feed vessels to a glass mixer piece (Y or T-piece) to produce 
liquid-segmented flow. Pumping the two feeds independently allows for greater control 
over the segment size and thus mixing conditions. The inlet of each feed line is also fitted 
with a solvent filter to ensure that dust or nuclei from the feed vessels do not enter the 
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system. The coils of the reactor are placed within vessels that can be temperature-
controlled, providing three temperature zones through which the segments flow, allowing 
the generation of supersaturation through cooling, before emerging at the filtration unit at 
the end of the crystalliser for recovery of the product. The temperature inside the KRAIC 
platform is controlled using various methods. The temperature of the feed vessels, mixer 
piece and tubing coils is controlled using hot-plate stirrers with Drysyn® formers, water 
and graphite baths, respectively. During the development of the crystalliser, flexible 
jackets for the tubing between the feed vessel and pump and pump and mixer piece were 
designed in collaboration with Asynt;177 these allow for temperature control of the tubing 
using a bath circulator. The jackets comprise two glass ends connected by outer silicone 
tubing through which the feed tubing is threaded. In addition, the outlet of the reactor 
features an end piece to aid propulsion of the solid product into the filtration unit and to 
recover the carrier fluid from the solution. The design of this end piece was evolved 
through several iterations which will be discussed in the development of the KRAIC 
platform. 
 
A standard crystallisation experiment in the KRAIC is achieved by the following 
procedure: 
 The tubing is primed with pure solvent and carrier fluid for 2 hours in order to 
activate temperature control for all active temperature zones (tubing jackets and 
water baths) and enable equilibration of the temperature within the KRAIC 
including areas of passive insulation (tubing coils); 
 Relative flow rates of the solution and carrier fluid are chosen to optimise the 
segment size and residence time; 
 Pure solvent is switched over to the solution feed to begin the experiment; 
 Supersaturation is generated within each segment by cooling over the length of 
the KRAIC; 
 Upon reaching the end of the crystalliser, recovery of the carrier fluid is followed 
by filtration of the crystals from the solution. The carrier fluid is recycled back into 
its feed vessel. 
 
The work reported herein was carried out as part of, and in parallel to, the development of 
the KRAIC platform. SA was selected as a model system to understand the capabilities of 
the crystalliser due to its fast growth rates when crystallised from water. Selection of this 
compound aimed to highlight areas of investigation for operational issues such as 
encrustation. The second aim of this study was to investigate the possibility of 
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transferring the additive controlled crystallisation of SA detailed in Chapter 4 into the 
continuous environment.  
 
5.1.2 Development of the KRAIC platform 
As SA was used as a model system to aid the development of the custom built KRAIC 
platform, multiple experiments were carried out to evaluate the capabilities of the 
crystalliser and to identify issues that required resolution. The initial design of the KRAIC 
comprised one feed vessel containing the solution which was pumped via a peristaltic 
pump through unjacketed tubing to a Y-piece in which segmentation with a continuous 
flow of air was facilitated. Upon reaching the end of the crystalliser the crystals were 
deposited directly from the end of the tubing into the filtration unit. Although use of air 
segmentation avoided issues with separation of the product from a carrier fluid, contact of 




Figure 5.3 - Image showing encrustation on the walls of the crystalliser in experiments using air 
segmentation. 
 
The fouling disrupted the flow of the segments of solution, caused back-mixing, 
encouraged further nucleation and growth and ultimately led to a blockage in the system. 
This type of segmentation was thus deemed unfeasible for future crystallisations. The 
solid form produced from the experiments was confirmed as the β-form of SA using 





Figure 5.4 - PXRD patterns of (a) β-SA (SUCACB02), (b) α-SA (SUCACB07) and (c) SA obtained 
from the KRAIC with air segmentation. 
 
As a result of the fouling experienced with air segmentation, liquid segmentation was then 
implemented as an alternative and a second feed vessel was added from which the 
carrier fluid was pumped to the mixer piece. The first experiments used dichloromethane 
(DCM) as the carrier fluid due to its immiscibility with water and low solubility of SA in 
DCM. Since the carrier fluid coats the walls of the crystalliser and thus prevents contact of 
the solution with the internal walls of the tubing, in experiments with liquid segmentation 
no encrustation on the walls of the crystalliser was observed once segmentation was 
achieved. Furthermore, the solution slugs were almost spherical in size enabling good 
mixing within the segments (Figure 5.5).  
 
 




However, after one hour of operation, the glass Y-piece showed signs of encrustation, 
segment size had become more inconsistent and fewer crystals were observed in each 
segment. Several minutes later a blockage in the tubing supplying the feed solution was 
detected at the exit of the peristaltic pump and prior to the segmenter piece. In this 
experiment the feed solution, containing a concentration of SA of 0.1 g ml1 (Tsat = 32 °C), 
was maintained at a temperature of 40 °C. It was supposed that the solution was 
sufficiently undersaturated for the SA to remain in solution until reaching the crystalliser. 
However, the rate of heat loss was underestimated and the solution temperature 
decreased sufficiently to induce nucleation within the tubing prior to segmentation.  
 
A series of experiments were then carried out in which the temperature of the feed 
solution was increased in attempt to prevent nucleation in the feed tubes prior to the 
segmentation. The temperature of the carrier fluid was also reduced to room temperature 
to counteract the higher start temperature of the solution thus maintaining expected yield. 
The concentration of the succinic acid solution was kept at 0.1 g ml1. However, no 
crystallisation was achieved with the feed solution at either 60 °C or subsequently at  
50 °C. As a result, the SA solution concentration was increased to 0.12 g ml1. With the 
feed temperature at 60 °C, solids were observed in the second coil. However, after 14 
minutes of operation, encrustation at the outlet of the tubing and after the peristaltic pump 
before the Y-piece was again observed. With the feed vessel at both 40 °C and 50 °C 
precipitation was observed in the first coil but this was accompanied by encrustation on 
the Y-piece within minutes. It was thought that the crystallisation in the Y-piece may have 
resulted from the difference in temperature between the solution and the carrier fluid. This 
experiment was then repeated with the carrier fluid set at 32 °C, but this again resulted in 
heavy encrustation to the Y-piece. Liquid segmentation was therefore effective in 
preventing the encrustation to the FEP body of the reactor tubing once segmentation had 
been achieved. However, encrustation was still possible prior to segmentation, in the Y-
piece as well as in the feed tube. In both cases these are positions at which the solution 
has contact with the reactor walls and is not protected by the carrier fluid. This fouling 
causes multiple issues such as reduction in solid recovery, disruption of segmentation, 
encouragement of further nucleation and growth and ultimately hindered the prolonged 
running of the platform.  
 
The carrier fluid was then changed to a perfluoropolyether liquid (Galden SV110); the 
inert nature of this fluid offers the benefits of being immiscible with a wider range of 
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solvents than DCM and less likely to solubilise the target compound, as well as having 
favourable contact angle with the FEP.  
 
Steps were also taken to try to prevent problems with encrustation (Figure 5.6): 
 The Y-piece segmentation unit was submerged in a glass water bath; 
 The tubes from the feed vessels to the pumps were jacketed with tubing 
connected to a bath circulator, designed in collaboration with Asynt,177 to prevent 
nucleation prior to the segmenter piece. 
 
 
Figure 5.6 - Image showing the water bath for the mixer piece and the tubing jackets. 
 
In previous experiments a double headed peristaltic pump was used to pump the solution 
and carrier fluid into the system. This was replaced with two gear pumps which offered 
the benefit of individual control of flow rates as well as producing more uniform segment 
sizes and less disruption to the flow due to the lower pulsation. The tubing conveying the 
carrier fluid from the feed vessel to the segmenter piece was also altered to 1 mm ID FEP 
tubing in place of 3.2 mm ID Masterflex® tubing. This change in internal diameter was 
implemented in order to avoid problems with air bubbles in the flow; the wetting 
properties of the tubing are such that a continual stream of carrier fluid is impossible in 
tubing with a larger diameter. The transparency of the FEP tubing enabled identification 
of any air in the system. To avoid blockages, the solution tubing was not changed to 
smaller diameters. Additionally, the mixer was changed to a T-piece which resulted in 




The feed and carrier solutions were maintained at 40 °C and room temperature, 
respectively, and a SA solution concentration of 0.12 g ml1 was used. The tubing jackets 
were set at 40 °C meaning that the carrier fluid did not require preheating due to the 
efficacy of tubing jackets around the feed lines and the large surface area for heat 
transfer provided by the small bore tubing. The water bath (40 °C) was effective in 
preventing encrustation to the segmenter piece and the tubing jackets prevented a build-
up of solids in the tubing prior to the segmenter. However, after 30 minutes of operation a 
build-up of solids was detected at the outlet of the crystalliser. At the end of the tubing the 
carrier fluid is able to slip past the solution slugs due to its high density, low viscosity and 
good wetting properties with the FEP tubing, allowing the surface of the tubing to become 
exposed to the suspended crystals. This problem led to the design of an end piece to 
help propel the solution into the collection vessel. An end piece with a split mouth was 
added to the outlet, designed to induce turbulence. This design enabled a run for one 
hour with no encrustation observed on the end of the tubing. 
 
Despite implementation of changes to prevent issues with encrustation one of the major 
continual problems encountered with the set-up was with filtration and the concomitant 
removal of the carrier fluid from the product. In previous experiments a Whatman glass frit 
filter was used to collect the solid product, however the bulk of this hindered the 
changeover of filter paper between residence times and the presence of the carrier fluid 
caused the filter paper to stick to the sintered glass. Problems with changing over the 
filtration unit were resolved by implementing a carousel of Buchner funnels. However, the 
presence of the carrier fluid facilitated adhesion of the particles as well as adhesion of the 
filter paper to the funnel. Together, these problems hindered filtration efficiency which 
resulted in continual growth of the crystals in a slurry in the filter funnel and therefore 
inconsistent measurement of solid recovery and poor recovery of the carrier fluid. A 
method of removing the carrier fluid prior to filtration was therefore desirable.  
 
The end-piece was therefore modified to feature carrier fluid recovery holes designed to 
separate the immiscible fluids through the difference in their wetting properties of the FEP 
tubing. This enabled the carrier fluid to be collected prior to filtration and the solution to 
continue to the filtration unit. This design was effective in removing the carrier fluid and 
reducing the adhesion of the filter paper to the filter funnel. However, after 45 minutes of 
operation, fouling was observed on the end piece at the point of separation of the two 
solution phases. This separation resulted in removal of the barrier between the solution 




A third end-piece design was then implemented which included an inlet for a neutral 
solvent prior to the carrier fluid recovery holes. The term neutral solvent here describes a 
solvent that does not dissolve the product or encourage further precipitation. This solvent 
was pumped into the end piece with the aim of increasing the slurry velocity to prevent 
adhesion of particles to the walls of the crystalliser. This method was effective in 
preventing the encrustation at the site of separation of the solution and carrier fluid for 
over an hour of operation. Furthermore, a test was carried out in which the flow of the 
neutral solvent was stopped; within minutes a blockage formed on the end piece, 




Figure 5.7 - Photograph of (left) the initial end piece design and (right) end piece with carrier fluid 
recovery and input of neutral solvent.  
 
In subsequent experiments, insulation (graphite or sand) was added to the cylinders 
housing the coils of tubing to aid efficient temperature control within the tubing. This was 
effective in insulating the coils and as a result the concentration of SA solution in the feed 
vessel was increased to 0.13 g ml1 to account for this.  
 
Interestingly, it was evident from the PXRD patterns of solid collected from the 
experiments that both the α and β polymorphs of SA were present in all of the samples 
produced with liquid segmentation with both types of carrier fluid (Figure 5.8). In both 
cases the majority of the obtained pattern matches that of the pattern for β-SA, however it 
also features multiple additional peaks. The most intense of these peaks at approximately 
 125 
 
22° and 27° 2 correlate with peaks present in the pattern for α-SA. The α-polymorph was 
not previously observed in the product from batch experiments or in KRAIC experiments 
with air segmentation. Furthermore, α-SA has only previously been produced though 
solution-based methods by use of spray drying.150 In both the liquid-segmentation in the 
KRAIC and in spray drying techniques there is no interaction of the solution with a solid 
interface; the lack of such an interface may be a factor in the solution-based production of 
α-SA. Alternatively, it is possible that the nucleation of the α-SA may be a result of an 
interaction of the solution with the carrier fluid. In order to investigate this further, a 10 ml 
scale batch cooling crystallisation with overhead stirring was carried out with an 8 ml 
saturated solution of SA in water with the same initial concentration as in the KRAIC  
(0.12 g ml1), with the vessel also containing 2 ml of the GaldenSV 110 carrier fluid. A 
cooling profile of 40 °C to 10 °C at 0.5 °C min1 was used. However; this crystallisation 
produced a sample containing only β-SA. 
 
 
Figure 5.8 - PXRD patterns of (a) β-SA (SUCACB02), (b) α-SA (SUCACB07), (c) sample from 
experiment with DCM as the carrier fluid and (d) a sample from experiment with GaldenSV 110 as 
the carrier fluid. 
 
The presence of two polymorphs in the samples can also be inferred from inspection of 
the crystal morphology of the product. The samples shown to contain α-SA and β-SA 
feature crystals of two distinct morphologies: plate-like crystals resembling those 
produced in batch experiments (β-SA) as well as fine and striated plate-like crystals only 
observed in samples containing α-SA (Figure 5.9). Unit cell determination for the striated 
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plate-like crystals by scXRD found such crystals to be α-SA. This suggests that the two 
morphologies observed may represent the two polymorphs of SA. 
 
 
Figure 5.9 - Microscope images showing the different crystal morphologies ((a) plate-like crystals 
and (b) striated plate-like crystals) which are present concomitantly in the samples (image (c)). 
 
5.1.3 Experiments carried out in the optimised design of the KRAIC 
Figure 5.10 shows a schematic of the optimised design of the KRAIC. The two feed 
solutions are independently pumped (using gear pumps) to the mixer piece via jacketed 
tubing. Upon reaching the mixer piece, the two phases are segmented and continue to 
flow through the three coils. Supersaturation is generated within the solution segments 
through cooling and upon reaching the end of the crystalliser the carrier fluid is recovered 
and the crystalline product isolated using vacuum filtration.  
 
Figure 5.10 - Schematic of the KRAIC set-up with temperature zones labelled (T1-7). 
 
5.1.3.1 Experimental information  
The experimental parameters used for all experiments in the optimised set-up are 
summarised in Table 5.1. Prior to the experiment the tubing was primed with pure solvent 
and carrier fluid (40 °C) for 2 hours. The residence volume in the KRAIC is the volume of 
the solution in each residence time and does not include the carrier fluid. 
(a)                            (b)                                 (c) 
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Table 5.1 - Table summarising the experimental information for the crystallisation of SA from water 














Liquid (GaldenSV 110, 
perfluoropolyether) 
16.6 T-piece 
9 min 15 
sec 
56 ml 
RT= Residence time RV = Residence volume 
 
The individual temperatures of the different temperature zones in the KRAIC (labelled in 
Figure 5.10) are detailed in Table 5.2. The three tubing coils were insulated but not 
actively heated thus achieving a smooth cooling gradient which was monitored using 
temperature probes. As shown in Figure 5.11, the temperature along the crystalliser 
varied from 40 °C to 19.6 °C. 
 
Table 5.2 - Temperature zones in the KRAIC and the temperatures used in the experiment. 
Temperature zone Description Temperature (°C) 
1a Feed vessel 40 
1b Feed vessel Room temperature 
2a, 2b Tubing jacket from feed to pump 40 
3a, 3b Tubing jacket from pump to mixer bath 40 
4 Mixer bath 40 
5 Coil 1 30 
6 Coil 2 24 
7 Coil 3 22 
 
 






The carrier fluid was recovered prior to filtration (as described in Section 5.1.2) and a 
neutral solvent (water from an ice bath) pumped into the end piece to continue 
transporting the product solution into the filtration stage. Solid product from each 
residence time was isolated using vacuum filtration, allowing for measurement of solid 
recovery and homogeneity of the crystallisation rate within the experiment (Table 5.3). 
 
Table 5.3 - Solid recovery for each residence time in the crystallisation of SA from water in the 
KRAIC with no additive present. 
% Yield 
RT1 RT2 RT3 RT4 RT5 RT6 RT7 RT8 
2.2 2.7 2.9 3.3 3.5 3.6 3.8 4.4 
 
The crystallisation of SA in the presence of Pluronic P123 (PP123) in the KRAIC followed 
the same experimental procedure as above with the exception that the feed solution also 
contained 0.5% PP123 (0.0007 g ml1). Due to reasons discussed below, accurate 
calculations of solid recovery are not reported for these experiments. The crystallisation 
of SA in the present of polypropylene glycol 4000 (PPG4000) again followed the same 
procedure but with 0.17% PPG4000 (0.0002 g ml1) present in the feed solution. Table 
5.4 shows the solid recovery for the experiment.   
 
Table 5.4 - Solid recovery for each residence time in the crystallisation of SA from water in the 
KRAIC with PPG4000 present. 
% Yield 
RT1 RT2 RT3 
0.5 1.1 1.0 
 
Crystal shape and size distribution was monitored visually using optical microscopy. 
Microscope images were captured using a Nikon Coolpix P5100 camera attachment to a 
Brunel Microscopes microscope and a Leica DM1000 microscope equipped with an 
Infinity 2 microscopy camera at 4x magnification. 
 
The solid form of the product was monitored using PXRD, for which further experimental 





5.1.3.2 Crystallisation of succinic acid with no additive present 
In repeated experiments in the optimised design of the KRAIC, SA crystals were 
consistently observed mixing inside the solution segments in the top of the second coil 
within 7 minutes of starting the experiment. This consistency of the nucleation point within 
the KRAIC, in the absence of seeding, may be a result of the sterile environment inside 
the platform. The solutions are filtered prior to entering the system and use of liquid 
segmented flow prevents exposure of the SA solution to any imperfections on the internal 
walls of the reactor, which can be a site of nucleation.  
 
With no additive present the crystalliser was successfully operated for 1.5 hours with no 
encrustation observed within the platform. An average yield of 0.24 g (2%) was collected 
for each residence time. However, the masses observed range from 0.16 g – 0.32 g 
throughout the duration of the experiment. This variation between residence times may 
be attributed to a gradual decrease in the segment size during the experiment. This may 
have resulted in an increased mixing efficiency which may have led to an increased 
number of nucleation and growth events. It is clear that the solid recovery requires 
optimisation and in future experiments temperature control could be implemented within 
the coils to lower the temperature and increase the solid yield. A different neutral solvent 
could also be identified to eliminate the possibility of dissolution of the precipitate 
following recovery of the carrier fluid. The solid form of the product of each residence time 
was investigated using PXRD. The PXRD pattern from each residence time shows peaks 
corresponding to both the α-SA and β-SA polymorphs, as shown in Figure 5.12.  
 
Figure 5.12 - PXRD patterns of (a) β-SA (SUCACB02), (b) α-SA (SUCACB07) and patterns from 
each RT in the KRAIC experiment with no additive present. 
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This correlates with the findings presented above from previous development 
experiments in the KRAIC with liquid segmentation. Preferred orientation effects can be 
observed in the patterns due to the sample preparation. The crystals were not ground to 
monodisperse sizes in order to avoid conversion of the polymorphs through grinding 
(discussed in Chapter 4).   
 
Figure 5.13 shows the morphology of the crystals produced in the experiment. As noted 
in previous development experiments, two types of morphology are observed: plate-like 
crystals of inconsistent sizes and fine, striated plate-like crystals. This finding correlates 




Figure 5.13 - Microscope images of the crystal morphology of SA produced in the optimised 
design of the KRAIC with no additive present. 
 
5.1.3.3 Crystallisation of succinic acid in the presence of polymer additives  
Additional experiments were also carried out in the presence of polymer additives with 
the aim of reproducing in the KRAIC the results observed in the batch environment. 
Firstly, experiments were carried out with 0.5% Pluronic P123 (PP123) present in the 
feed solution. Needle-like crystals were produced in the presence of the additive, 
modified from the plates, as observed in the batch environment under these conditions 
(Figure 5.14). Production of the more favourable block-like crystals would require lower 
starting concentrations of SA and therefore, operation at lower temperatures. Conditions 
which nucleated at room temperature, producing needle-like crystals, were tested as a 
starting point to obtain the correct conditions to observe a morphology change in this 
platform.  
RT1           RT2          RT3         RT4 




Figure 5.14 - Microscope image of SA crystals produced in the presence of PP123 in the KRIAC. 
 
Despite the observed morphology change, showing the initial success in transferring the 
additive effect to a continuous crystallisation environment, the surfactant properties of the 
polymer enabled the polymer to act as an emulsifier of the water and carrier fluid and 
consequently disrupted the segmentation. Interestingly, in the presence of the polymer, 
only pure β-SA was produced with no α-SA present in the solid product, unlike 
experiments with no polymer present discussed above. This may be as a result of the 
disruption of the segmentation and subsequent contact with the crystalliser walls. PXRD 
patterns showing these findings are presented in Figure 5.15. 
 
Figure 5.15 - PXRD patterns of (a) β-SA (SUCACB02), (b) α-SA (SUCACB07) and (c) SA sample 
from the KRAIC run in the presence of PP123. 
 
As a result of the incompatibility of the carrier fluid and the water containing PP123, 
experiments were also carried out with polypropylene glycol 4000 (PPG4000) present in 
solution. In the batch experiments, the presence of PPG4000 displayed a similar effect to 
PP123, producing block-like crystals of SA in a broader range of concentrations. The 
block-like crystals could be produced in the case of PPG4000 additive with small 
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quantities of polymer present and therefore a concentration of 0.17 % was used for the 
experiment in the KRAIC. However, unlike in the batch environment the block-like 
morphology was not reproduced. Instead, plate-like crystals with well-defined edges were 
observed in addition to fine plate-like crystals with striated edges (Figure 5.16).  
 
Figure 5.16 - Microscope images of crystals produced in the KRAIC in the presence of PPG4000. 
 
This lack of production of the block-like crystals may be as a result of the gentler mixing 
conditions in the KRAIC in comparison to the batch environment and therefore a higher 
concentration of the additive may be required to produce a comparable effect on the 
crystal morphology of SA. The solid recovery was also lower than with no additive present 
with very limited crystallisation observed within the slugs. This may be due to the polymer 
imparting an inhibiting effect on nucleation under these conditions. However, the 
presence of the PPG4000 polymer in this case did not disrupt the segmentation and 
therefore future work could be directed towards optimisation of this experiment with a 
higher starting concentration of both SA and the PPG polymer. PXRD analysis of the 
samples from each residence time showed that both α-SA and β-SA were present in the 
samples (Figure 5.17).  
 
Figure 5.17 - PXRD patterns of (a) β-SA (SUCACB02), (b) α-SA (SUCACB07) and samples 
obtained from the KRAIC experiment with PPG4000 present in: (c) RT1, (d) RT2 and (e) RT3. 
RT1           RT2          RT3         RT4 
 133 
 
This finding, in the situation where segmentation has not been disrupted, correlates with 
the reasoning that α-SA may form in solution in the absence of a solid interface discussed 
in Section 5.1.2. 
 
 
5.2 Crystallisation in the Continuous Oscillatory Baffled Crystalliser 
5.2.1 Introduction and aims 
The Continuous Oscillatory Baffled Crystalliser (COBC) is a marketed platform developed 
by NiTech Solutions.80 It operates at larger scale than the KRAIC (g h1) and is a glass, 
tubular crystalliser with jacketed straights comprising small cells separated by equally 
spaced orifice baffles (Figure 5.18).  
 
 
Figure 5.18 - The DN15 Continuous Oscillatory Baffled Crystalliser (COBC) used in this study. 
 
The solution is pumped into the crystalliser with oscillatory motion superimposed on the 
net flow, and the interaction of the flow with the baffles generates eddy currents enabling 
good mixing conditions in each cell (Figure 5.19).178 As in many flow platforms, the high 
surface area to volume ratio also allows for excellent heat transfer throughout the system, 
an advantage over stirred tank reactors in providing precise control over temperature. 
Through the combination of net flow from the peristaltic pump and the oscillation, the 
platform is designed to operate in plug flow; which describes the situation in which the 
same residence time is achieved for all elements of the liquid.179 In theory, this is 
beneficial since under these conditions every particle experiences the same conditions, 










The oscillatory flow in the COBC can be described by three dimensionless numbers: the 
oscillatory Reynolds number (Reo), the Strouhal number (St) and the net flow Reynolds 
number (Ren). The intensity of the oscillation in the COBC is governed by the oscillatory 
Reynolds number,178-180 the ratio of the tube diameter to the oscillation amplitude is 
described by the Strouhal number, thus describing the propagation of eddies through the 
baffles, and the net flow Reynolds number describes the oscillatory mixing under 
flow.5,179,181 These parameters are described by the following equations: 
 















Where f = frequency (Hz), xo = centre to peak amplitude (m), ρ = density (kg m
3),  
d = internal tube diameter (m), μ = fluid viscosity (kg m1 s1) and u = mean velocity 
(ms1). 
 
The calculation of Reo and Ren allows for the determination of the velocity ratio, , which 
relates the oscillatory velocity and net flow velocity through the following equation: 
 







The velocity ratio should be greater than one, with the velocity of oscillation higher than 
the velocity of net flow through the crystalliser for effective mixing.179 To achieve plug 
flow, it is recommended that oscillatory flow proceeds with Reo ≥ 100, St ≤ 0.5, Ren ≥ 50 
and the velocity ratio should remain in the range of 2-10.179-181 
 
Several studies of crystallisation under continuous oscillatory flow have recently been 
reported. Briggs et al. demonstrated the successful seeded continuous cooling 
crystallisation of L-glutamic acid in a COBC in which control over polymorphic form was 
achieved.181 Continuous crystallisation of a model API was reported and a residence time 
of 12 minutes was used compared to a 9 hour and 40 minutes batch crystallisation.5 
Multi-component materials have also successfully been produced in the continuous 
oscillatory environment such as the crystallisation and scale-up of α-lipoic 
acid:nicotinamide co-crystal.178 However, there are currently no reports of the combined 
use of polymer additives to control crystal morphology whilst operating in a continuous 
oscillatory environment. Therefore, the aim of this study was to investigate the transfer of 
the additive-mediated morphology change of SA crystals when crystallised from water 
(reported in Chapter 4) achieved in a batch environment, to the continuous environment 
under oscillatory flow.  
 
5.2.2 Experimental information 
In this work the DN15 COBC was used in a vertical set-up comprising four jacketed glass 
straights and three unjacketed glass bends (Figure 5.20). The set-up has a working 
volume of 612 ml and the glass tubes have an internal diameter of 15 mm. The inside 
temperature of the glass straights was controlled using four circulating baths via jackets 
(one per straight) and the solution temperature was monitored during the crystallisation 
using in situ thermocouples located at the end of the first three straights. The solution 
was pumped into the system via a peristaltic pump and the oscillation was provided 





Figure 5.20 - Schematic of the 4-straight COBC set-up. Grey areas indicate the location of ports 
for monitoring the solution (T = thermocouple port and P = pressure gauze). 
 
For all experiments SA, purchased from Sigma Aldrich, was used at an initial 
concentration of 0.09 g ml1 (Tsat = 30 °C) and deionised water was used as the 
crystallisation solvent. The contents of the feed vessel were heated to 35 °C to ensure 
complete dissolution of the SA. In the experiments containing additives (Pluronic P123 
and polypropylene glycol 4000), the polymer was dissolved in a small aliquot of the feed 
solvent and was added to the remaining solution containing SA in a 3 L round-bottomed 
flask and left to dissolve. The temperature was controlled using a Drysyn® former with a 
thermocouple submerged in the solution, mixing within the feed vessel was facilitated 
using magnetic bottom stirring or overhead stirring for experiments with large feed 
volumes.  
 
Prior to all experiments, the COBC was primed with deionised water at 35 °C 
(temperature of the feed vessel) to remove all air bubbles from the system. The inlet tube 
was then transferred to the feed vessel with minimal disturbance to the system by 
temporarily pausing the peristaltic pump and oscillator. Upon reaching the end of the 
COBC, product from each residence time was collected and separated from the solution 
via vacuum filtration using a Buchner flask and funnel. The crystal morphology of the 
product was examined under an optical microscope (a Leica DM1000 microscope 
equipped with an Infinity 2 microscopy camera at 4x magnification) and the solid form 











Input of saturated solution 















5.2.2.1 Pump calibration for different oscillation conditions 
The solution flow rate was calibrated to 50 ml min1 resulting in an initial mean residence 
time of 12 min 14 s. Prior to experiments with different oscillation conditions to those used 
previously, the flow rate was recalibrated as shown in Table 5.5. 
 
Table 5.5 - Pump calibration for different oscillation conditions in the COBC. 
1Hz and 10mm 
Time Volume rpm Flow rate 
5mins 254ml 4.2 50.8ml/min 
5mins 250ml 4.1 50ml/min 
5mins 250ml 4.1 50ml/min 
5mins 250ml 4.1 50ml/min 
Residence time = 12 min 14 sec 
 
2Hz and 10mm 
Time Volume rpm Flow rate 
1 min 52ml 4.1 52ml/min 
1 min 52ml 4.1 52ml/min 
Residence time = 11 min 46 sec 
 
2Hz and 25mm 
Time Volume rpm Flow rate 
1 min 50ml 4.1 50ml/min 
1 min 50ml 4.1 50ml/min 
Residence time = 12 min 14 sec 
 
Table 5.6 summarises the experimental information and solid recovery for all of the 
COBC experiments. 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































5.2.3 Experiments with no additive 
Although the focus of this work involved achieving the additive-mediated morphology in 
the continuous environment, initial COBC experiments were carried out with no additive 
present in solution to gain initial understanding of the system and its morphology under 
flow conditions.  
 
NP(1): T1 = 30 C, T2 = 23 C, T3 = 17 C, T4 = 10 C, oscillation 1 Hz 10 mm 
From batch experiments at 350 ml scale, it was expected that the solution would nucleate 
between 16-17 °C and the cooling profile was therefore designed accordingly. In the first 
experiment (NP(1)), back-mixing of air from the outlet into the top (fourth) straight led to 
the presence of large air bubbles in the fourth straight resulting in a large volume 
decrease for the solution. After 20 minutes, crystallisation was observed in the top 
straight (10 °C), indicating that the nucleation temperature may be lower in the COBC 
than in the batch environment. However, not long after crystals were observed in the 
fourth straight, encrustation on the inside of the glass walls was evident. This was 
exacerbated by the presence of air in the system. Issues with encrustation and the 
formation of a blockage on the end piece (which has a smaller aperture than the glass 
tubes) led to the premature termination of the experiment during the second residence 
time RT2 (Figure 5.21).  
 
 
Figure 5.21 - Encrustation on the walls of the crystalliser (left) and on the end piece (right) in 
experiment NP(1). 
 
Figure 5.22 shows microscope images of the crystal morphology of the product of RT1-2. 
The crystals are non-uniform in size and shape; this may be expected given the 
encrustation and possibility of attrition between the particles. The crystals are also smaller 
than those produced in the batch experiments, possibly due to the fact that nucleation 





Figure 5.22 - Microscope images showing the crystal morphology of product from RT1-2 for 
experiment NP(1). 
 
NP(2): T1 = 25 C, T2 = 15 C, T3 = 8 C, T4 = 12 C, oscillation 1 Hz 10 mm 
In the second experiment (NP(2)) with no additive present, the previous appearance of air 
bubbles in the fourth straight was prevented by improved sealing of thermocouple 
connections and priming the exit tube with water. The temperature profile was also 
altered based on knowledge gained from the first experiment. The aim was to encourage 
nucleation to occur earlier by lowering the temperature of the third straight and to prevent 
further nucleation on the walls of the crystalliser by increasing the temperature of the 
fourth straight. At the beginning of RT1, crystals were observed in the third straight in 
suspension and on the crystalliser walls. At the end of RT1 crystals were also evident in 
the second straight and sedimentation was evident between the third bend and the fourth 
straight as well as at the beginning of bends two and three suggesting that the mixing 
conditions were not sufficient to suspend the crystals and flow against gravity through the 
bends (Figure 5.23). The unjacketed poly ether ether ketone (PEEK) thermocouple joints 
and metal thermocouple may be a site for nucleation. The experiment was terminated 
after two residence times due to the sedimentation issues.  
 
 
Figure 5.23 - Sedimentation at the end of the second straight in experiment NP(2). 
 
Figure 5.24 shows the crystal morphology from this experiment. As observed in the 
previous experiment, the crystals appear non-uniform in shape and size with several 
1                2 
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diamond-shaped plates evident in the second residence time; in Chapter 4 it was shown 
that such plates are produced from SA crystallisation from water.  
 
 
Figure 5.24 - Microscope images showing the crystal morphology of product from RT1 and RT2 for 
experiment NP(2). 
 
NP(3): T1 = 25 C, T2 = 15 C, T3 = 8 C, T4 = 12 C, oscillation 2 Hz 10 mm 
As a result of the sedimentation issues experienced previously, the oscillation conditions 
were altered in the third experiment (NP(3)) but the temperature profile was retained. The 
residence time was re-determined as a result of this change in conditions (Table 5.5). As 
reported in the previous experiment, crystals were observed in the third straight in 
suspension but also on the crystalliser walls; however, this occurred slightly later than in 
the previous experiment, in the middle of RT1 (Figure 5.25). At the end of RT1, 
sedimentation was observed in the same sites as in the previous experiment and in 
addition was observed on the outlet tube. The encrustation observed in the third straight 
worsened with time yet no encrustation was observed in the final straight, indicating that 
the higher temperature was effective in preventing nucleation on the walls of the 
crystalliser. At the beginning of RT2 crystals were observed in the second straight, 
suggesting that back-mixing of crystals may be occurring. However, by the end of RT2 
the quantity of crystals in the final straight had decreased with respect to RT1. It is 
presumed that sedimentation and reduced suspension capability through the vertical 
bends led to this reduction in crystals reaching the final straight. This continued 
sedimentation led to the termination of the experiment at the end of RT2.   
 
 
Figure 5.25 - Encrustation on the third straight in experiment NP(3). 
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Figure 5.26 shows the crystal morphology from the experiment. The crystals have a 
similar appearance to those from experiment NP(2).  
 
. 
Figure 5.26 - Microscope images showing the crystal morphology of product from RT1 and RT2 in 
experiment NP(3). 
 
5.2.4 Experiments with PP123 additive 
PP123(1): T1 = 25 C, T2 = 15 C, T3 = 8 C, T4 = 12 C, oscillation 2 Hz 10 mm, 
0.17% PP123 
For experiments with the PP123 additive present, the temperature profile and oscillation 
conditions used for the experiments with no additive were initially selected as a starting 
point. Initial additive concentrations were selected based on the conditions required to 
produce the desirable block-like crystals observed in the batch crystallisations and 
therefore a starting concentration of 0.17% was used. In the first experiment (PP123(1)), 
a longer induction time for crystallisation was evident and crystals were not observed until 
25 minutes after the experiment commenced (i.e. at the beginning of RT2); this was 
approximately 8 minutes later than the experiments with no additive present. However, 
the crystals were initially observed in the same location, in the third straight. It was also 
evident that in the presence of the polymer, crystals were nucleating on the walls of the 
crystalliser at a slower rate, suggesting that the polymer may be creating a more viscous 
environment, enhancing suspension (Figure 5.27). Several minutes after the first 
observation of crystals in the third straight, crystals were also observed to be present in 
the second straight. However, encrustation was only occurring on the walls of the third 
straight suggesting that the presence of the crystals in this location may be as a result of 
back-mixing of suspended solids rather than nucleation in the second straight.  
 




Figure 5.27 - Encrustation on the third straight in experiment PP123(1). 
 
At the beginning of RT3 sedimentation was observed in the system in several locations: 
the exit piece, exit tube and at the second and third thermocouple ports. As with the 
encrustation, the sedimentation was not as severe as for the experiments with no additive 
present, suggesting that the crystals are suspended more effectively in the presence of 
the additive. After five residence times the experiment was terminated as the feed 
solution had been expended. The sedimented material within the COBC was also 
collected for analysis of the crystal morphology. Figure 5.28 shows the crystal 
morphology produced in each residence time in this experiment. 
 
 
Figure 5.28 - Microscope images showing the crystal morphology of product from RT2-5 and 
sedimented material (6) for PP123(1). 
 
Firstly, it can be concluded that the crystals are larger in the presence of the PP123 
additive in comparison to the case when no additive is present. As observed in the batch 
experiments, block-like crystals are evident in the samples, showing the additive effect. 
However, they are not uniform in size and are accompanied by smaller fine crystals, 
especially in the first three residence times. As the experiment progresses the crystals 
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became larger and the block-like crystals are replaced with more rod-like crystals. There 
is also evidence of partial dissolution of the particles as they reach the higher 
temperature final straight, which is most clearly shown in the images of SA from RT5 and 
the remaining contents of the crystalliser (6) in Figure 5.28, in which the crystals have 
more rounded edges. The presence of block and rod crystals shows that the additive 
morphology effect has been successfully reproduced in the continuous crystallisation 
environment in the COBC. 
     
 
PP123(2): T1 = 25 C, T2 = 15 C, T3 = 10 C, T4 = 8 C, oscillation 2 Hz 10 mm, 
0.17% PP123 
In the second experiment with the PP123 additive (PP123(2)), the cooling profile was 
altered to remove the heating step in the final straight to prevent dissolution of the 
particles. The temperature of the final straight was thus lowered to 8 °C and that of the 
other straights changed accordingly to maintain a linear cooling profile (see Table 5.6). 
Within 20 minutes of commencing the experiment (end of RT2), crystals were observed in 
the third straight and in the fourth straight several minutes afterwards. Five minutes after 
the first crystals were reported, sedimentation was observed near the exit piece, exit tube 
and near the third thermocouple port. A small quantity of encrustation was observed on 
the walls of the third straight but this was not as severe as in experiments with no additive 
present. At the end of the second residence time sedimentation was observed prior to the 
final bend and crystals were beginning to emerge into the second straight through back-
mixing. The experiment was then terminated due to these sedimentation issues. The 
experiment was more successful with the temperature profile used in PP123(1). Removal 
of the heating step in the final straight, as implemented in PP123(2), led to more 
nucleation, more crystals and as a result, more sedimentation. The crystal morphology 
shown in the microscope images in Figure 5.29 demonstrates that block-like crystals (i.e. 
with favourably modified morphology) were produced in the residence times for which the 
system was operated.  
 
 
Figure 5.29 - Microscope images showing the crystal morphology of product from RT2-3 for 
experiment PP123(2). 
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PP123(3): T1 = 25 C, T2 = 15 C, T3 = 12 C, T4 = 10 C, oscillation 2 Hz 25 mm, 
0.17% PP123 
In the third experiment with additive (PP123(3)), the aim was to achieve the improved 
morphology (block-like crystals) whilst improving the mixing conditions to prevent 
sedimentation. In comparison to the previous experiment, the final temperature was 
raised and the amplitude of the oscillation was also increased. This was intended to 
suspend the crystals more effectively and mitigate the problems experienced with 
sedimentation. As the oscillation conditions were altered, the residence time was re-
determined (Table 5.5). After 26 minutes, small crystals were observed in the outlet tube 
and subsequently in the final straight. Three minutes later crystals were observed in the 
third straight suggesting that enhanced back-mixing may be occurring due to the 
increased amplitude of oscillation. However, this amplitude was required to suspend the 
particles more effectively. The experiment was run for five residence times. 
Sedimentation in this experiment was not as severe as observed previously and crystals 
were able to flow through the bends more readily. Evidence of encrustation was also 
more limited than previously observed. However, upon inspection of the resulting crystal 
morphology from each residence time it can be concluded that the morphology is very 
inconsistent and non-uniform. There is also limited evidence of the block-like crystals and 
instead, the crystals become increasingly elongated over the residence times  




Figure 5.30 - Microscope images showing the crystal morphology of product from RT2-5 for 
experiment PP123(3). 
 
A number of observations, explanations and possibilities can be noted from the crystal 
morphology resulting from this experiment: 
 Upon increasing the amplitude of oscillation, the sedimentation was significantly 
reduced and the crystals were able to flow through the bends more readily. 
Improved mixing may result in a larger quantity of additive interacting with the 
crystal surface and producing a more enhanced effect with respect to experiments 
PP123(1/2). Batch experiments in an STR showed that, with consistent mixing 
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conditions but with increased levels of polymer additive, the morphology became 
more elongated. Therefore, it may be that, due to the enhanced mixing conditions 
produced, a lower concentration of additive is required to have the same effect in 
the continuous environment with these oscillation conditions. Next step: Lower 
the quantity of additive; 
 Back-mixing of crystals into the previous, higher temperature straights results in 
such crystals acting as seeds and inducing crystal growth at this higher 
temperature. Batch experiments with PP123 in an STR showed that the 
morphology change is dependent on the crystallisation temperature: at high 
temperatures more elongated crystals are produced. Next step: Improve the 
mixing conditions to prevent back-mixing or increase the temperature of the 
second straight to dissolve back-propagated crystals. If the crystals still do not 
dissolve a more enhanced effect can be expected due to the crystallisation 
occurring at higher temperature and thus generating more elongated 
morphologies;  
 Filtration issues (such as caking) and continual washing of precipitate with effluent 
during a residence time may result in changes to the morphology. Next step: 
Collect a small sample of product from each residence time for more 
representative inspection of the morphology. 
 
For all subsequent PP123 experiments SA solutions containing a reduced quantity of 
polymer (0.13%) were used. The filtration procedure was also changed to investigate the 
effect of continual washing of the filtrate with effluent. The product of each RT was 
collected in a large Buchner funnel in the normal procedure, however 30 seconds before 
the end of each residence time the collection vessel was changed to another, smaller 
Buchner funnel to observe the morphology of a small sample. This filtration procedure 
was implemented for all experiments that follow.  
 
PP123(4): T1 = 25 C, T2 = 15 C, T3 = 8 C, T4 = 12 C, oscillation 2 Hz 25 mm, 
0.13% PP123 
In the fourth experiment with PP123 present (PP123(4); with the reduced quantity of 
polymer additive), the same temperature profile and oscillation conditions as employed in 
PP123(3) were used. After 25 minutes, small crystals were observed in the outlet tube 
and subsequently observed in the final straight; this correlates with the previous 
experiment. During the third residence time crystals were also observed in the second 
straight suggesting that back-mixing may be occurring. The severity of sedimentation and 
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encrustation was similar to those observed in the previous experiment. The experiment 
was run for five residence times. The crystals produced from this experiment had a more 
desirable morphology than those observed previously. As anticipated, decreasing the 
quantity of polymer present in solution was effective in producing the desired block-like 
morphology in initial residence times, with crystals from RT2 and RT3 being uniformly 
block-like (Figure 5.31). However, the crystals produced in subsequent residence times 
were less uniform – the morphology was still predominantly blocks, but rod-like and 
needle-like fines were also now evident. This change in crystal morphology over 
residence times could be due to the back-mixing of crystals from straight three to straight 
two. Batch crystallisations in an STR have shown that the additive effect is dependent on 
the crystallisation temperature; in later residence times the back propagation of seed 
crystals, from straight three to straight two, would result in such crystals growing at a 
higher temperature than in prior residence times.  
 
Figure 5.31 - Microscope images showing the crystal morphology of a small sample of product 
from RT2-4 for experiment PP123(4). 
 
The crystal morphology from the bulk residence time samples is shown in Figure 5.32. 
The crystal shape produced is similar to those obtained from the small sample, however 
there are more fines present and the crystal surface appears more irregular. The 
presence of the polymer in solution may encourage adhesion of the smaller particles to 
the larger ones as the effluent washes over the precipitate. From this point forward 
morphology analysis will be reported for determinations carried out from the small 
samples which are less likely to be affected by filtration issues. 
 
Figure 5.32 - Microscope images showing the crystal morphology of the bulk sample of product 
from RT2-5 for experiment PP123(4). 
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PP123(5): T1 = 25 C, T2 = 18 C, T3 = 12 C, T4 = 10 C, oscillation 2 Hz 10 mm, 
0.13% PP123 
In experiment PP123(5), the temperature profile was altered with the aim of limiting the 
production of needle-like crystals by alleviating the effect of the back-mixing of crystals 
into the second straight. The temperature of the second straight was increased by 3 °C to 
promote dissolution of any seed crystals which may appear within the straight by back 
propagation. As reported in the previous two experiments, crystals were observed in the 
fourth and third straight after around 27 minutes of the start of the experiment and several 
minutes later crystals were observed in the second straight. Crystals near the second 
bend were observed descending to the second straight due to gravity; this helped 
facilitate the back-mixing. This suggests that increasing the temperature of the second 
straight by 3 °C was not effective in dissolving the crystals. However, it was noted that 
crystals never back-mix into the first straight from the second straight, as it is likely that 
the temperature of the first straight is high enough for the crystals to dissolve. 
Sedimentation was also observed in the same sites as previously in this experiment. The 
experiment was terminated at the end of RT4. The crystal morphology produced was 
block-like for the first residence time and increasingly rod-like for the residence times that 
followed. This supports the theory that the back-propagated crystals are seeding the 
higher temperature straights and growing in the presence of the additive into different 
morphologies (Figure 5.33). 
 
 
Figure 5.33 - Microscope images showing the crystal morphology of product from RT2-4 for 
experiment PP123(5).  
 
PP123(6): T1 = 25 C, T2 = 23 C, T3 = 12 C, T4 = 10 C, oscillation 2 Hz 10 mm, 
0.13% PP123 
In the sixth experiment (PP123(6)) the jacket temperature of the second straight was 
increased further, by 5 °C to 23 °C, with the aim of preventing the back-mixing by 
dissolving the back-mixed particles or to observe the morphology produced if back-mixing 
did occur. After 25 minutes, crystals were observed in the exit tube and subsequently in 
the final straight. Several minutes later crystals were observed in the third straight and 
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had reached the second straight by the end of the RT2. There were however, more 
particles in the bend at the end of the second straight than in the second straight which 
suggest partial dissolution of crystals upon reaching the second straight was occurring. 
Furthermore, throughout the experiment there was no encrustation observed on the walls 
of the second straight suggesting that no secondary nucleation was occurring. There 
were also fewer crystals in the third straight, especially at the beginning where the two 
temperature zones met (23 °C and 12 °C). This is to be expected as this is a large 
change in temperature and at this point at the beginning of the third straight the 
temperature is likely to be higher than 12 °C where it meets the warm solution emerging 
from straight 2. There was also more encrustation to the third straight which is also 
expected as rapid crystallisation is likely at this large temperature jump due to a sudden 
change in solubility. The experiment was terminated at the end of RT4. The crystal 
morphologies produced from this experiment are shown in Figure 5.34. The microscope 
images suggest that the block-like crystals were produced for longer than in the previous 
experiment, persisting into RT4 unlike in previous experiments in which rod-like crystals 
were produced by this residence time. This suggests that the higher temperature of the 
second straight was effective in suppressing the effect of the back-mixing on the crystal 
morphology. However, the block-like crystals are accompanied by small needle-like 
crystals which may have resulted from the crystals that continued to back-mix into the 




Figure 5.34 - Microscope images showing the crystal morphology of samples from RT2-4 for 
experiment PP123(6). 
 
5.2.5 Experiments with PPG4000 additive 
Although the morphology modification effect has been demonstrated on the COBC runs, 
and the incremental evolution of the experimental parameters tending towards producing 
the block-like crystals more reliably, there were still problems with inconsistent crystal 
morphology over the course of an experiment with PP123 additive. Further experiments 
were therefore carried out using PPG4000 as an additive. It was previously observed in 
batch experiments that, using PPG4000, the crystal morphology was less dependent on 
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crystallisation temperature and the more desirable block-like crystals could be accessed 
over a broader range of conditions and temperatures rather than needles (Chapter 4). 
 
The temperature profile used for experiment PP123(5) was selected for the experiments 
with PPG4000. In the batch experiments, the presence of 0.17% PPG4000 produced 
block-like crystals, however in the COBC experiments with PP123, lower concentrations 
of the additive (0.13%) were still effective in producing the desired block-like crystals. 
Therefore, a starting concentration of 0.13% PPG4000 was selected for these 
experiments. PPG4000 is poorly soluble in water so use of a lower concentration is more 
desirable.  
 
PPG(1): T1 = 25 C, T2 = 18 C, T3 = 12 C, T4 = 10 C, oscillation 2 Hz 10 mm, 0.13% 
PPG4000 
In the first experiment with PPG4000 as an additive (PPG(1)), crystals were observed in 
the final straight after 25 minutes and in the third straight two minutes later. During the 
second residence time encrustation was observed on the end piece as well as in all 
straights except the first. There was also evidence for crystals back-mixing into the 
second straight. At the end of RT4, the experiment was terminated. It was evident that, 
with the PPG4000 additive, the encrustation is worse in comparison to when the PP123 
additive is present in solution (Figure 5.35).  
 
 
Figure 5.35 - Encrustation in experiment PPG(1). 
 
However, in terms of crystal morphology, block-like crystals were produced more 
consistently over the course of the experiment (Figure 5.36). The obtained crystals did 
appear to increase in size over the experiment which may be as a result of the 





Figure 5.36 - Microscope images showing the crystal morphology of samples from RT2-4 for 
experiment PPG(1). 
 
PPG(2): T1 = 25 C, T2 = 18 C, T3 = 12 C, T4 = 10 C, oscillation 2 Hz 10 mm, 0.10% 
PPG4000 
As block-like crystals were produced in the previous experiment, the concentration of 
PPG was further reduced to 0.1% for the second experiment (PPG(2)). After 24 minutes, 
crystals were observed in the final straight and in the third straight a minute later. By RT2 
fouling was again evident on the end piece and crystals were also present in the second 
straight. In RT3, larger crystals were observed encrusting on all straights except the first 
one. The lower concentration of additive had no effect on the severity of encrustation. At 
the end of RT4 the experiment was terminated. Images of the crystal morphology 
produced in this experiment are shown in Figure 5.37. A lower concentration of polymer 
was still effective in producing the block-like crystals, however once again they increased 




Figure 5.37 - Microscope images showing the crystal morphology of samples from RT2-4 for 
experiment PPG(2). 
 
PPG(3): T1 = 25 C, T2 = 18 C, T3 = 12 C, T4 = 10 C, oscillation 2 Hz 10 mm, 0.10% 
PPG4000 
In the third experiment (PPG(3)), a larger quantity of feed solution was prepared with the 
aim of operating the crystalliser for a longer period of time. Due to the larger volume of 
solution, overhead stirring was used to mix the feed solution at a rate of 600 rpm. After 26 
minutes crystals were observed in the final straight, followed by crystals appearing in the 
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third straight after several minutes. Again by RT2, crystals had back-mixed into the 
second straight and encrustation was observed on all straights except the first one. In 
RT5 there was evidence of sedimentation at the end of the second straight where large 
particles could not suspend themselves against gravity through the bends. During the 
final residence time (RT6) the yield decreased significantly, likely to be due to the 
sedimentation at the end of the second straight. Almost all of the crystals in the system 
were either sedimented or encrusted on the walls of the crystalliser and as a result the 
experiment was terminated at the end of the sixth residence time. The crystal morphology 
of the product is shown in Figure 5.38 where it can be observed that only the favourable 
block-like crystals were produced in all residence times. However, as the experiment 
progresses the surface of the crystals produced is less faceted suggesting that the 
crystals may have grown at higher supersaturation or temperature. 
 
 
Figure 5.38 - Microscope images showing the crystal morphology of samples from RT2-6 for 
experiment PPG(6), and the persistence of the block-like morphology. 
 
The production of block-like crystals shows the success not only of transferring the 
polymer-additive morphology effect from batch to continuous, but a step forward in 
optimising the continuous crystallisation runs in the COBC to maximise the production of 
the favourable block-like morphology in the presence of polymer additive. 
 
5.2.6 Solid form analysis 
In all of the COBC experiments PXRD analysis was carried out on samples collected from 
each residence time. As observed in the batch environment, the presence of the polymer 
had no effect on the solid form of the product, which remained as the β-polymorph in all 
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cases. Figure 5.39 shows PXRD patterns of samples produced in the COBC in the 
presence of the different concentrations of additive used.  
 
 
Figure 5.39 - (a) Calculated PXRD pattern of β-SA (SUCACB02) and PXRD patterns of SA 
produced in the COBC in the presence of (a) no polymer, (b) 0.17% PP123, (c) 0.13% PP123, (d) 




5.3.1 Crystallisation in segmented flow 
The SA system has been used to aid the development and evaluation of a mesoscale 
segmented flow reactor. Initial experiments used air segmentation, however this resulted 
in significant fouling to the body of the reactor. In subsequent experiments liquid 
segmentation was employed which eliminated encrustation on the reactor walls. 
However, significant fouling was observed on the mixer piece and inside the feed tubes. 
This was overcome by implementing improved temperature control through development 
of a water bath for the mixer piece and jackets for the feed tubes. Expulsion of the 
crystals from the outlet of the crystalliser proved problematic, but this was mitigated by 
the implementation of an end piece at the outlet of the crystalliser designed to propel the 
crystals into the filtration unit. A system designed to separate the carrier fluid from the 
solution prior to filtration was also implemented in the experiments, which prevented 
problems with adhesion of the filter paper to the filter funnel, caking of precipitate and 




Such developments of the platform enabled effective operation of the crystalliser with the 
target SA system for over an hour without any observation of encrustation. Recovery of 
the carrier fluid prior to filtration was achieved and this also helped to overcome filtration 
issues. Furthermore, the unique environment for crystal nucleation and growth provided 
by the liquid segmentation enabled the unexpected production of α-SA (as part of a 
mixture of both α- and β-polymorphs of SA) which may be the result of crystallisation 
occurring in the absence of a solid interface. 
 
Additional experiments were also carried out with the aim of achieving, under continuous 
crystallisation conditions in the KRAIC platform, the polymer additive-mediated 
morphology changes observed in the batch environment. These were successful in the 
case of the PP123 polymer; however despite the low concentrations of the polymer 
added to the solution, issues with incompatibility of the polymer with the carrier fluid were 
experienced, resulting in disruption of the segmentation and poor control over the 
crystallisation. This resulted in testing of the PPG polymer for an additive effect in 
crystallisations carried out in the KRAIC. Although the presence of this polymer in 
solution did not disrupt the segmentation in the system, the presence of the additive did 
not produce the optimised morphology of SA observed in the batch environment and 
instead large, plate-like crystals were produced. It was theorised that the mixing in the 
KRAIC platform is gentler than in the batch environment and future steps towards 
achieving the additive-mediated morphology of SA in the KRAIC should encompass use 
of higher concentrations of the additive in the feed solution. Furthermore, it is clear that 
the solid recovery, in experiments both with and without polymer additive present, 
requires significant optimisation and this will form the theme of future experiments within 
the KRAIC.  
 
5.3.2 Crystallisation in the COBC 
Significant steps towards the aim of reproducing in the continuous environment the 
additive-mediated morphology changes produced in the batch environment, were 
achieved to a greater extent in the COBC platform. SA crystals of block-like morphology 
were successfully produced in the presence of both the PP123 and the PPG polymers in 
the continuous environment of the COBC.  
 
However, in all experiments fouling and sedimentation remained a large barrier to the 
successful operation of the COBC and despite making changes to the mixing and 
temperature conditions; these problems could not be mitigated. The mixing conditions 
were not sufficient to enable suspension of the particles, with back-mixing of crystals 
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evident in the system. Although the optimised morphology of SA was produced in initial 
residence times, these challenges were reflected in the morphology and size of the 
resultant crystals in later residence times in which production of the favourable block-like 
morphology was not sustained. This was especially true in crystallisations carried out in 
the presence of the PP123 polymer in which the shape of the SA crystals produced is 
more dependent on the temperature of crystallisation than with PPG. Interestingly, 
although the presence of the PP123 resulted in less severe encrustation, the crystals 
back-mixing into previous, higher temperature straights acted as seeds inducing crystal 
growth at higher temperatures resulting in inconsistent morphologies over residence 
times. The use of PPG as an alternative additive was selected in attempt to overcome 
this issue, due to the morphology change in the presence of this additive being less 
dependent on crystallisation temperature. This was effective and the crystals were of 
block-like morphology for multiple residence times. However, encrustation and 
sedimentation remained an issue affecting the prolonged running of the platform in all 
experiments. Unlike in crystallisations in the KRAIC, where the segmentation ensures the 
sample solution does not encounter a solid interface (at the walls of the crystalliser), solid 
produced from the COBC both with and without a polymer additive present in solution 
was found to be pure β-SA. 
 
Encrustation leads to loss of control of the crystallisation and, as noted by McGlone et al., 
encrustation is one of the biggest challenges associated with continuous crystallisation.179 
Briggs et al. reported that encrustation issues experienced in unseeded crystallisations of  
L-glutamic acid in the COBC were overcome with the implementation of seeding and 
operation was possible for at least 10 hours.181 Thus, the application of seeding methods 
to the crystallisation of SA in the COBC may enable problems with encrustation and 
fouling to be overcome and more uniform crystals to be produced.  
 
The work presented in this Chapter represents the first example of a polymer-additive 
mediated morphology effect being implemented in continuous crystallisation in the fine 
chemicals and pharmaceuticals area. It shows the potential for successful continuous 
crystallisation of complex multi-component preparations, and also demonstrates the 
importance of optimising batch conditions prior to transferring these to continuous; in this 
case the basic parameters for the batch experiments represented a viable start point for 

















Chapter 6  
Investigating the effect of additives on the 
crystal morphology of isoniazid 
 
6.1 Introduction and aims 
The aim of this work was to investigate the effect of a range of additives (structurally 
similar, sized matched and polymer) on the crystal morphology of a pharmaceutical 
compound through small scale screening experiments using different crystallisation 
methods. Identified morphology changes in the presence of additives could then be 
rationalised theoretically based on the intermolecular interactions present on the surface 
of the crystal faces, as implemented in the case of SA in Chapter 4.  
 
Isoniazid (Figure 6.1; IZN) is an active pharmaceutical ingredient (API) used in the 
treatment of tuberculosis.  
 
 






There is currently only one reported polymorphic form of IZN, which crystallises in the 
orthorhombic space group P212121 with an asymmetric unit containing one IZN molecule. 
The crystal structure182 consists of herringbone chains of molecules connected through 
intermolecular N3-H…N1 hydrogen bonds between a hydrogen atom on the amine group 
on one IZN molecule and the nitrogen atom on the pyridine ring (N1) of another IZN 
molecule with an N3…N1 distance of 3.0403(3) Å. The chains interact with one another 
through intermolecular N2-H…N3 hydrogen bonds between the amide N-H bond and the 
nitrogen atom of the amine group (N3) (N2…N3 distance of 2.9147(2) Å). These 
interactions result in the formation of nets of molecules with the orientation of the IZN 
molecule alternating between chains due to the presence of a 2-fold screw axis (Figure 
6.2, left). The nets stack along the a axis through bridging N3-H…N1 hydrogen bonds 
between the terminal amine group and the nitrogen atom on the pyridine ring with an 
N3…N1 distance of 3.1442(3) Å (Figure 6.2, right).  
 
 
Figure 6.2 - Crystal packing in the only reported polymorphic form of IZN (from INICAC03)
182
: 
(left) hydrogen bonded nets of IZN molecules viewed down the crystallographic a axis, and (right) 
infinite hydrogen bonds running along the a axis viewed down the b axis. 
 
IZN crystallises in a needle or plate-like habit from many organic solvents145,183 and most 
multi-component molecular complexes of IZN are also reported to crystallise in a needle-
like habit.145,184-186 As these morphologies tend to be unfavourable for pharmaceutical 
materials processing, this makes it a suitable compound for this work targeting the use of 
additives to modify morphology. This experimentally observed shape of IZN crystals 




Figure 6.3 - Predicted morphology of IZN (INICAC03)
182
 using the BFDH tool in Mercury.
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In the predicted morphology there are four fast growing faces which intercept the 
direction of the crystallographic a axis ((101), (101̅), (110) and (11̅0)). This suggests that 
the bridging N3-H…N1 interactions between the IZN molecules, involving the amine group 
and pyridine nitrogen atom and running along the crystallographic a axis, are the 
dominant interactions in the crystal structure.  An additive may be successful in slowing 
down crystal growth in this direction and thus altering the overall morphology by 
intercepting and interrupting the assembly of the structure via these favourable hydrogen 
bonds. The N3-H…N1 interaction between the N3-H bond of the terminal amine group and 
the nitrogen atom of the pyridine ring, formed in the direction of the crystallographic c 
axis, is intercepted by the slow growing faces and an additive that interrupts that 
interaction may result in crystals with increased elongation.  
 
6.1.1 Selection of additives 
There are several structurally similar molecules to IZN that are also Generally 
Recognized As Safe (GRAS) compounds, making them ideal candidates for employment 
as additives; these include nicotinic acid and nicotinamide. In addition, other compounds 
of similar size to IZN that contain hydrogen bond donor and acceptor groups were used in 





Figure 6.4 - Molecular structures of structurally similar and size-matched additives used for 
morphology studies of IZN. 
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Several polymers were also investigated for an additive effect, as investigated for 
succinic acid in Chapter 4, and their molecular structures are shown in Figure 6.5. 
 
 
Figure 6.5 - Molecular structure of polymer additives used. 
 
Crystallisations were carried out using a variety of methods including evaporative 
crystallisation and cooling crystallisation at different scales.  
 
 
6.2 Experimental information 
All compounds used were obtained from commercial sources and used without further 
purification. 
 
6.2.1 Solubility determination 
Solubility measurements of IZN from ethanol and water were carried out using the 
Technobis Crystallization Systems Crystalline at 3 ml scale and the Technobis 
Crystallization Systems Crystal16 at 1 ml scale, respectively. Vials containing the chosen 
solvent and different concentrations of IZN were heated from 20 °C to 70 °C at a heating 
rate of 0.5 °C min1 using magnetic bottom stirring at 400 rpm. The data were analysed 
using CrystalClear software.133  
 
6.2.2 Evaporative crystallisation 
Evaporative crystallisations were prepared by dissolving small quantities of IZN  
(0.0137 g) and the additive compound in the minimum amount of solvent in 7 ml vials. 
Holes were pierced in the lids allowing for slow evaporation of the solvent at room 
temperature. Solvents used included water, ethanol, methanol, isopropanol/water (1:1). 
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IZN to additive molar (for size-matched) or mass (for polymer) ratios investigated were 
1:1, 10:1 and 100:1. 
 
6.2.3 Cooling crystallisation 
All cooling crystallisations were carried out using the Cambridge Reactor Design Polar 
Bear Plus crystalliser. For crystallisations from ethanol, an IZN concentration 0.025 g ml1 
(Tsat = 42 °C) was used with a linear cooling profile of 75 °C to 5 °C with a cooling rate of 
0.5 °C min1 implemented. Mixing was induced using magnetic bottom stirring. A stirring 
rate of 400 rpm was used in initial experiments, however, at this stirring speed the 
resulting crystals were extremely small, forming a microcrystalline powder that was 
difficult to analyse. Stirring rates of 150 and 200 rpm were then tested. At 150 rpm the 
crystals produced were larger but less uniform in shape suggesting that the mixing was 
not sufficient at this speed. At 200 rpm the crystals were larger than at 400 rpm and more 
uniform, balancing good mixing with ease of observation of morphology changes; this 
stirring rate was thus chosen for comparison of the crystal morphology in the presence of 
additives. Crystallisations from water were prepared in a concentration of 0.2 g ml1  
(Tsat = 35 °C) of IZN and a linear cooling profile of 60 °C to 5 °C with a cooling rate of  
0.5 °C min1 used. Mixing was induced using magnetic bottom stirring at 400 rpm, which 
produced appropriate crystals in this case. 1 ml and 5 ml scale crystallisations were 
carried out in 1.5 ml and 20 ml glass vials, respectively. Crystallisations were prepared 
with an IZN to additive molar (for size-matched) or mass (for polymer) ratio of 10:1. 10 ml 
scale crystallisations were carried out in 20 ml glass vials and overhead stirring was 
implemented using a magnetically controlled overhead stirrer from Technobis 
Crystallization Systems. In parallel to the crystallisations in the presence of additives, a 
control crystallisation containing no additive was prepared for all crystallisation conditions 
for comparison of the resulting crystal morphology. At the end of the crystallisation, visual 
analysis of the crystal morphology was carried out using optical microscopy. 
 
6.2.4 Single crystal structures 
Several of the evaporative crystallisations prepared in a 1:1 molar ratio resulted in the 
formation of multi-component molecular complexes and single crystal structures were 
determined. All of the structures were solved by direct methods using SHELXS-2013137 
and refined using SHELXL-2013138 within the WinGX139,140 program. Crystallographic data 






Table 6.1 - Crystallographic information for IZN crystal structures. 























M / g mol
-1
 227.18 247.25 349.27 
T (K), radiation 150, Mo Kα 150, Mo Kα 150, Mo Kα 
Space Group P21/c P21/c P b c a 
a (Å) 7.4160(10) 5.0740(2) 6.9781(2) 
b (Å) 18.621(2) 15.9115(9) 15.1035(5) 
c (Å) 6.8475(9) 14.7309(6) 27.6939(9) 
α (
o
) 90 90 90 
β (
o
) 109.404(16) 96.926(4) 90 
γ (
o
) 90 90 90 
Volume (Å
3
) 891.9(2) 1180.62(10) 2918.76(16) 
Z 4 4 8 
ρcal/ Mg cm
-3
 1.692 1.391 1.590 
μ/mm
-1
 0.143 0.102 0.132 
θ range/° 3.339-25.677 3.785-25.672 3.299–26.369 
Completeness 99.8 99.8 96.2 % 
Refln. Collected 3473 7053 19973 
Independent 1688 2241 2815 
Refln (obs.I>2σ(I)) 1418 1782 2240 
Rint 0.032 0.029 0.042 
Parameters 181 215 270 
GooF 1.086 1.042 1.047 
R1 (obs) 0.044 0.041 0.036 
R1 (all) 0.054 0.057 0.051 
wR2 (all) 0.099 0.090 0.088 
ρmax,min/e Å
-3
 0.209,-0.290 0.175,-0.197 0.195,-0.274 
 
 
Preparation of single crystals 
(1) Isoniazid oxalic acid (1:1) (IZN2+  OA2-) 
Equimolar quantities of IZN (0.014 g) and OA (0.009 g) were combined and dissolved in 
water. Slow evaporation produced rod-like crystals. Data were collected using the Rigaku 
Oxford Diffraction SuperNova diffractometer with Mo-Kα radiation (λ=0.71073 Å) at 150 K. 
 
(2) Isoniazid resorcinol (1:1) (IZN RES) 
A molecular complex of IZN (0.014 g) with RES (0.012 g) was produced from an 
equimolar solution of the two components left to evaporate from water. Data were 
collected using the Rigaku Oxford Diffraction Xcalibur diffractometer with Mo-Kα radiation 
(λ=0.71073 Å) at 150 K. 
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(3) Isoniazid 2,4-dinitrobenzoic acid (1:1) (IZN+ 24DNBA) 
A molecular salt of IZN (0.014 g) with 24DNBA (0.024 g) was produced when equimolar 
quantities were dissolved in water and left to crystallise by evaporation. Data were 
collected using the Rigaku Oxford Diffraction Gemini Ultra A CCD diffractometer with Mo-
Kα radiation (λ=0.71073 Å) at 150 K. 
 
 
6.2.5 Analytical methods 
Microscope images of crystals from evaporative crystallisations and 1 ml scale cooling 
crystallisations were taken on a Nikon Coolpix P5100 camera through a Brunel 
Microscopes microscope. Microscope images of crystals from 10 ml scale crystallisations 
were taken using a Leica DM1000 microscope equipped with an Infinity 2 microscopy 
camera at 4x magnification. 
 
Scanning Electron Microscopy (SEM) images were obtained using a JEOL SEM6480LV 
SEM in which samples were coated with chrome using a Quoron QT Chrome Coater with 
a film thickness of 20 nm. 
 
Face indexing was carried out using a Rigaku Oxford Diffraction (formerly Agilent 
Technologies) Xcalibur diffractometer with Mo-Kα (λ=0.71073 Å) radiation. Unit cell 
screenings were carried out at 150 K where the temperature was controlled using an 
Oxford Cryosystems Cryostream. Face indexing was then carried out using the 
CrysAlisPro 171.37.33 software.134  Analysis of the crystal structure and morphology of 
IZN and use of the BFDH morphology tool was carried out using Mercury 3.5.141 
 
Experimental information for the PXRD, DSC and NMR measurements undertaken are 













6.3 Characterisation of IZN starting material 
Figure 6.6 shows the PXRD pattern of the only reported polymorph of IZN calculated from 
single crystal XRD data alongside the measured pattern of the IZN obtained from Sigma 
Aldrich. A good match between the peaks in each pattern is observed, confirming the 
starting material as the known polymorph of IZN.  
 
 
Figure 6.6 - PXRD patterns of IZN: (a) calculated from the structure of the only reported polymorph 
(CSD ref. code = INICAC) and (b) IZN starting material.  
 
The material obtained from Sigma Aldrich was also characterised using DSC, showing a 
sharp endothermic peak at 171 °C representing its melting point (Figure 6.7).  
 
 




The solubility of IZN in water and in ethanol was determined with respect to temperature 
using turbidometric techniques described in Section 6.2.1; the solubility curves are shown 
in Figure 6.8.  
 
 
 Figure 6.8 - Solubility curves of IZN in (a) water and (b) ethanol with lines of fit based on a Van’t 
Hoff functional form as a guide to the eye. 
 
The morphology of the raw material is shown in Figure 6.9. The crystals are of needle-like 
morphology in a mixture of lengths and thicknesses.  
 
 
Figure 6.9 - Microscope images of the crystal morphology of IZN obtained from Sigma Aldrich. 
 
 
6.4 Effect of solvent on crystal morphology of IZN 
It is common for crystallisation from different solvents to produce different crystal 
morphologies as a result of different face-specific interactions of the solvent molecules 
with the growing crystal surface.32,66 The crystallisation of IZN from a number of solvents 
in cooling and evaporative crystallisation was therefore carried out and the resulting 




6.4.1 Crystallisation from ethanol 
In evaporative crystallisation of IZN from ethanol, elongated plate-like crystals are 
produced, the size and shape of which varied significantly, as shown in Figure 6.10. This 
may be as a result of lack of agitation in the solution in evaporative crystallisation 
resulting in a non-homogeneous solution and poor mass transfer.  
 
 
Figure 6.10 - Microscope images of IZN crystals produced from ethanol in an evaporative 
crystallisation. 
 
In cooling crystallisation from ethanol, with magnetic bottom stirring at 1 ml scale, small 
plate-like crystals were consistently produced, as shown in Figure 6.11. The rough edges 
observed on some of the crystals suggest that crystal breakage may have occurred from 
the abrasive action of the stirring bar. The surfaces of the crystals are also rounded 
suggesting that they may have been produced at high supersaturation. In contrast, when 
overhead stirring was implemented at 10 ml scale, more uniform plate-like crystals were 
produced in which the edges of the crystals are less rounded (Figure 6.11 right).  
 
 
Figure 6.11 - Plate-like crystals of IZN produced from ethanol cooling crystallisations with (left) 
magnetic bottom stirring and (right) overhead stirring. 
 
The large size of the crystals produced from evaporative crystallisation and cooling 
crystallisation with overhead stirring made it possible to undertake face indexing. In each 
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case the same faces were observed as dominant in the morphology. Figure 6.12 shows 
the indexed faces of a plate-like crystal produced from evaporative crystallisation. The 
(010) face is the largest and slowest growing face, while the (001), (101) and (101̅) 
faces grow more quickly relative to the (010) face which results in the plate-like shape of 
the crystal.  
 
 
Figure 6.12 - Face indexing of plate-like crystals of IZN produced from ethanol. 
 
In the crystal structure of IZN the (101) and (101̅) planes – lying parallel to the smallest 
and fastest growing faces – intercept the direction of stacking of the hydrogen bonded 
nets of IZN molecules through an infinite network of N3-H…N1 hydrogen bonds. In 
contrast, the (010) plane (the slowest growing face) intercepts the direction of 
interactions between the chains of IZN molecules and therefore the N2-H…N3 hydrogen 
bonds linking the amide N-H bond and the nitrogen atom of the amine group in two IZN 
molecules that lie adjacent to one another. These interactions, however, are not infinite in 
the direction perpendicular to the face (along the crystallographic b axis), and growth in 
that direction will potentially therefore be slower than in the direction of the infinite  
N3-H…N1 bridging interactions forming along the a axis. The hydroxyl groups of the 
solvent ethanol molecules could also interact favourably with the nitrogen atom of the 
amine group, interrupting the interaction between IZN molecules and further slowing 
down growth in the direction of the crystallographic b axis. The (001) plane intercepts the 
direction of hydrogen bonded herringbone chains of IZN molecules forming along the c 
axis. The morphology suggests that the (001) face grows faster than the (010) face but 
slower than the (101) and (101̅) faces. 
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Comparisons can also be made between the shape and faces present in the predicted 
BFDH morphology of IZN and the experimental morphology (Figure 6.13). The BFDH 
prediction generates an elongated morphology in which four different faces on the sides 
of the crystal are present ((011), (01̅1̅), (01̅1) and (011̅)) which are not present in the 
experimental morphology. Instead, the experimental plate-like morphology features the 
(010) and (01̅0) faces. Both morphologies share the (001), (101) and (101̅) faces, 
allowing the plate-like morphology to be superimposed on the BFDH morphology (dotted 
lines in Figure 6.13 left). As the BFDH model does not take into account molecular-level 
interactions, the difference in the experimental and predicted morphologies could be a 
result of the ethanol molecules interacting strongly with the (010) face, diminishing the 
(011) and (01̅1) faces in the experimental morphology.  
 
Figure 6.13 - Comparison of (left) BFDH morphology and (right) indexed faces. 
 
6.4.2 Crystallisation from water 
Unlike in the case of crystallisation from ethanol, IZN reproducibly crystallises from water 
in an unfavourable, fine needle-like habit in both evaporative and cooling crystallisation 
(Figure 6.14). Due to the fine needle-like habit produced from the crystallisations from 
water, accurate indexing of the crystal faces was not possible.  
 
 
Figure 6.14 - Microscope images of IZN crystals produced from an aqueous solution in (a) cooling 
crystallisation and (b) evaporative crystallisation. 
                (a)                                 (b) 
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Crystallisation of IZN from isopropanol/water (1:1), acetonitrile and methanol was also 




6.5 Crystallisation of IZN in the presence of 4,4’-bipyridine 
The most significant finding from the screening crystallisations of IZN with a range of 
additives present in solution was the modified crystal morphology produced from ethanol 
in the presence of 4,4’-bipyridine (44BP). The molecular structures of IZN and 44BP are 
shown in Figure 6.15. The molecules show structural similarity in the presence of a 
pyridine ring in each structure. 
 
 
Figure 6.15 - Molecular structure of (left) isoniazid and (right) 4,4'-bipyridine. 
 
6.5.1 Analysis of crystal morphology and solid form 
Initial evaporative crystallisations of IZN from ethanol prepared in a 10:1 IZN to 44BP 
molar ratio resulted in the reproducible production of needle-like crystals of consistent 
size and shape (Figure 6.16). This presents a significant change in morphology 
compared to the plate-like crystals produced from ethanol with no additive present. 
Although needle-like crystals are largely unfavourable for processing, an understanding 
of the molecular level interactions inducing this change in the shape of the crystals may 








Additional evaporative experiments were also prepared with an IZN to 44BP molar ratio 
of 20:1. These resulted in crystals with a plate-like morphology, comparable to those 
produced in the presence of no additive. This suggests that the 44BP additive must be 
present in a higher concentration to result in a significant effect on the relative growth 
rates of the crystal faces. 
 
In addition to evaporative crystallisation, it was also possible to produce the needle-like 
crystals in a cooling environment reproducibly. At 1 ml scale with magnetic bottom 
stirring, needle-like crystals were observed, however they were significantly smaller than 
those produced by evaporative crystallisation which may be a result of the mixing 
conditions in the 1 ml vials. Interestingly, initial experiments carried out at 10 ml scale with 
overhead stirring resulted in longer needle-like crystals (Figure 6.17). The crystals appear 
finer than those produced by evaporative crystallisation which may be a consequence of 
the faster growth rates and better mixing in the cooling crystallisation experiments. This 




Figure 6.17 - Microscope images of IZN crystals produced in the presence of 44BP in cooling 
crystallisation at (left) 1 ml scale with magnetic bottom stirring, and (right) 10 ml scale with 
overhead stirring. 
 
The solid form of the product of each type of crystallisation was analysed using PXRD, as 
shown in Figure 6.18; this shows that the presence of the additive in the crystallisation 
does not result in a change in the solid form of isoniazid. Furthermore, the patterns do not 
show any peaks corresponding to 44BP suggesting that the additive is not present in the 






Figure 6.18 - PXRD patterns of (a) IZN starting material, IZN crystallised with 44BP present (10:1) 
in (b) an evaporative environment, (c) a cooling environment (1 ml scale), and (d) a cooling 
environment (10 ml scale).  
 
 
6.5.2 Face indexing analysis 
Due to the reproducible nature of the interaction of IZN crystals with the 44BP additive in 
crystallisation from ethanol, further investigation into the additive-induced change in 
morphology from plates to needles was carried out through face indexing. The aim was to 
identify the dominant faces in the needle-like morphology and understand the functional 
groups present on the surfaces of the faces that may form an interaction with the additive. 
Face indexing analysis was carried out on crystals from evaporative crystallisation. The 
small size of the crystals produced by cooling crystallisation limited the ability to perform 
face indexing, however, comparable needle-like morphologies were achieved in both 
evaporative and cooling crystallisation in the presence of 44BP, with indexed faces 





Figure 6.19 - Face indexing of needle-like crystals of IZN produced by crystallisation from ethanol 
in the presence of 44BP.  
 
The fast growing end face in this crystal is the (1̅10) face. This face is present in the 
predicted BFDH morphology of IZN and makes a similar angle with the direction of the a 
axis as do the (101̅) and (101) faces present on the plate-like morphology of IZN 
produced from ethanol with no additive present. The (01̅0) face is common to both plate 
and needle-like morphologies, but in the needle-like morphology the (010) face is 
diminished. The (01̅0) face is accompanied by the (01̅2̅) and (01̅2) faces and their 
corresponding mirror faces on the side of the crystal. The change in crystal shape from 
plate to needle suggests that it is the growth of these side faces that is inhibited by the 
44BP additive. 
 
This can be supported by analysing the crystal structure and by identifying the functional 
groups that lie in the direction of the slow growing crystal faces. In the crystal structure of 
IZN, the IZN molecules lie at two angles. Figure 6.20 shows the view along the (01̅2) 
plane; this plane intercepts interactions between the IZN molecules due to bridging  
N3-H…N1 hydrogen bonds between the amine group and the nitrogen atom on the 




Figure 6.20 - Stacked chains of IZN molecules viewed along the (01̅2) plane. 
 
A similar observation can be made when viewing the crystal structure along the (01̅2̅) 
plane in which the same interaction is intercepted between IZN molecules lying in the 
other orientation (Figure 6.21). These interactions can be observed more clearly when 
the crystal packing is viewed down the a axis, as shown in Figure 6.22. 
 
 





Figure 6.22 - View along the (01̅2) and (01̅2̅) planes looking down the crystallographic a axis with 
relevant interactions intersected by the planes circled in red. 
 
The position of these planes in the crystal structure suggests that the action of the 
additive may proceed through the 44BP molecule, mimicking the action of the pyridine 
ring in the IZN molecule and interacting with the amine N3-H bond of IZN molecules. The 
44BP molecule does not contain any hydrogen bond donor groups and thus may prevent 
the addition of further IZN molecules and hence slows down growth in the direction 
perpendicular to such faces. 
 
6.5.3 1H NMR analysis 
For crystallisation studies in the presence of additives it is important to maintain the 
solution as undersaturated with respect to the additive compound to ensure the impurity 
is not present in the final product. The presence of 44BP in the crystallisation product 
would be unfavourable due to its toxicity, which presents a disadvantage of using 
structurally similar additives in comparison to polymer additives – many polymers are 
often used as excipients in pharmaceutical formulations. 1H NMR was therefore used to 
investigate the purity of the product (see Appendix A6.1). The results suggest that there 
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is no 44BP present in the product in quantities detectable by NMR, and that there is no 
uptake of the additive into the crystal lattice. 
 
 
6.6 Crystallisation of IZN in the presence of other additives 
In addition to 44BP, many other compounds were investigated for an additive effect on 
the crystal morphology of IZN when crystallised from ethanol and from water; these 
screening experiments were largely undertaken by R. Lunt and the author during the 
former’s undergraduate MChem project at the University of Bath. Optical microscopy and 
SEM were used to visualise the crystal morphology produced from these trials and PXRD 
analysis was used to confirm the solid form of the product. With the exception of 
crystallisations prepared in a 1:1 molar ratio in which, in some cases, multi-component 
complexes were produced or unless otherwise stated, the additives had no effect on the 
solid form (polymorph) of the IZN product (see Appendix A6.3 for PXRD patterns). In 
terms of morphology of IZN, none of the polymer additives showed a morphology-
modifying effect in either water or ethanol; however, several of the structurally similar and 
size-matched additives were found to affect the morphology of IZN and the most 
significant findings are presented here.  
 
6.6.1 Evaporative crystallisation from ethanol 
Evaporative crystallisations from ethanol were initially prepared in a 100:1 IZN to additive 
molar ratio with structurally similar additives. These crystallisations resulted in no change 
in crystal morphology and as a result, subsequent crystallisations were carried out in a 
10:1 molar ratio, from the products of which several morphology changes were observed.  
 
Evaporative crystallisation from ethanol in the presence of imidazole, 4-fluorobenzoic acid 
and 4-hydroxybenzoic acid resulted in small changes in the shape of the plate-like 
crystals; in some cases the crystals were more elongated than those produced without 
additives. However, as shown in Figure 6.23, these observations were not fully 
reproducible; results from repeat crystallisations gave different results in terms of crystal 





Figure 6.23 - Inconsistent morphologies of IZN produced in repeat evaporative crystallisations 
from ethanol in the presence of (a) imidazole, (b) 4-flurobenzoic acid and (c) 4-hydroxybenzoic 
acid. 
 
The control crystallisations also resulted in variability in the size and shape of the plate-
like crystals (as shown in Section 6.4.1); such inconsistencies in morphology produced in 
an evaporative environment may result from lack of agitation in the system and poor 
mass transfer. 
 
Crystallisation in the presence of many of the other additives produced plate-like crystals 
of inconsistent size, similar to those produced with no additive present. However, in the 




















than in some of the crystallisations with no additive present (Figure 6.24). This 
morphology change was small and not fully reproducible, and this lack of consistency 
was also evident when a series of 4-substituted benzoic acids were used as additives 
(see Appendix A6.1); inconsistencies in the outcomes of repeat experiments lead to the 
conclusion that the morphology changes cannot definitively be attributed to the presence 
of the additive. 
 
 
Figure 6.24 - Plate-like crystals of IZN produced in the presence of (a) resorcinol and (b) benzoic 
acid in an evaporative environment from ethanol. Two images are shown for each case, 
highlighting inconstancies.  
 
6.6.2 Cooling crystallisation from ethanol 
Cooling crystallisation of IZN was carried out in the presence of all additive compounds 
utilised in the evaporative experiments. Due to the small size of the crystals produced at 
1 ml scale, SEM was used to observe the crystal morphology. As noted previously, the 
morphology of IZN produced from ethanol with no additive present in a cooling 
environment is plate-like and more consistent in repeat crystallisations than in the 
evaporative crystallisations. Therefore, more conclusive comparisons can be made with 
experiments carried out in the presence of an additive. This may be as a result of 
improved temperature control and mixing in the cooling crystallisation experimental set-



















some of the additives in an IZN to additive molar ratio of 10:1 in a cooling environment, 
including the structurally similar additives.  
 
In the presence of isonicotinic acid and 2-picolinic acid, plate-like crystals of IZN were 
observed, however they are more elongated than those produced with no additive 
present. Figure 6.25 shows the SEM images of the crystal morphologies. The crystals 
produced in the presence of isonicotinic acid appear to be thinner than those produced in 
the presence of 2-picolinic acid. This suggests that the isonicotinic acid may be 
interacting with the slowest growing (010) face and inhibiting growth in the direction 
perpendicular to the face (the crystallographic b axis) by intercepting N2-H…N3 
interactions. Isonicotinic acid and 2-picolinic acid differ only by the position of the nitrogen 
atom in the pyridine ring; positioned in the para and ortho positions, respectively. This 
nitrogen atom may interfere with the interactions by offering an alternative hydrogen bond 
acceptor. The different morphologies produced may suggest that the position of the 
nitrogen atom on the ring is important in facilitating an inhibiting effect of crystal growth in 
the direction of the crystallographic b axis.  
 
  
Figure 6.25 - SEM images of IZN crystals produced in the presence of (a) no additive, (b) 
isonicotinic acid and (c) 2-picolinic acid. 
 
Furthermore, use of nicotinamide and isonicotinamide as additives did not have an effect 
on the crystal morphology of IZN. This suggests that the carboxylic acid group on the 
isonicotinic acid and the 2-picolinic acid molecules is also important and may interact 
favourably with the growing crystal of IZN. This is further supported by the observation 
that in some cases nicotinic acid had a similar effect on morphology, although this effect 
was not as reproducible as with isonicotinic acid and 2-picolinic acid. Modifications in the 
crystal morphology of IZN were also observed in the presence of other size-matched 
additives in a 10:1 molar ratio; biuret and 2,4-dinitrobenzoic acid as additives in solution 
consistently produced elongated plates of IZN.  
              (a)                                 (b)                                (c) 
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Further crystallisations with those additives that produced a morphology modification 
effect at 1 ml scale were repeated at 10 ml scale with overhead stirring. Microscope 
images of the crystal morphologies produced are shown in Figure 6.26.  
 
 
Figure 6.26 - Microscope images of IZN crystals produced at 10 ml scale in the presence of 
different additives in a 10:1 IZN to additive molar ratio.  
 
At 10 ml scale the size of the crystals were larger, but comparable results to the small 
scale crystallisations were observed in terms of morphology. In the presence of 2-picolinic 
acid, elongated plates were observed whereas with isonicotinic acid present very thin 
plate-like crystals of IZN were produced. The presence of biuret produced needle-like 
crystals, finer than those observed at small scale. A control experiment was also carried 
out under these conditions, with no additive present, in which plate-like crystals were 
produced. Despite the observation of morphology changes in the presence of additives, 
none of the additives improved the crystal morphology of IZN (in terms of favourable 
particle shapes for processing) in comparison to this control crystallisation. 
 
6.6.3 Evaporative crystallisation from water 
As mentioned previously, crystallisation of IZN from water results in the formation of 
needle-like crystals. In parallel to the crystallisations from ethanol initial evaporative 
crystallisations from water focused on the use of structurally similar additives in a 100:1 
IZN to additive molar ratio. The use of such additives resulted in needle-like crystals of 
            No additive                          2-picolinic acid 
         Isonicotinic acid                               Biuret         
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IZN in all cases, however, the needles varied in length in comparison to those produced 
in the absence of additive (Figure 6.27). For example, crystallisation of IZN in the 
presence of isonicotinamide resulted in shorter needles suggesting that the additive may 
influence the growth of the fast growing end face of the needle. Such small changes in 
crystal morphology were not, however, deemed significant enough to pursue for further 
study.  
 
Figure 6.27 - Microscope images of crystal morphology of IZN produced through evaporation from 
water in the presence of (a) isonicotinic acid and (b) 2-picolinic acid. 
 
A broader range of sized-matched additives were then investigated at a higher IZN to 
additive molar ratio of 10:1, in which a more significant effect of the additives on crystal 
morphology was observed (Figure 6.28).  
 
 
Figure 6.28 - Microscope images of IZN crystals produced in the presence of (a) resorcinol, (b) 
urea and (c) 4-hydroxybenzoic acid. 
 
In the presence of resorcinol, elongated plate-like crystals were produced. In the 
presence of urea as an additive, the IZN crystals displayed a needle-like morphology, but 
these needles were broader and longer than observed in the presence of no additive, 
resembling a blade-like morphology. In the presence of 4-hydroxybenzoic acid a mixture 
(a)                                  (b) 
 (a)                            (b)                           (c) 
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of morphologies were produced from needle-like to block-like crystals. The solid form of 
all products was identified as the known polymorph of IZN. A more detailed analysis of 
the two morphologies is presented in the next section.  
 
6.6.4 Cooling crystallisation from water 
In the cooling crystallisation experiments, stirring was implemented allowing for more 
uniform mass transfer than in evaporative crystallisations. All cooling crystallisations with 
additives present were prepared in an IZN to additive molar ratio of 10:1. None of the 
structurally similar additives produced a significant morphology change in a cooling 
environment under the conditions measured. In contrast, some of the size-matched 
additives induced a morphology change, but only two of these produced the effect 
reproducibly.  
 
In the presence of 2,2’-bipyridyl, in some cases the product needle-like crystals displayed 
a larger aspect ratio; this suggests that the additive may have an inhibiting effect of 
growth perpendicular to the side faces of the crystals, further increasing the relative 
growth rate of the fast growing face. However, in other cases the needles resembled 
those produced from water in the presence of no additive so the effect was not 
considered significant. In the presence of imidazole, initially the crystals produced were 
broader and more plate-like needles. However, this result was not reproducible and 
needle-like crystals were produced upon repetition of the experiment. The morphology 
effect of the presence of 4-hydroxybenzoic acid and urea were each found to be 
reproducible; microscope images of the crystals produced in the presence of these 
additives are shown in Figure 6.29.  
 
 
Figure 6.29 - Microscope images of IZN crystals produced from cooling crystallisation in the 
presence of (a) urea and (b) 4-hydroxybenzoic acid. 
 
           (a)                           (b) 
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As observed in evaporative crystallisations from water, blade-like crystals produced in the 
presence of urea were observed in a cooling environment. This may imply that the 
additive may slow down growth of one of the slow growing side faces of the needle-like 
crystal. Based on the BFDH morphology prediction, this would result from interruption of 
N-H…N hydrogen bonding in the direction of the crystallographic b or c axes. These 
hydrogen bonds both involve the amine group on the IZN molecule; the urea molecule 
also features amine groups which may mimic the interactions of the IZN molecules.   
 
Crystallisations carried out in the presence of 4-hydroxybenzoic acid (4HBA) resulted in a 
mixture of crystal morphologies with needle and block-like crystals produced, which 
correlates with the results from the evaporative crystallisations. Cooling crystallisation 
was also repeated at 5 ml scale with the same mixture of morphologies produced. A 
PXRD pattern of the product shows peaks corresponding to the known IZN polymorph; 
however, unlike in the evaporative sample, these peaks are accompanied by several less 
intense peaks (e.g. at ~13°, 13.5°, and 20° 2). Aitipamula et al. recently reported the 
structures of two concomitant polymorphs of hydrated co-crystals of IZN and 4HBA 
produced when the two starting materials are combined in equimolar quantities. The 
polymorphs show block and needle-like morphologies.145  Figure 6.30 shows the PXRD 
pattern of the product from the cooling crystallisation, along with calculated patterns of 
the reported co-crystals.  
 
 
Figure 6.30 - PXRD patterns of (a) IZN starting material, (b) sample from IZN cooling 
crystallisation from water in the presence of 4HBA (10:1), (c) IZN 4HBA hydrate form II (BICQUB) 




The additional low intensity peaks present in the pattern of the cooling crystallisation in 
this work may correspond to peaks present in the patterns of the co-crystals. The patterns 
of the two co-crystals are very similar and therefore it is difficult to deduce which 
polymorph may be present in the crystallisation product; the polymorphs are reported to 
form concomitantly so they may both be present in the sample. In addition, hot-stage 
microscopy was also used to characterise the sample and this showed the block-like 
crystals present in the sample turning opaque in the region of 110-125 °C. This correlates 
with the temperature at which water is lost in both hydrates reported in the literature.145 
The conclusion from this is that the modified morphologies observed in the presence of 
10% 4HBA may be the result of co-crystal formation rather than modification of IZN 
morphology; isolation of pure samples of each morphology suitable for X-ray diffraction 
was not possible so this could not be confirmed.  
 
 
6.7 Crystallisation of multi-component complexes of IZN 
One drawback of using structurally similar additive compounds for control of crystal 
morphology as opposed to polymer additives is that when used in high concentrations, 
the additive compound may be incorporated into the crystal structure forming a multi-
component complex such as a co-crystal, salt or solid solution instead of producing an 
additive effect and remaining in solution. For example, the co-crystals of 4HBA and IZN 
noted above.145 Additionally, in other cases the presence of an additive in high 
concentrations can have an effect on the polymorphic form of the starting material.47,48 To 
investigate the likelihood of these effects occurring for the chosen additives, 
crystallisations with IZN and the additive in equimolar quantities were thus also prepared. 
These experiments produced a number of molecular complexes co-crystals that have 
been analysed using X-ray diffraction and thermal analysis and are presented here.   
 
6.7.1 IZN2+ oxalic acid2 
Crystallisation of IZN in the presence of equimolar quantities of oxalic acid (OA) resulted 
in a salt form. The complex crystallises in the monoclinic space group P21/c and the 
asymmetric unit consists of one doubly protonated IZN molecule and one doubly 
deprotonated OA molecule (Figure 6.31). One proton from the OA molecule has 
transferred to the terminal amine group on the IZN molecule and the other proton has 
transferred across a strong hydrogen bond to be located closer to the nitrogen atom on 
the pyridine ring. The pyridyl N+-H bond has a N…H distance of 1.22(4) Å and the O…H 




Figure 6.31 - Asymmetric unit of the IZN
2+
 OA
2 complex viewed down the crystallographic c axis. 
 
Hydrogen bonding between the nitrogen atom on the pyridine ring of the IZN molecule 
and a carboxylic acid group on the co-former molecule is a common synthon in IZN 
structures. A Cambridge Structural Database (CSD) search of IZN structures produced 
46 complexes with co-formers containing a carboxylic acid group and of those, 41 feature 
such an interaction. Proton transfer across this hydrogen bond is observed in six 
complexes. This hydrogen bond is particularly short and strong in this complex, with an 
O…N distance of 2.532(2) Å, which makes it an ideal candidate for temperature 
dependent proton transfer studies. Such studies have previously been carried out on a 
complex of IZN and 4-aminosalicylic acid.187 
 
In the structure the molecules assemble in herringbone chains through a bifurcated 
hydrogen bond between the other carboxylate group of the OA molecule and the N-H 
amide bond of the IZN molecule. In addition, an N+-H…O hydrogen bond forms between 
this carboxylate group and the protonated terminal amine group on the IZN molecule, 
linking the herringbone chains together (Figure 6.32).  
 
 




The remaining two N+-H groups on the terminal amine group of the IZN molecule form 
hydrogen bonds with C-O groups on the oxalic acid molecule and these interactions link 
the layers of herringbone chains in the third dimension, as show in Figure 6.33. 
 
 
Figure 6.33 - Stacking of the layers of molecules viewed down the crystallographic a axis. 
 
Table 6.2 - Hydrogen bonds in IZN
2+
 OA










O(5)#1 0.94(2) 2.39(2) 3.208(2) 145.8(18) 
 C(6)-H(3)
...
O(3)#2 1.02(2) 2.34(3) 3.231(3) 145.1(18) 
 N(3)-H(7)
...
O(2)#3 0.95(2) 1.82(2) 2.768(2) 171(2) 
 N(3)-H(8)
...
O(1)#4 1.02(3) 1.77(3) 2.773(2) 168(2) 
 N(3)-H(6)
...
O(5) 0.95(3) 2.15(2) 2.664(2) 112.9(18) 
 N(2)-H(5)
...
O(1)#5 1.02(2) 2.63(2) 3.433(2) 136.1(16) 
 N(2)-H(5)
...
O(2)#5 1.02(2) 1.72(3) 2.685(2) 157(2) 
 N(1)-H(9)
...
O(4) 1.22(4) 1.32(4) 2.532(2) 171(3) 
 N(1)-H(9)
...
O(3) 1.22(4) 2.64(3) 3.535(2) 129(2) 
Symmetry transformations used to generate equivalent atoms:  
#1 x-1,y,z    #2 x+1,y,z    #3 x+1,-y+3/2,z-1/2  
#4 x+1,-y+3/2,z+1/2    #5 -x,y+1/2,-z+1/2  
 
In addition to singe crystal X-ray diffraction (scXRD), PXRD was used to determine the 
phase purity of the sample from evaporative crystallisation. Figure 6.34 shows the PXRD 
pattern of the bulk material alongside the pattern calculated from scXRD data as well as 
diffraction patterns for the two starting materials; this suggests that the sample has good 





Figure 6.34 - PXRD patterns (a) IZN, (b) OA, (c) IZN
2+
 OA






Analysis of a single crystal product from evaporative crystallisation of IZN and OA in a 
10:1 ratio was also carried out using scXRD and it was found that under these conditions 
the salt was not produced; the sample isolated was IZN. This suggests that the salt will 
not form with lower additive ratios and therefore the OA could be used as an additive to 
disrupt crystal growth in such lower concentrations. However, the crystallisation produced 
low yields and therefore bulk analysis was not possible to confirm that none of the salt 
form was present in the sample.  
 
The salt form was also analysed thermally using DSC (Figure 6.35).  
 






Two endothermic events (at 197 and 211 °C) are observed, at temperatures that are 
higher than the melting point of both IZN (171 °C) and OA (189.5 °C).188 This suggests 
that the salt form is more thermally stable than the IZN and OA starting materials. 
 
To investigate these events further, hot-stage microscopy was also carried out; the 
images are shown in Figure 6.36. Firstly, a thermosalient effect is observed around  
160 °C in which the crystals appear to jump and move on the microscope slide. At around 
190 °C the crystals become opaque and begin partially to melt suggesting that they may 
undergo a phase transition to a high temperature form. This is then followed by a full melt 
of the crystal between 220 and 230 °C.  
 
 
Figure 6.36 - Hot-stage microscopy images of IZN
2+
 OA
2 molecular complex. 
 
6.7.2 IZN resorcinol*  
An evaporative crystallisation of IZN and resorcinol (RES) combined in equimolar 
quantities produced a 1:1 molecular complex of the two starting materials. The structure 
crystallises in the monoclinic space group P21/c and the asymmetric unit contains one 
molecule of IZN and one molecule of RES. The nitrogen atom on the pyridine ring of the 
IZN molecule forms an O-H…N hydrogen bond with one of the hydroxyl groups on the 
RES molecule with the rings of each molecule lying co-planar to one another. The other 
hydroxyl group on the RES molecule forms two interactions, each with a different IZN 
molecule. First, the hydroxyl group forms an O-H…N interaction with the nitrogen atom of 
the amine group of one IZN molecule. Secondly, the oxygen atom of the hydroxyl group 
on the RES molecule interacts with one of the N-H bonds of the amine group of a 
                                               
* This structure was subsequently published by Swapna et al. during these studies.186  
30 °C 165 °C 190 °C 
200 °C 225 °C 
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different IZN molecule in an N-H…O interaction (Figure 6.37). The IZN molecule has two 
other hydrogen bond donor groups which form interactions in the structure. The N-H bond 
of the amide group forms an N-H…O hydrogen bond with the amide carbonyl group of an 
IZN molecule directly below it, allowing the co-planar IZN and RES units to stack off-set 
to one another.  
 
 
Figure 6.37 - Hydrogen bond interactions in the IZN RES complex viewed down the 
crystallographic b axis. 
 
Secondly, the N-H bond on the amine group of the IZN molecule also forms an N-H…O 
hydrogen bond with the amide carbonyl group on a symmetry generated IZN molecule. 
The combination of these hydrogen bonds forms two-molecule deep layers of IZN and 
RES molecules (Figure 6.38). 
 
 
Figure 6.38 - Layers of IZN and RES molecules in the IZN RES complex. 
 
Weak C-H…C interactions hold groups of layers together with an angle of 73.8° between 





Figure 6.39 - Packing of IZN and RES molecules in the complex viewed down the crystallographic 
c axis. 
 










O(2)#1 0.924(18) 2.638(18) 3.282(2) 127.4(13) 
 N(5)-H(13)
...
O(3)#2 0.932(19) 2.122(19) 3.0038(19) 157.4(15) 
 N(5)-H(12)
...
O(1) 0.91(2) 2.21(2) 3.0960(18) 162.8(17) 
 N(4)-H(11)
...
O(3)#3 0.865(18) 2.109(19) 2.9205(17) 156.1(16) 
 O(1)-H(1)
...
N(5)#4 0.92(2) 1.94(2) 2.8438(18) 169.9(19) 
 O(2)-H(3)
...
N(3)#5 0.92(2) 1.86(2) 2.7669(17) 168(2) 
Symmetry transformations used to generate equivalent atoms:  
#1 -x,-y+1,-z+1    #2 -x+1,-y+1,-z+1    #3 x+1,y,z  
#4 x-1,y,z    #5 x-1,y,z-1  
 
PXRD analysis of the bulk material from the evaporative crystallisation was also carried 
out (Figure 6.40), suggesting that the complex is produced as a phase pure sample under 
the conditions used.   
 
Figure 6.40 - PXRD patterns of (a) IZN, (b) RES, (c) IZN RES measured, (d) IZN RES calculated 
and (e) product of crystallisation of IZN and RES prepared in a 10:1 molar ratio. 
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PXRD analysis of the product of a crystallisation prepared with an IZN to RES ratio of 
10:1 is shown in Figure 6.40e. The pattern shows peaks related to the pattern for the IZN 
starting material as well as several small peaks matching that of the IZN RES complex. 
This suggests that in this case under these conditions the complex forms in small 
quantities and the excess IZN crystallises as the known polymorph. Thus in evaporative 
crystallisation, this concentration of RES (10:1) could not be used for an additive effect 
without compromising the purity of the product by concomitantly producing the IZN RES 
complex. 
 
The thermal properties of the bulk product were also analysed using DSC, as shown in 
Figure 6.41. A sharp endothermic melting event is present at 147 °C, lower than that of 
the IZN starting material but higher than the RES starting material. This suggests that the 
complex is less thermally stable than IZN but more thermally stable than RES.  
 
 
Figure 6.41 - DSC traces of (a) IZN RES, (b) IZN and (c) RES. 
 
6.7.3 IZN+ 2,4-dinitrobenzoic acid 
An equimolar combination of IZN and 2,4-dinitrobenzoic acid (24DNBA) resulted in the 
formation of a salt. The structure crystallises in the orthorhombic space group Pbca. 
Proton transfer has occurred from the carboxylic acid proton on the 24DNBA molecule to 
the terminal amine group on the IZN molecule. 
 
Unlike in the complex with oxalic acid, the carboxylate group of the 24DNBA molecule 
does not interact with the nitrogen atom on the pyridine ring of the IZN molecule. Instead, 
a hydrogen bonded dimer forms between the two molecules through two N-H…O 
hydrogen bonds. The oxygen atoms in the carboxylate group of the 24DNBA molecule 
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interact with the amide N-H bond of the IZN molecule and with the protonated nitrogen 
atom of the terminal amine group of the IZN molecule. The latter of these two hydrogen 
bonds is relatively short and strong with a N…O distance of 2.5819(17) Å. The nitrogen 
atom of the pyridine ring on the IZN molecule instead forms an N-H…N hydrogen bond 
with an N-H bond on the terminal amine of another IZN molecule. The third N-H bond on 
the amine group on the IZN molecule forms an N-H…O hydrogen bond with the amide 
carbonyl group of another IZN molecule. These interactions allow the molecules to 
assemble in a two dimensional hydrogen bonded chain of IZN molecules flanked by 
24DNBA molecules on either side (Figure 6.42).  
 
 
Figure 6.42 - Hydrogen bonding in the IZN
+
 24DNBA complex viewed down the crystallographic a 
axis. 
 
The hydrogen bonded sheets stack off-set to one another as shown in Figure 6.43 where 





Figure 6.43 - Overall packing arrangement viewed down the crystallographic a axis. Colour coding 
shows the molecules of IZN in red and 24DNBA in blue and highlights the way in which they 
overlay. 
 
Table 6.4 - Hydrogen bonds in IZN
+










O(5)#1 0.963(18) 2.612(18) 3.352(2) 133.8(13) 
 C(7)-H(1)
...
O(2)#2 0.962(17) 2.372(17) 3.3159(19) 166.7(14) 
 N(2)-H(7)
...
O(2)#3 0.928(18) 1.910(18) 2.7769(17) 154.5(16) 
 C(4)-H(8)
...
O(6)#4 0.955(18) 2.424(17) 3.044(2) 122.4(13) 
 N(3)-H(6)
...
O(1)#5 0.91(2) 1.93(2) 2.8406(17) 173.8(17) 
 N(3)-H(4)
...
N(1)#6 0.96(2) 1.84(2) 2.7925(19) 170.7(17) 
 N(3)-H(5)
...
O(2)#3 1.07(2) 2.618(19) 3.2237(17) 115.5(13) 
 N(3)-H(5)
...
O(3)#3 1.07(2) 1.52(2) 2.5819(17) 172.8(17) 
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,-y+1,-z+1    #2 x+1/2,-y+3/2,-z+1    #3 -x,y-1/2,-z+1/2  
#4 -x+1,y-1/2,-z+1/2    #5 x-1/2,y,-z+1/2    #6 -x+1/2,y+1/2,z  
 
As for the other complexes, PXRD analysis was carried out to analyse the purity of the 
bulk product from the evaporative crystallisation. The PXRD patterns are shown in  
Figure 6.44, there is a significant match between the peaks in the measured and 
calculated patterns suggesting that the bulk product exhibits phase purity; however, the 





Figure 6.44 - PXRD patterns of (a) IZN, (b) 24DNBA, (c) IZN
+
 24DNBA measured (d) IZN
+
 
24DNBA calculated and (e) from a 10:1 IZN:24DNBA staring material molar ratio. 
 
PXRD analysis was also carried out for a sample prepared in a 10:1 IZN to 24DNBA ratio; 
the peaks in the resulting pattern match those for IZN, suggesting that the salt is not 
produced under these conditions with this concentration of 24DNBA. 
 
DSC analysis on the complex shows a broad endothermic peak at 145 °C representing 
the melting point of the complex (Figure 6.45). However, the onset for this peak is at the 
much lower temperature of 120 °C suggesting that the sample may not be pure. The 
melting point is also lower than those of the IZN and 24DNBA starting materials 
suggesting that the salt form is less thermally stable than the starting materials.  
 
Figure 6.45 - DSC traces of (a) IZN
+




The crystal morphology of the API isoniazid (IZN) produced from different solvents and in 
the presence of different ratios of a range of additive compounds has been investigated in 
a batch environment. The additives were categorised into structurally similar, size-
matched and polymer additives. Some of the structurally similar compounds used are 
also Generally Recognised as Safe (GRAS) compounds. 
 
IZN was found to crystallise in a plate-like morphology from ethanol and in a needle-like 
morphology from water, both of which are undesirable morphologies for the downstream 
processing of a pharmaceutical ingredient. The modification of the crystal morphology of 
IZN using additives was difficult to achieve, with limited success using structurally similar 
GRAS additives. Some of the size-matched additives did show an effect on crystal 
morphology, however problems with reproducibility were encountered in many of the 
experiments, especially those using evaporative crystallisation. The lack of active mixing, 
resulting in poor mass transfer in evaporative crystallisation, may be a reason for this 
variability in crystal shape. Cooling crystallisation showed more reproducible results with 
some of the additives inducing morphology changes in crystallisations from ethanol. None 
of the polymer additives used displayed an effect on crystal morphology of IZN. In 
contrast to crystallisations of SA in the presence of very low concentrations of polymer 
additives presented in Chapter 4, higher concentrations of structurally similar and size-
matched additives are required in order to induce an effect on the shape of the crystals.  
 
One of the most reproducible findings in this work was the crystallisation of IZN in the 
presence of 4,4’-bipyridyl (44BP) in which elongated crystals were produced from both 
evaporative and cooling crystallisation from ethanol. This presented a large change in 
crystal morphology from the plate-like crystals produced in the presence of no additive; its 
favourability was demonstrated by the reproducible nature of the morphology change. 
Face indexing was carried out to compare the most dominant faces present in the plate-
like morphology produced from ethanol with no additives and the elongated morphology 
produced with 44BP present in solution. It was found that in the presence of the 44BP 
additive, the slow growing faces change and it is suggested that the (01̅2̅) and (01̅2) 
faces in the elongated crystals are those with which the additive may be interacting. 
 
Identification of the functional groups present on the surface of the slow growing faces of 
the elongated crystals allowed a possible mechanism to be constructed. The action of the 
44BP additive may proceed through the molecule mimicking the interaction of the 
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pyridine ring of the IZN molecule with the amine N-H bond of the IZN molecules. The 
44BP molecule does not feature any hydrogen bond donor groups and as a result, 
prevents the addition of further IZN molecules interacting with the growing face whilst the 
molecule is occupying the site. Many of the structurally similar additive molecules used 
feature a pyridine ring, but in contrast to 44BP they also contain a hydrogen bond donor 
group in the form of an acid or amide group. This difference could have been a factor in 
the limited success of the structurally similar compounds suggesting that they are “too” 
structurally similar to IZN to have an effect and do not inhibit the addition of further IZN 
molecules interacting with the crystal surface. This study has emphasised that the design 
of additives for growth inhibition still largely relies on trial-and-error methods.39 However, 
gaining an understanding of the molecular level interactions enabling this change in 
shape may aid the design of future additives for a more desirable effect on the crystal 
morphology of IZN.  
 
Additives were also added to crystallisations of IZN in equimolar quantities and some of 
these crystallisations produced multi-component complexes of the two starting materials 
rather than an additive effect on the morphology of the starting material. These 
experiments confirm that additives must be used in low enough concentrations to prevent 
compromising the purity of the product by producing mixed component systems. The 
potential for complex formation must be considered when attempting to induce 












Molecular complexes of piroxicam 
 
Solubility measurements made by the author and presented in this chapter were included 
in part in the following journal article: 
L. H. Thomas, A. R. Klapwijk, C. Wales and C. C. Wilson, Intermolecular hydrogen 
transfer and solubility tuning in multi-component molecular crystals of the API piroxicam. 
CrystEngComm, 2014, 16 (26), 5924 – 5932. 
 
7.1 Introduction and aims 
Piroxicam (PX) is a non-steroidal anti-inflammatory drug (NSAID) used for the treatment 
of inflammatory diseases, relieving the symptoms of rheumatoid arthritis and 
osteoarthritis.189 It is well reported in the literature that PX exists in different ionisation 
states in the solid state. Figure 7.1a shows the non-ionised tautomer of PX (PXN) in 
which the conformation is locked by an O-H…O intramolecular hydrogen bond. 
Intramolecular hydrogen transfer of the hydroxyl hydrogen atom to the nitrogen atom on 
the pyridine ring results in the formation of the zwitterionic tautomer of PX (PXZ)  
(Figure 7.1b), which is accompanied by a significant change in the conformation of the 
molecule about the amide bond, maximising the number and strength of charge assisted 
intramolecular N-H…O hydrogen bonds.190 Charged forms of PX may also exist where 
intermolecular proton transfer has occurred (Figure 7.1c and d). In the case of the 
protonated PX molecule (PX+), where both nitrogen atoms are protonated, the 
conformation of the PX molecule is the same as the neutral PX which is governed by an 
O-H…O intramolecular hydrogen bond.  The opposite is true for the deprotonated PX 
molecule (PX), in which a single N-H…O intramolecular hydrogen bond is present and 






Figure 7.1 - The different possible configurations of the piroxicam molecule with the sites relevant 




The tautomeric form and conformation of PX may also be distinguished based on the 
colour of the material whereby PX present in its non-ionised form is characteristically 
white and PX present in its zwitterionic form is yellow in colour.191  
 
As for many active pharmaceutical ingredients (APIs), PX is polymorphic – the ability for 
the same molecule to occupy different packing arrangements in the solid state. There are 
currently four fully structurally-characterised polymorphic forms reported; PX exists in its 
non-ionised state in forms I, II and III. The structure of form IV has recently been 
published by Thomas et al. and adopts an unusual mixed ionic state, featuring five PX 
molecules in the asymmetric unit, four of which are present as the non-ionised tautomer 
and one in the zwitterionic state.48 A new multi-component (“templated” crystallisation) 
route to producing single crystals of form III, previously solved only from PXRD data,192 
was also reported. Furthermore, PXRD data of other new PX forms were recently 
published by Nyström et al. in an electrospray study193 and Lavrič et al. as part of a study 
on PX polymorphs using 14N nuclear quadrupole resonance analysis and a range of 
other, non-crystallographic, analytical techniques.194 A purely zwitterionic polymorph of 
PX remains unreported, although this tautomer has been observed in form IV (coexistent 
with the neutral form), the monohydrated form195 and other solvated forms, and in 
molecular complexes.  
 
PX is known for possessing low aqueous solubility at physiological pH.191 Poor aqueous 
solubility can impact the bioavailability of an active pharmaceutical ingredient and so new 
crystalline forms may be desirable for access to improved properties. There are thus 
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many previously reported co-crystals and salts of PX, a large proportion of which include 
co-formers containing the carboxylic acid functionality such as substituted benzoic 
acids196,197 and dicarboxylic acids.191 Molecular complexes of PX with N-heterocycles and 
haloanilic acids have also recently been reported,190 as well as an extensive screening of 
the effect of co-former and crystallisation conditions on the formation of multi-component 
molecular complexes of PX.198 The study also reports several solid forms from 
crystallisations with trimesic acid (TA), also used in this study; however, as it was part of 
an extensive screening investigation, full structural characterisation of these PX TA 
complexes was not reported. There are also several solvates of PX reported, including 
with p-dioxane,191 acetic and isobutyric acid199 as well as with methanol.48 The driving 
force for the tautomeric form adopted in the solid state is unclear and it has been 
suggested that the pKa of the co-former may affect the outcome. Wales et al. grouped  
co-formers based on their pKa value and found that the co-formers with the lowest or 
highest pKa values resulted in complexes with the zwitterionic tautomer of PX.
197 The rare 
phenomenon of tautomeric polymorphism has also been observed in molecular 
complexes of PX. Examples include the multi-component complexes of PX with  
4-hydroxybenzoic acid191 as well as with 2-, 3- and 4-fluorobenzoic acid.197 Such 
examples present an exception to observations and predictions based on pKa. 
 
 
7.1.1 Structural targets and design strategy 
This work aims to produce layered solid-state molecular systems of PX in which 
molecular disorder is present; in particular, the approach adopted targets situations 
where a whole molecule or part of a molecule in a structure adopts different orientations 
in different unit cells, with the potential to create void spaces in the structure. Such 
structural attributes may introduce desired properties such as compressibility through 
slippage of the layers, or the enhanced solubility often observed in disordered molecular 
materials. Symmetrical, planar co-former molecules were selected for use in multi-
component crystallisation with this target in mind. Some of the resulting complexes also 
have interesting thermal properties which will be presented. Figure 7.2 shows the 
molecular structure of the co-formers used in this study. Although use of GRAS 
compounds was desirable in this work, some non-GRAS compounds were also used to 





Figure 7.2 - Molecular structure of each co-former used. 
 
 
7.2 Experimental information 
All of the compounds and solvents used were obtained from commercial sources and 
used without further purification.  
 
7.2.1 Preparation of single crystals and structural information 
All single crystals suitable for X-ray diffraction were produced using evaporative 
crystallisation with the exception of the crystal used to determine the structure of the 
piroxicam trimesic acid complex, which was accessed via a phase transition (see below). 
A small quantity of each component was dissolved in a solvent and left to evaporate 
slowly at room temperature, on temperature controlled hot plates or in the refrigerator. 
Crystallisations were prepared for a range of solvents, temperatures and starting material 
stoichiometries. Data were collected using three laboratory Rigaku Oxford Diffraction 
diffractometers: the Gemini A Ultra, Supernova and Xcalibur. In addition, synchrotron 
radiation was used in the determination of one of the structures. A detailed description of 
the preparation of single crystals and the data collection method used for each complex is 
outlined below. All of the structures were solved by direct methods using  
SHELXS-2013137 and refined using SHELXL-2013138 within the WinGX139,140 program. 




(1) Piroxicam trimesic acid acetone (1:1:1) (PXZ TA ACT)  
PX (0.020 g) and TA (0.013 g) were combined in a 1:1 molar ratio and dissolved in 
acetone. Slow evaporation at room temperature yielded yellow plate-like crystals. Data 
were collected using the Rigaku Oxford Diffraction SuperNova diffractometer with Mo K 
radiation at 100 K.  
 
(2) Piroxicam trimesic acid acetonitrile (1:1:1) (PXZ TA ACN) 
PX (0.020 g) and TA (0.013 g) were combined in a 1:1 molar ratio and dissolved in 
acetonitrile. Slow evaporation at room temperature yielded yellow elongated plate-like 
crystals. Data were collected using the Rigaku Oxford Diffraction Gemini Ultra A CCD 
diffractometer with Mo K radiation at 100K. Dynamic disorder of the methyl group on the 
acetonitrile molecule in this structure could not be resolved and therefore the hydrogen 
atoms were placed in an idealised position based on a riding model. 
 
(3) Piroxicam trimesic acid (1:1) (PXN TA) 
Attempts to obtain the desolvated form at ambient conditions were unsuccessful and this 
complex could only be obtained by desolvation of either solvate (1) or (2). A reasonable 
structural model of the desolvated form was obtained by slow heating of the solvated 
single crystals to 140 °C using a Mettler Toledo FP82 temperature controllable stage, 
cooling to room temperature and transferring a crystal to a Rigaku Oxford Diffraction 
SuperNova diffractometer and collecting the data at 100 K. These small and weakly 
scattering crystals gave a twinned diffraction pattern which may have been caused by 
splitting of the crystal during the phase transition or when subject to the cryostream. As a 
result, data of higher quality were collected using synchrotron radiation at the Advanced 
Light Source, Berkeley, USA, where in-situ heating could be carried out.  A single crystal 
of PXZ TA ATN was mounted at room temperature and the temperature was ramped at 
360 K hr1 to 390 K followed by a further ramp to 420 K at 120 K hr1. The sample was 
then cooled to room temperature, but this led to loss of crystallinity of the sample. A 
cluster of crystals were then mounted at room temperature and these were heated to  
390 K at 360 K hr1 then to 420 K at 120 K hr1. A single crystal was selected from the 
cluster of crystals and re-mounted at room temperature. The crystal was then cooled to 
100 K in-situ and a full data collection carried out at 2 second exposure time. An incident 






(4) Piroxicam 3,5-dihydroxybenzoic acid (1:1) (PXZ 35DHBA) 
PX (0.021 g) and 35DHBA (0.010 g) were combined in a 1:1 molar ratio and dissolved in 
acetonitrile. Slow evaporation at 30 °C yielded yellow plate-like crystals. Data were 
collected using the Rigaku Oxford Diffraction Gemini Ultra A CCD diffractometer with Mo 
K radiation at 100 K.  
 
(5) Piroxicam resorcinol (1:1) (PXZ RES) 
PX (0.021 g) and RES (0.014 g) were combined in a 1:2 molar ratio and dissolved in a 
mixed solvent of acetonitrile and methanol in a 1:1 v/v ratio. Slow evaporation of solvent 
at 50 °C yielded yellow block crystals within a multi-phase sample. Data were collected 
using the Rigaku Oxford Diffraction Gemini Ultra A CCD diffractometer with Mo K 
radiation at 100 K.  
 
(6) Piroxicam 3,4-dihydroxybenzoic acid acetonitrile (2:1:2) (PXZ 34DHBA ACN) 
PX (0.020 g) and 34DHBA (0.009 g) were combined in a 1:1 molar ratio and dissolved in 
acetonitrile. Slow evaporation at room temperature yielded yellow plate-like crystals. Data 
were collected using the Rigaku Oxford Diffraction Xcalibur diffractometer with Mo K 
radiation at 150 K. All hydrogen atoms on the 3,4-dihydroxybenzoic acid molecule were 
placed in an idealised position based on a riding model.  
 
(7) Piroxicam 3,5-dinitrobenozic acid (1:1) (PXN 35DNBA) 
PX (0.025 g) and 35DNBA (0.032 g) were combined in a 1:2 molar ratio and dissolved in 
a mixture of methanol and acetonitrile (1:1 v/v). Slow evaporation at 40 °C yielded 
colourless plate-like crystals. Data were collected using the Rigaku Oxford Diffraction 
SuperNova diffractometer with Cu K radiation at 150 K. The hydrogen atoms of the 
methyl group on the PX molecule were placed in an idealised position based on a riding 
model. 
 
(8) Piroxicam 3,5-dinitrosalicylic acid (1:1) (PX+ 35DNSA) 
PX (0.021 g) and 35DNSA (0.014 g) were combined in a 1:1 molar ratio and dissolved in 
a mixture of methanol and acetonitrile (1:1 v/v mixture). Slow evaporation at room 
temperature yielded colourless prism crystals. Data were collected using the Rigaku 
Oxford Diffraction Xcalibur diffractometer with Mo K radiation at 150 K. An aromatic 






(9) Piroxicam 2,4-dinitrobenzoic acid acetonitrile (1:1:1) (PX+ 24DNBA ACN) 
PX (0.020 g) and 24DNBA (0.026 g) were combined in a 1:2 molar ratio and dissolved in 
acetonitrile. Slow evaporation at room temperature yielded colourless plate-like crystals. 
Data were collected using the Rigaku Oxford Diffraction Xcalibur diffractometer with Mo 
K radiation at 150 K. 
 
(10) Piroxicam 2,6-dihydroxybenzoic acid (1:1) (PX+ 26DHBA) 
PX (0.020 g) and 26DHBA (0.009 g) were combined in a 1:1 molar ratio and dissolved in 
a 1:1 mixture of acetonitrile and methanol. Slow evaporation at 50 °C yielded colourless 
block-like crystals. Data were collected using the Rigaku Oxford Diffraction SuperNova 
diffractometer with Cu K radiation at 150 K. In the refinement of this crystal structure, 
additional electron density was observed in a site that would occupy a disordered sulphur 
atom, however modelling of this low level of disorder was not possible and as a result the 
nearby methyl hydrogen atoms on the PX molecule were placed in an idealised position 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































7.2.2 Other preparation methods of PX TA complexes 
Experiments using other crystallisation methods such as grinding, solution mediated 
(slurrying) and cooling were carried out in attempt to prepare multi-component complexes 




Dry and liquid assisted grinding experiments were carried out manually using a mortar 
and pestle. In the case of liquid assisted grinding, several drops of solvent were added 
during grinding. In each experiment the starting materials were combined in an equimolar 
quantity and ground together for a defined period of time; Table 7.2 outlines all other 
experimental information.  
 










0.010 0.006 Acetone 2 drops 10 
0.010 0.006 Acetonitrile 2 drops 10 
0.010 0.060 - - 5 
0.010 0.064 - - 10 
 
7.2.2.2 Rapid cooling crystallisation 
Initial cooling crystallisations were carried out using a rapid cooling method. In each 
experiment the starting materials were combined in equimolar quantities and dissolved in 
the specified solvent to produce a saturated solution. The vial was then transferred to an 
ice bath to facilitate rapid cooling of the solution and subsequent crystallisation. Table 7.3 
summarises the experimental conditions used.  
 








0.040 0.026 1:1 Acetone 5 




*in the case of mixed solvents, 1:1 v/v mixtures were used. 
 
7.2.2.3 Controlled cooling crystallisation 
After rapid cooling experiments, small-scale controlled, cooling crystallisations were 
carried out in 20 ml vials using the Cambridge Reactor Design Polar Bear Plus 
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crystalliser. A linear cooling profile of 50°C to 5°C at 0.5 °C min1 was used employing 
magnetic bottom stirring at a stirring speed of 350 rpm. 
 








0.08 0.050 1:1 Acetone 10 












*in the case of mixed solvents, 1:1 v/v mixtures were used unless otherwise specified. 
 
7.2.2.4 Solution mediated (slurrying) 
Equimolar quantities of PX and TA were weighed into 20 ml vials and a specified quantity 
of solvent was added. The slurries were stirred using magnetic bottom stirring (150 rpm) 
at a constant temperature of 20 °C maintained using the Cambridge Reactor Design 
Polar Bear Plus. The product was filtered and the solid form characterised using PXRD. 
Table 7.5 summarises the conditions used for each experiment.  
 










0.150 0.095 Acetone 2 1 
0.150 0.095 Acetone 2 4.5 
0.150 0.095 Acetone 4 14 
0.150 0.095 Acetonitrile 2 1 









*in the case of mixed solvents, 1:1 v/v mixtures were used. 
 
7.2.3 Vapour diffusion experiments 
Vapour diffusion experiments were carried out by placing a small quantity (~25 mg) of the 
crystalline powder in a vial which was then placed in a larger vial containing 1 ml of the 
chosen solvent. The larger vial was sealed with a lid as well as paraffin film allowing for 
slow diffusion of the solvent into the smaller vial at ambient conditions whilst preventing 
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vapour escaping from the vessel (Figure 7.3). PXRD, DSC and FTIR were used to 
confirm the solid form of the material following vapour diffusion.  
 
 
Figure 7.3 - Experimental set-up for vapour diffusion experiments. 
 
7.2.4 Analytical methods 
Experimental information for analytical techniques used exclusively in the work in this 
chapter is outlined below. Experimental information for techniques relevant to other 
chapters is outlined in Chapter 3. 
 
7.2.4.1 Variable temperature powder X-ray diffraction (VT-PXRD) 
VT-PXRD was carried out at the I11 beamline at Diamond Light Source. A sample of PXZ 
TA ACT was heated to 140 °C at a rate of 360 K hr-1 and a PXRD pattern recorded at 
1 °C intervals until the desolvation transition at which point the temperature was held at 
140 °C. 
 
7.2.4.2 Variable temperature Raman spectroscopy 
A Renishaw inVia Raman Microscope along with a Mettler Toledo FP82 hot stage was 
used for the variable temperature Raman spectroscopy measurements. Samples were 
heated at a rate of 10 °C min1 and spectra were taken every 10 °C from room 
temperature to 150 °C. 
 
 
7.2.4.3 Solubility measurements 
Solubility measurements of PX in ethanol and methanol were carried out using the 
Technobis Crystallization Systems Crystal16 at 1 ml scale. Vials containing different 
concentrations of PX were heated between temperatures of 5 °C and 75 °C using a 
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heating/cooling rate of 0.5 °C min1, with magnetic bottom stirring at 800 rpm employed. 
The data were analysed using CrystalClear software.133  
 
 
7.3 Characterisation of PX starting material 
Figure 7.4 shows an experimental PXRD pattern of the PX starting material, compared 
with calculated patterns of PX polymorphs and its monohydrate from the Cambridge 
Structural Database (CSD). The starting material is seen to be PX form I.  
 
Figure 7.4 - PXRD patterns of PX: (a) raw material, (b) PX form I (BIYSEH04), (c) PX form II 
(BIYSEH06), (d) PX form III (BIYSEH07) and (e) PX monohydrate (CIDYAP01). 
 
The solubility of PX was measured turbidometrically using the Technobis Crystallization 
Systems Crystal16 platform in two solvents: methanol and ethanol (Figure 7.5).190  
 
Figure 7.5 - Solubility curves of PX in (a) methanol and (b) ethanol with lines of fit based on a Van’t 
Hoff functional form as a guide to the eye. 
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7.4 Solvates of a multi-component system of piroxicam with trimesic acid 
Two solvates of a molecular complex of PX and TA with acetone and with acetonitrile as 
well as the desolvated form were produced. The structural results are complemented with 
thermal and spectroscopic analysis. 
 
7.4.1 Structural comparison of solvates 
Both PX-TA solvate co-crystals crystallise in the triclinic space group P1̅ with the 
asymmetric unit containing one molecule each of PX, TA and acetone or acetonitrile. 
Intramolecular proton transfer from the hydroxyl group to the nitrogen atom of the pyridine 
ring on the PX molecule means that PX is present in its zwitterionic form in both solvates. 
The deprotonated oxygen atom forms an intramolecular electrostatic interaction with the 
nearby protonated nitrogen atom. Furthermore, the protonated nitrogen atom on the 
pyridine ring forms an electrostatic interaction with the carbonyl oxygen atom alongside it. 
These intramolecular interactions lock the conformation of the molecule.  
 
In both solvates the PX molecules form a co-planar hydrogen bonded dimer unit held 
together by two N+-H…O charge assisted hydrogen bonds. A TA molecule lies on either 
side of the PX dimer interacting through a charge assisted O-H…O hydrogen bond from 
the hydroxyl group on the TA molecule to the deprotonated hydroxyl group on the 
zwitterionic PX molecule. There is also a weak C-H…O interaction between the carbonyl 
oxygen atom on the carboxylic acid group of the TA molecule and the hydrogen atom on 
the pyridine ring of the PX molecule. These interactions allow the molecules to arrange 
themselves in a four molecule tetrameric hydrogen bonded unit, a common synthon 
present in zwitterionic PX complexes,190,191,197 as well as in complexes of the related API 
tenoxicam.200 In both solvates this synthon is planar with the exception of the methyl and 
sulfonyl groups of the PX molecules (and a slight rotation of the benzene ring on PX). 
Another common synthon, the carboxylic acid dimer, can be found in both structures 
linking one-dimensional zig-zag chains of TA molecules.  
 
Although the two solvates both contain these common synthons they are not 
isostructural. In the acetone solvate, chains of TA molecules are disrupted by the 
formation of an O-H…O hydrogen bond between a carboxylic acid hydroxyl group on the 
TA molecule and the carbonyl oxygen atom on the acetone molecule (Figure 7.6). This 
hydrogen bond forms in preference to a carboxylic acid dimer between the two TA 




Figure 7.6 - Hydrogen bonded layers of molecules in the PXZ TA ACT solvate viewed down the 
crystallographic b axis. Colour coding shows the molecules of PXZ in red, TA in blue and acetone 
in green. 
 
As a result of this interaction the methyl groups of the acetone molecule project out of the 
layers forming weak C-H…O bifurcated interactions with the nearby oxygen atom of the 
sulfonyl group on the PX molecule in the next layer. The layers stack offset to one 
another to allow space for the projecting methyl and sulfonyl groups and the acetone 
molecules (Figure 7.7). The acetone molecules therefore sit in pockets within the 
structure and do not form obvious connected channels.  
 
 
Figure 7.7 - Packing arrangement of the molecules in PXZ TA ACT viewed down the 
crystallographic c axis. 
 
In contrast, in the acetonitrile solvate the molecules arrange themselves in a two-
dimensional hydrogen bonded ribbon with the TA molecules forming infinite zig-zag 
chains which are linked to one another by hydrogen bonds to PX dimers. Unlike in the 
acetone solvate, the acetonitrile molecules do not form hydrogen bonds in the structure. 
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The acetonitrile molecules sit free in the void space created by the zig-zag arrangement 
of TA molecules (Figure 7.8).  
 
 
Figure 7.8 - Hydrogen bonded ribbons of molecules in PXZ TA ACN. Colour coding shows the 
molecules of PXZ in red, TA in blue and acetonitrile in green. 
 
These ribbons make up infinite layers held together by weak interactions within the 
structure. As in the acetone solvate, offset stacking of these layers means that the gaps 
within the layers containing the solvent molecule form discrete pores instead of open 
channels (Figure 7.9). As well as hosting a solvent molecule, the pores accommodate the 
methyl and sulfonyl groups that lie out of the plane. The layers of tetrameric units have an 
interlayer distance of between 3.0 and 3.2 Å and are held together by weak interactions. 
Achieving layered forms was one of the aims of these co-crystallisation experiments – 
these weak interactions between the layers may encourage slippage and subsequently 
improve the compaction and solubility properties of the bulk material. 
 
 














O(5)#1 0.91(3) 2.27(2) 3.143(3) 161.6(18) 
 C(14)-H(1)
...
O(9)#2 0.95(2) 2.50(2) 3.432(3) 168.9(17) 
 N(2)-H(5)
...
O(10) 0.91(3) 1.82(3) 2.623(2) 146(2) 
 N(1)-H(10)
...
O(11) 0.94(3) 1.84(3) 2.595(2) 136(3) 
 N(1)-H(10)
...
O(11)#3 0.94(3) 2.19(3) 2.875(3) 130(2) 
 C(27)-H(9)
...
O(11)#3 0.98(3) 2.53(2) 3.095(3) 116.5(16) 
 C(27)-H(9)
...
N(3)#3 0.98(3) 2.35(3) 3.311(3) 169.0(17) 
 O(4)-H(17)
...
O(10)#4 0.83(4) 1.75(4) 2.571(2) 169(3) 
 C(3)-H(18)
...
O(8)#5 0.96(2) 2.64(2) 3.522(3) 153.9(18) 
 O(3)-H(24)
...
O(2)#6 0.91(3) 1.73(3) 2.636(2) 177(3) 
 O(6)-H(25)
...
O(1)#7 0.97(3) 1.67(3) 2.641(2) 172(3) 
Symmetry transformations used to generate equivalent atoms:  
#1 x+1,y,z    #2 -x,-y,-z+1    #3 -x,-y,-z+2    #4 x-1,y,z  
#5 x,y+1,z    #6 -x+1,-y+1,-z+2    #7 x,y,z+1  
 










O(4)#1 0.961(19) 2.547(19) 3.0989(19) 116.6(14) 
 C(14)-H(9)
...
N(3)#2 0.933(18) 2.418(18) 3.343(2) 170.9(14) 
 C(14)-H(9)
...
O(2)#2 0.933(18) 2.591(16) 3.1341(19) 117.6(12) 
 C(11)-H(6)
...
O(5)#3 0.967(19) 2.258(19) 3.2006(19) 164.5(15) 
 N(2)-H(5)
...
O(1) 0.89(2) 1.82(2) 2.5792(17) 143.1(18) 
 N(1)-H(10)
...
O(2) 0.92(2) 1.91(2) 2.6206(16) 132.7(17) 
 N(1)-H(10)
...
O(2)#2 0.92(2) 2.17(2) 2.8852(17) 134.2(17) 
 O(6)-H(14)
...
O(1)#3 0.90(2) 1.64(2) 2.5378(15) 177(2) 
 O(7)-H(18)
...
O(8)#4 0.91(3) 1.72(3) 2.6246(15) 176(2) 
 O(10)-H(16)
...
O(9)#5 1.05(4) 1.54(3) 2.5878(15) 177(3) 
Symmetry transformations used to generate equivalent atoms:  
#1 -x,-y+1,-z+1    #2 -x+1,-y+2,-z+2    #3 -x,-y+2,-z+2  
#4 -x+1,-y+2,-z+1    #5 -x+2,-y+3,-z+2  
 
 
7.4.2 PXRD analysis of evaporative crystallisation 
Figure 7.10 shows the PXRD patterns calculated from the single crystal XRD structure of 
each solvate and the corresponding measured pattern from the bulk material produced 
from evaporative crystallisation. In both cases, a good match between the two patterns is 
observed showing that the single crystal selected from the product of evaporative 





Figure 7.10 - PXRD patterns of (left) PXZ TA ACT and (right) PXZ TA ACN: (a) calculated from 
single crystal data and (b) measured from bulk product of evaporative crystallisation. 
 
7.4.3 Transfer to other methods of crystallisation  
Although the products of evaporative crystallisation showed phase purity, in order to 
produce the solvates of PX and TA in larger quantities for thorough investigations into 
their thermal behaviour, alternative methods of crystallisation for their production such as 
grinding, cooling and slurrying were tested. 
 
7.4.3.1 Liquid assisted grinding using a mortar and pestle 
Manual grinding in the presence of several drops of solvent was carried out in an attempt 
to produce the two solvates of PX previously produced by evaporative crystallisation. 
Figure 7.11 shows the PXRD patterns of the products of LAG with acetone (c) and with 
acetonitrile (d).  
 
Figure 7.11 - PXRD patterns of (a) PX form I (BIYSEH04), (b) TA (BTCOAC), (c) product of LAG 
with acetone for 10 minutes and (d) product of LAG with acetonitrile for 10 minutes.  
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It can be concluded that LAG was unsuccessful as a method of producing both of the 
solvates and instead produced a physical mixture of the starting materials with broad 
diffraction peaks. 
 
7.4.3.2 Cooling crystallisation 
Cooling crystallisation was also investigated as a method to produce the complexes. 
Initial studies investigated rapid cooling crystallisation and this was followed by controlled 
cooling experiments. All samples obtained from these experiments were analysed using 
PXRD.  
 
Figure 7.12 shows the PXRD patterns of the rapid and controlled cooling experiments 
with PX and TA in acetone. Both patterns match well with the reference pattern for the 
acetone solvate showing that the solvate can be prepared by cooling crystallisation at two 
different cooling rates, indicating its favourable formation.  
 
 
Figure 7.12 - PXRD patterns of (a) PXZ TA ACT reference, (b) rapid cooling of PX and TA (1:1) in 
acetone and (c) controlled cooling of PX and TA (1:1) in acetone. 
 
Production of the acetonitrile solvate through cooling crystallisation was more 
challenging, these experiments producing poor quality PXRD patterns, as shown in 
Figure 7.13. There is evidence from the patterns that the solvate may have formed, 
however there are additional broad peaks that may result from residual starting materials 
or another solid form. Altering the ratio of the starting materials had little effect on the 





Figure 7.13 - PXRD patterns of (a) PXZ TA ACN reference, (b) TA (BTCOAC), (c) PX form I 
(BIYSEH04), (d) PX and TA (1:1) rapid cooling in acetonitrile, and controlled cooling in acetonitrile 
of: (e) PX and TA (1:1), (f) PX and TA (1:2) and (g) PX and TA (2:1).  
 
7.4.3.3 Solution mediated (slurrying) 
Crystallisation of multi-component materials can sometimes be facilitated by slurrying the 
two starting materials in a chosen solvent for a given amount of time. This method of 
crystallisation was more successful than the method of grinding or cooling for the 
production of the PXTA solvates. However, some optimisation of the conditions was 
required. Initially the starting materials were stirred in 2 ml of the solvent used for the 
evaporative crystallisations (acetone for the acetone solvate and acetonitrile/methanol 
mixture for the acetonitrile solvate) for one hour. The stirring time and quantity of solvent 
used was adjusted to produce the solvated materials.  
 
Figure 7.14 shows the PXRD patterns produced from the slurrying experiments of PX and 
TA in acetone. After one hour of stirring the starting materials in acetone the solvated 
complex was produced, however more complete conversion was achieved after slurrying 





Figure 7.14 - PXRD patterns of products from slurrying experiments of PX and TA in acetone: (a) 
PXZ TA ACT reference from evaporative experiments, (b) slurrying for 1 hour, (c) slurrying for 4.5 
hours and (d) slurrying for 14 hours.  
 
For the acetonitrile solvate, slurrying was initially carried out in the crystallisation solvent 
used for evaporative crystallisations (1:1 mixture of acetonitrile and methanol). As shown 
in Figure 7.15, complete conversion to the solvate was achieved after one hour; however 
stirring for 4.5 hours produced a PXRD pattern with sharper peaks indicating more 
complete conversion and improved crystallinity.  
 
 
Figure 7.15 - PXRD patterns of products from slurrying experiments of PX and TA in 
acetonitrile:methanol (1:1) mixture (a) PXTA ACN reference from evaporative experiments, (b) 




In the evaporative and cooling crystallisations a solvent mixture of acetonitrile and 
methanol was required to facilitate the dissolution of the TA which showed poor solubility 
in acetonitrile. However, this means that the product could also potentially contain a 
methanol solvate of the two materials isostructural to the acetonitrile solvate. As slurrying 
does not require all of the starting materials to be completely dissolved in the slurrying 
solvent at once, additional experiments were carried out in pure acetonitrile. PXRD 
patterns from these experiments are shown in Figure 7.16. The patterns show that the 
desired acetonitrile solvate was successfully produced after one hour of slurrying. 
However, there is evidence of residual starting materials, with extra peaks corresponding 
to those in the patterns of the starting materials. Upon slurrying for a longer period of 
time, phase pure material was produced. This finding was beneficial for further analysis of 
the solvate as it provided pure PXZ TA ACN solvate and eliminated the possibility of the 
presence of an isostructural methanol solvate in the sample. 
 
 
Figure 7.16 - PXRD patterns of slurrying experiments of PX and TA in acetonitrile: (a) PX form I 
(BIYSEH04), (b) TA (BTCOAC), (c) PXTA ACN reference from evaporative experiments,  
(d) slurrying for 1 hour and (e) slurrying for 4.5 hours.  
 
7.4.4 Thermal Analysis 
The thermal properties of both solvates were analysed using three complementary 
techniques, hot-stage microscopy (HSM), differential scanning calorimetry (DSC) and 
thermogravimetric analysis (TGA). HSM allowed for a visual representation of the thermal 




Figure 7.17 - DSC (exotherm up) and TGA traces of (a) PXZ TA ACT and (b) PXZ TA ACN. 
 
A broad endothermic event is common to the DSC trace of each solvate indicating the 
loss of solvent from the complexes. It is worth noting that this temperature is much higher 
than the boiling points of the solvents which is typical when the solvent molecule is bound 
within the crystal lattice.130 This solvent loss occurs in the range of 125-150 °C for the 
acetone solvate and appears to occur more gradually for the acetonitrile solvate  
(110-160 °C). These slight differences may be related to the different hydrogen bonding 
and subtleties of the situation of the solvent molecules within a very similar packing in the 
two solvate structures. Desolvation of the acetonitrile solvent is also followed by a small 
exothermic event which may represent a solid-solid phase transition. The results from the 
DSC correlate with those observed in the TGA patterns with a loss in mass of 8.70 % at 
170 °C corresponding to one solvent molecule per asymmetric unit for acetone 
(theoretical = 9.69 %) and a loss in mass of 6.80 % at 160 °C corresponding to one 
solvent molecule per asymmetric unit for acetonitrile (theoretical = 7.05 %). Upon further 
heating a sharp endothermic event is observed with an onset temperature of 240 °C 
representing melting of the desolvated form, which is followed by an exothermic event at 
255 °C, characteristic of a recrystallisation event. Following loss of the solvent molecule 
in the TGA, a second mass loss of 40 % for the acetone solvate and 42 % for the 
acetonitrile solvate occurs between 230°C and 270°C which correlates to the loss of one 
TA molecule per asymmetric unit (36.1%). This is immediately followed by the 
decomposition of PX and therefore the experimental mass loss is slightly more than the 
theoretical value due to the overlap of the mass loss and decomposition events. The 
events after the desolvation event are common to the DSC and TGA profiles of both 
solvates at the same temperature suggesting that upon loss of the solvent from the 




HSM images correlate with the events seen in the DSC and TGA traces (Figure 7.18 and 
Figure 7.19). However, for both solvates, the onset of desolvation is observed at a higher 
temperature than in the DSC traces: at 138 °C and 165 °C for the acetone solvate and 
the acetonitrile solvate, respectively.  
 
 
Figure 7.18 – HSM images of PXZ TA ACT solvate. 
 
 
Figure 7.19 - HSM images of PXZ TA ACN solvate. 
 
Bubbles of solvent are released in parallel to the crystals becoming opaque as the 
transition occurs across the crystals. This loss of transparency is common in 
stoichiometric solvates as the solvate forms multiple small crystallites of the desolvated 
form whilst maintaining its original shape.201 Desolvation is then followed by melting and 
31 °C 138 °C 146 °C 
161 °C 260 °C 268 °C 
31 °C 165 °C 189 °C 
280 °C 295 °C 
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recrystallisation which also occurs at a higher temperature than in the DSC traces. The 
recrystallisation event is observed clearly in the HSM image of a larger crystal of the 
acetonitrile solvate shown in Figure 7.20. Differences in the temperatures at which the 
thermal events occur in the DSC and the HSM may be a result of the nature of the 
sample and the different sample environments in the two techniques. The microcrystalline 
powder is confined in a sample pan for the DSC measurements whereas in HSM the 
single crystal is open to the environment. 
 
 
Figure 7.20 - HSM image capturing a recrystallisation event in crystals of the  
PXZ TA ACN complex.  
 
It was possible to isolate the desolvated form of both solvates and a number of 
observations can be made about this desolvated phase. Firstly, DSC and TGA profiles of 
the desolvated form (Figure 7.21 a and b) no longer show evidence of a solvent loss 
event, suggesting that all of the solvent has been lost. The melting and recrystallisation 
events around 250 °C previously observed in the DSC for the solvated material are also 
present in the traces for the desolvated form.  
 
 
Figure 7.21 - DSC (exotherm up) and TGA traces after heating (a) PXZ TA ACT and (b) PXZ TA 




Secondly, upon loss of the solvent from the complexes, crystallinity is maintained and 
unique diffraction peaks in the PXRD pattern suggest that the molecules rearrange to 
form a new crystal structure (Figure 7.22c). In addition, both solvates form the same 
desolvated form, producing the same PXRD pattern. Finally, upon heating a powder of 
each solvate, it is evident visually that the colour of the powder changes from yellow to 
white. As noted above, it is well reported in the literature191,198 that the tautomeric form of 
PX present can be deduced from the colour of the material; the crystalline powder or 
single crystal is reported as yellow when the zwitterionic form is present and white (or 
colourless for single crystals) for the non-ionised form. The observed colour change 
suggests that upon desolvation there may be a change in the tautomeric form of the PX 
molecule in the complex. This would result in a large conformational change within the 
solid state, significantly altering the packing arrangement of the molecules.  
 
Crystalline powders of the stable, desolvated form can be resolvated with either solvent 
(acetone, acetonitrile) by exposing the powder to solvent vapour at ambient conditions. 
The high volatility of acetone means that the vapour diffusion process occurred more 
quickly for this solvent than for acetonitrile using the same volume of solvent; after 24 
hours colour change from white to yellow had occurred, resulting from acetone uptake 
into the structure. In the acetonitrile case, solvent induced conversion occurred more 
slowly; seven days were required for the transition to occur.  TGA analysis of the 
resolvated samples (Figure 7.23 a and b) also shows that the same quantity of solvent is 
reabsorbed by the material with a mass loss of 9.70 % at 150 °C for the acetone solvate 
(theoretical = 9.69 %) and a mass loss of 6.73 % at 160 °C for the acetonitrile solvate 
(theoretical = 7.05 %). The DSC traces also show a broad endothermic event 
representing this solvent loss. This thermal event occurs between 100-150 °C for the 
acetone solvate, a lower onset temperature than the initial solvate which can also be 
noted from the desolvation temperature in the TGA. This may be a result of some loss of 
crystallinity of the substance following the phase transitions. For the acetonitrile solvate, 
desolvation occurs in the same temperature range as before, between 110-160 °C. The 
melting and recrystallisation events following desolvation in the DSC occur at the same 
temperature (onset: 140 °C) for each resolvated complex as observed previously. Upon 
resolvation, there is a clear colour change with the colour of the powder reverting from 
white back to yellow and the crystal structure returns back to its original form  
(Figure 7.22d and Figure 7.24). The possibility of resolvation is surprising since the 
solvent molecules do not sit in channels in either crystal structure, instead being 
positioned in discrete pockets within the structure. Furthermore, the acetone molecules in 
the acetone solvate are involved in the hydrogen bonding of the crystal structure. This 
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suggests that the mechanism of desolvation may be driven by a change in tautomeric 
form upon heating which allows for the solvent molecules trapped in these discrete pores 
to escape. Alternatively, the loss of the solvent molecules may allow freedom for the 
molecules to rearrange within the structure.  
 
 
Figure 7.22 - PXRD patterns of (left) PXZ TA ACT and (right) PXZ TA ACN: (a) calculated from 
single crystal data, (b) measured from bulk product of evaporative crystallisation, (c) after heating 
sample b and (d) after vapour diffusion of sample c. 
 
 
Figure 7.23 - DSC (exotherm up) and TGA traces of the desolvated form after vapour diffusion 














Transitions between tautomeric forms within the solid state have been observed 
previously. For example, tautomeric polymorphs of the complex of PX with 2-
fluorobenzoic acid were reported and it was shown that a transition from the zwitterionic 
form to the non-ionised form occurred upon heating,197 however this was not reported as 
reversible. Based on the literature on tautomeric polymorphs of PX, attempts were made 
to prepare the desolvated form at ambient conditions using evaporative crystallisation; it  
has previously been reported that a small alteration in crystallisation conditions such as 
temperature197 or solvent191 may promote preferential growth of a tautomeric polymorph. 
However, these attempts were unsuccessful, yielding crystals of either starting materials 
or a solvate. The solvates were also placed under vacuum in search of a more gentle 
method of desolvation than heating; this was unsuccessful and heating was required in 
order for the solvent mediated transition to occur.  
 
Dry grinding was also investigated as a possible route to the desolvated form of PX TA. 
Figure 7.25 shows the resulting PXRD patterns after dry grinding the two starting 
materials for 5 minutes (Figure 7.25d) and for 10 minutes (Figure 7.25e). 
 
 
Figure 7.25 - PXRD patterns: (a) heated form of PXTA reference, (b) PX form I (BIYSEH04), 
(c) TA (BTCOAC), (d) product of dry grinding for 5 minutes and (e) product of dry grinding for 10 
minutes.  
 
The PXRD patterns show that dry grinding of the two starting materials for up to 10 
minutes results in a physical mixture of PX and TA starting materials. After 10 minutes a 
slight broadening of the peaks (Figure 7.25e) suggests that prolonged grinding may result 
in increased amorphous content in the samples.  
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7.4.5 Structural analysis of desolvated form 
The crystal structure of the desolvated form remains in the triclinic space group 𝑃1̅ and 
confirms the loss of the solvent with the asymmetric unit containing one PX molecule and 
one TA molecule. The structure also confirms that a tautomeric transition has occurred 
upon desolvation, with the PX molecule now present in its non-ionised form. As a result of 
this change in ionisation state, the PX molecule has undergone a significant 
conformational rearrangement in the solid state. Intramolecular proton transfer on the PX 
molecule has occurred from the hydrogen atom bonded to the nitrogen atom of the 
pyridine ring to the oxygen atom to form a hydroxyl group. This allows for the formation of 
an O-H…O intramolecular hydrogen bond locking the conformation of the PX molecule.  
 
As the PX molecule is no longer in its zwitterionic form and the conformation of the 
molecule is different, the PX molecules no longer assemble in dimers linked by charge 
assisted hydrogen bonds. Instead, one PX molecule sits between chains of TA 
molecules. Two hydrogen bonds link the PX molecule to a TA molecule via one of its 
carboxylic acid groups. An O-H…N hydrogen bond of length 2.582(3) Å forms between the 
O-H group on the TA molecule and the pyridine nitrogen atom on the PX molecule. 
Alongside this is an N-H…O hydrogen bond of length 3.064(3) Å between the carbonyl 
oxygen atom on the TA molecule and the N-H group on the PX molecule. As observed in 
the acetonitrile solvate, the two other carboxylic acid groups on the TA molecule form 
hydrogen bond dimers with other TA molecules forming a sheet of infinite herringbone 
chains of TA molecules flanked by PX molecules (Figure 7.26).  
 
 
Figure 7.26 - Sheets of molecules in the PXN TA complex made up of an infinite herringbone 
chain of TA molecules flanked by PXN molecules. Colour coding shows the molecules of PXN in 
red and TA in blue. 
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Interestingly, whereas in both solvates all the TA molecules are co-planar in the crystal 
structure, in the desolvated form there is a change in the torsion angles of one of the 
carboxylic acid groups on the TA molecule. This results in the TA molecules in the chain 
lying parallel but not in the same plane. Furthermore, due to the position of the groups 
involved in the hydrogen bonds formed between the PX and TA molecules and the 
change in the conformation of the PX molecules, the PX and TA molecules do not lie in 
the same plane. The structure is therefore, no longer layered.  
 
As the PX molecules do not form hydrogen bonded dimers in the non-ionised 
conformation, the sheets interlock in a zip-like nature (Figure 7.27). This occurs through 
weak interactions including a C-H…O interaction with a C…O distance of 3.445(4) Å 
between a hydrogen atom of the methyl group on the PX molecule and a C=O bond on 
the PX molecule in the next sheet. The overall packing arrangement of the structure is 
built up through offset stacking of the sheets of molecules, as shown in Figure 7.28. 
 
 




















O(10) 0.95(3) 2.20(3) 2.808(4) 121(2) 
 N(2)-H(19)
...
O(1)#1 0.85(3) 2.26(3) 3.064(3) 159(3) 
 O(2)-H(1)
...
N(3)#2 1.06(4) 1.53(4) 2.582(3) 169(4) 
 O(3)-H(3)
...
O(4)#3 0.91(4) 1.73(4) 2.637(3) 176(3) 
 O(9)-H(11)
...
O(10) 0.94(5) 1.65(5) 2.525(3) 152(4) 
 O(5)-H(5)
...
O(6)#4 0.99(4) 1.63(4) 2.615(3) 173(4) 
Symmetry transformations used to generate equivalent atoms:  
#1 x+1,y,z    #2 x-1,y,z    #3 -x,-y+1,-z+1    #4 -x,-y+2,-z  
 
A good match of the powder pattern predicted from the single crystal structure to the 
measured PXRD pattern was observed (Figure 7.29). 
 
 
Figure 7.29 - PXRD patterns of PXN TA (a) calculated and (b) experimental. 
 
7.4.6 Other analytical techniques 
Several other techniques were also implemented to characterise the tautomeric transition 
in the PX-TA solvates including variable-temperature powder X-ray diffraction, variable-
temperature Raman spectroscopy and FTIR spectroscopy.  
 
7.4.6.1 Variable-temperature powder X-ray diffraction 
VT-PXRD was carried out for the acetone solvate in order to observe the desolvation 
event. Figure 7.30 shows the patterns at the transition point. It is evident that the onset of 
the transition occurs at 137.5 °C; the peak at 5.5° 2 begins to appear at this 









































7.4.6.2 Variable temperature Raman spectroscopy 
Different solid forms of PX can be identified using Raman spectroscopy191,202-204 and it 
was therefore possible to monitor the desolvation and tautomeric transition by monitoring 





Figure 7.31 - Raman spectra of (top) PXZ TA ACT and (bottom) PXZ TA ACN at different 
temperatures. 
 
The zwitterionic tautomer can be identified by the presence of Raman bands at  
~1410 cm1 and ~1470 cm1 which are present in the Raman signal for both solvates at 
room temperature. Upon increasing the temperature, the Raman signal changes; in the 
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acetone solvate the intensity of this peak decreases at 130 °C and by 140 °C these 
indicative peaks are no longer present and a new Raman spectrum is produced. As 
observed in the thermal analysis, the transition occurs later for the acetonitrile solvate 
and the peaks at 1410 cm1 and 1470 cm1 decrease in intensity at 140 °C; by 150 °C the 
Raman spectrum of the desolvated form is observed. For the acetonitrile solvate the 
Raman spectrum at 145 °C shows peaks representing both the solvate and the 
desolvate. 
 
7.4.6.3 Fourier transform infra-red spectroscopy 
FTIR spectra of each solvate were collected before and after heating, as well as after 
vapour diffusion experiments (Figure 7.32).  
 
 
Figure 7.32 - FTIR spectra of (a) solvate, (b) solvate heated and (c) vapour diffusion of sample of  
(top) PXZ TA ACT and (bottom) PXZ TA ACN. 
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The spectra support the PXRD data showing that both solvates return to their original 
form after vapour diffusion experiments; they also confirm that both solvates form the 
same desolvated form upon heating.  
 
 
7.5 Structural comparison with other molecular complexes of PX 
In this study ten multi-component molecular complexes were produced (including those 
with TA); PX is present in its zwitterionic form (PXZ) in five of the complexes. In this form, 
the formation of two intramolecular hydrogen bonds locks the conformation of the 
molecule. Two of the remaining complexes feature PX in its non-ionised form (PXN). In 
the final three complexes, intermolecular proton transfer from the carboxylic acid group of 
the co-former molecule to the nitrogen atom on the pyridine ring of the PX molecule 
results in the formation of a salt with a protonated PX molecule (PX+); one of these salts 
is solvated with acetonitrile. The protonated PX+ has only previously been observed in the 
solid state in complexes with strong acids: chloranilic acid and bromanilic acid.190 In both 
the PX+ and the PXN complexes an O-H…O intramolecular hydrogen bond is present 
allowing the PX molecule to adopt a different conformation to that found in the PXZ 
complexes. None of the complexes feature the deprotonated PX. 
 
7.5.1 PXZ complexes 
As observed in the solvated structures of PX with TA (Section 7.4.1), in all of the 
remaining complexes containing PX in its zwitterionic form, the PXZ molecules self-
assemble in hydrogen bonded dimers. Such dimers form through two charge assisted  
N+-H…O hydrogen bonds between the protonated pyridinal nitrogen atom and the 
carbonyl oxygen atom. In each complex, a co-former molecule lies on either side of the 
PX dimers interacting through a charge assisted O-H…O hydrogen bond to the 
deprotonated hydroxyl group on the zwitterionic PX molecule. This makes up a four 
molecule tetrameric hydrogen bonded unit comprising two PX molecules forming a dimer 
in the centre197 (Figure 7.33).  
 
However, although each PXZ complex contains this unit, the overall packing arrangement 
of the tetrameric units in each complex differs as a result of the position of the different 





Figure 7.33 - Four molecule tetrameric hydrogen bonded unit in the PXZ RES complex. 
 
As observed in the complexes with TA, in the 35DHBA complex, the units assemble in 
AABB chains with the tetrameric units interacting through carboxylic acid dimers between 
the two 35DHBA molecules (Figure 7.34). 
 
 
Figure 7.34 - AABB chains of PXZ and 35DHBA molecules in the PXZ 35DHBA complex. 
 
However, unlike the TA complexes, the dimers lie above and below the plane of the PX 
dimer. The infinite chains stack in offset layers with the remaining hydrogen bonding 
donor hydroxyl group on the 35DHBA molecule interacting with the S=O group on the PX 
molecule in the layer above with an O…O distance of 2.8407(15) Å (Figure 7.35). 
 
 














O(2) 0.921(17) 2.597(16) 3.2789(17) 131.3(12) 
C(14)-H(9)
...
O(3)#1 0.942(18) 2.602(18) 3.1268(18) 115.6(13) 
C(14)-H(9)
...
N(3)#1 0.942(18) 2.546(18) 3.4496(19) 161.0(14) 
N(2)-H(5)
...
O(4) 0.91(2) 1.72(2) 2.5516(15) 148.9(18) 
C(22)-H(11)
...
O(5)#1 1.016(19) 2.544(19) 3.5302(19) 163.5(14) 
N(1)-H(10)
...
O(3) 0.87(2) 1.95(2) 2.6443(16) 135.3(17) 
N(1)-H(10)
...
O(3)#1 0.87(2) 2.188(19) 2.8531(16) 132.9(16) 
O(8)-H(18)
...
O(4)#2 0.87(2) 1.77(2) 2.6343(14) 174(2) 
O(7)-H(14)
...
O(2) 0.85(2) 2.00(2) 2.8407(15) 172.4(19) 
O(6)-H(16)
...
O(5)#3 1.04(3) 1.56(4) 2.5938(14) 177(3) 
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,-y+1,-z+2    #2 -x+1,-y+1,-z+1    #3 -x,-y+1,-z+2  
 
Resorcinol is the structural analogue of 35DHBA without the carboxylic acid group. 
Therefore, the four molecule tetrameric units do not form chains in the same way as in 
PXZ 35DHBA as there is no hydrogen bond dimer present in the 1-position. However, the 
hydroxyl groups on the resorcinol molecule interact in the same way as observed in the 
35DHBA structure. The tetrameric units therefore overlay and interlock through O-H…O 
hydrogen bond interactions with the S=O groups on the PX molecules, as observed in the 
35DHBA complex with a similar O…O distance of 2.8397(18) Å (Figure 7.36). 
 
 
Figure 7.36 - Hydrogen bonded chains of PXZ RES molecules. 
 
As shown in Figure 7.37, the chains stack through offset -stacking interactions which are 
present between the overlapping aromatic rings of PX molecules at an inter-planar 
distance of ~3.2 Å.   
 
Figure 7.37 - Offset -stacking interactions between PX molecules in the PXZ RES complex. 
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O(1)#1 0.941(19) 2.558(19) 3.131(2) 119.6(14) 
 N(2)-H(15)
...
O(6) 0.89(2) 1.92(2) 2.6122(18) 133(2) 
 N(2)-H(15)
...
O(6)#2 0.89(2) 2.19(2) 2.8643(19) 132.9(19) 
 C(19)-H(10)
...
N(3)#2 0.91(2) 2.50(2) 3.342(2) 152.6(18) 
 N(1)-H(14)
...
O(5) 0.92(2) 1.78(2) 2.5839(18) 144.2(19) 
 C(21)-H(9)
...
O(6) 0.99(2) 2.63(2) 3.180(2) 115.4(15) 
 O(2)-H(19)
...
O(3) 0.88(3) 1.96(3) 2.8397(18) 175(2) 
 C(21)-H(7)
...
O(4)#3 0.97(2) 2.44(2) 3.346(2) 153.8(18) 
 O(1)-H(18)
...
O(5)#4 0.87(3) 1.80(3) 2.6679(18) 172(2) 
Symmetry transformations used to generate equivalent atoms:  
#1 x,y-1,z    #2 -x,-y+1,-z    #3 -x,-y,-z    #4 -x,-y+1,-z+1  
 
 
In the complex of PX with 34DHBA, the 34DHBA molecule lies on an inversion centre, 
with a resulting 50:50 ratio of the occupancies in each symmetry dependent orientation 
(Figure 7.38). As a result of this disorder the asymmetric unit contains one PX molecule, 
half a 34DHBA molecule and one acetonitrile molecule.  
  
 
Figure 7.38 - Disorder of the 34DHBA molecule over an inversion centre in the PXZ 34DHBA 
complex with the two positions in green and purple overlaid. 
 
In contrast to RES and 35DHBA, there is a hydrogen bond donor group (a hydroxyl 
group) on the 4-position of the benzene ring of the 34DHBA molecule. This allows for the 
PX dimers to interact with 34DHBA on either side of the molecule through O-H…O 
hydrogen bonds of almost equivalent strength (length) from the hydroxyl group and the 
carboxylic acid group. As observed in the TA complexes, the presence of the carbonyl 
group on the carboxylic acid group on the 34DHBA molecule allows for a C-H…O 
interaction to form, reinforcing the interaction of the PXZ and 34DHBA molecules. The 
other hydrogen bond dimer of the 34DHBA molecule interacts with the sulfonyl group of 
 234 
 
the PX molecule in the layer below through an O-H…O interaction with an O…O distance 
of 2.871(3) Å, as observed in the previous two complexes.  
 
The complex is solvated and each PX molecule forms a weak C-H…N interaction with a 
molecule of acetonitrile. Sheets of dimers of PX molecules separated by a disordered 
34DHBA molecule and two acetonitrile molecules assemble in a layered arrangement 
with the methyl and sulfonyl groups of PX sticking out of the plane (Figure 7.39). These 
layers stack with the molecules offset to one another (Figure 7.40 and Figure 7.41).  
 
 
Figure 7.39 - Sheets of molecules in the PXZ 34DHBA ACN complex. 
 
 
Figure 7.40 - Layers of PXZ 34DHBA ACN sheets viewed down the crystallographic c axis.  
  
 
Figure 7.41 - Layers of molecules in the PXZ 34DHBA ACN complex.  
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N(1)#4 0.93(2) 2.53(2) 3.445(3) 166.3(18) 
 
 
Symmetry transformations used to generate equivalent atoms:  
 #1 x,y-1,z    #2 -x+2,-y+2,-z    #3 x,y+1,z    #4 -x+1,-y+1,-z    #5 -x+1,-y+1,-z+1   
 
Of the five PXZ complexes produced, three of the structures show a layered packing 
arrangement with one also showing disorder in the crystal structure, two features targeted 
in these PX co-crystallisation investigations. All of the co-formers that produced layered 
crystal structures interact with the PXZ molecule via the carboxylic acid functional group. 
This allows for two interactions to form between the molecules: an O-H…O interaction and 
a weaker C-H…O interaction. The combination of interactions allows for the molecules to 
lie in the same plane and form a layered arrangement. In the structures that did not 
produce a layered packing arrangement, on the other hand, the co-former molecule 
interacts with the PX molecule through a hydroxyl group which only forms one interaction.  
 
7.5.2 PXN complexes 
PX is present in its neutral form in the complex with 35DNBA as well as in the desolvated 
complex with TA (previously discussed in Section 7.4.5). In both complexes PX interacts 
with the carboxylic acid group of the respective co-former molecule through two hydrogen 
bonds (Figure 7.42). The first of these is between the hydroxyl group on the co-former 
molecule and the deprotonated nitrogen atom of the pyridine ring on the PX molecule. In 
the 35DNBA structure this hydrogen bond is short and strong (2.521(5) Å) indicating that 
proton transfer could be possible across this hydrogen bond (for example in the complex 
with 24DNBA in Section 7.5.3). The second intermolecular hydrogen bond common to 
both structures is an N-H…O hydrogen bond between the carbonyl group of the carboxylic 





Figure 7.42 - Hydrogen bonding in the asymmetric unit of the PXN 35DNBA complex viewed down 
the crystallographic a axis. 
 
Unlike the desolvated crystal structure of PXN with TA, in the structure with PXN and 
35DNBA the molecules self-assemble in one-dimensional ABAB hydrogen bonded chains 
(Figure 7.43). Whereas in the TA molecule the presence of additional carboxylic acid 
groups on the co-former molecule allows for dimers to form between the TA molecules, 
the nitro groups on the 35DNBA molecule cannot form this interaction. Instead, one of the 
nitro groups on the 35DNBA molecule interacts favourably with the hydroxyl group on the 
PX molecule creating a bifurcated hydrogen bond.  
 
Figure 7.43 - Hydrogen bonded chains in the PXN 35DNBA complex viewed down the 
crystallographic a axis. 
 
Weak interactions link the ABAB chains of PX and 35DNBA molecules to form sheets 
made up of PXN and 35DNBA molecules (Figure 7.44). These interactions comprise 
hydrophobic C-H…H-C interactions as well as a C-H…O interaction between two PX 





Figure 7.44 - Sheets of PXN and 35DNBA viewed down the crystallographic a axis. 
 
The hydrogen bonded sheets stack through further weak interactions to form layers of 
molecules (Figure 7.45). 
 
 
Figure 7.45 - Layers of PZN 35DNBA sheets viewed down the crystallographic c axis. 
 










O(4) 0.90(5) 2.20(5) 2.770(6) 121(4) 
 N(2)-H(11)
...
O(5) 0.83(5) 2.15(5) 2.973(5) 171(4) 
 C(13)-H(8)
...
O(2)#1 1.00(5) 2.53(5) 3.328(6) 136(3) 
 O(6)-H(10)
...
N(2) 1.22(8) 2.68(8) 3.665(5) 138(5) 
 O(6)-H(10)
...
N(3) 1.22(8) 1.34(8) 2.521(5) 161(7) 
 N(3)-H(10)
...
O(5) 1.34(8) 2.41(8) 3.342(5) 124(5) 
 O(3)-H(5)
...
O(4) 0.82(7) 1.77(7) 2.524(4) 152(7) 
 O(3)-H(5)
...
O(8)#2 0.82(7) 2.48(7) 3.041(5) 127(6) 
 C(15)-H(15C)
...
O(1)#3 0.96 2.61 3.077(5) 110.6 
Symmetry transformations used to generate equivalent atoms:  




7.5.3 PX+ complexes 
In each of the three PX+ complexes, the co-former molecule interacts with a PX molecule 
through three N-H…O hydrogen bonds between the deprotonated carboxylate group on 
the co-former molecule and the protonated nitrogen atoms of the PX molecule. In each 
complex, one of the oxygen atoms in the carboxylate group forms a bifurcated hydrogen 
bond, forming an interaction with both N-H bonds which is also observed in the PX+ 
complexes reported by Thomas et al.190 In the 35DNSA complex, the groups lie offset to 
one another which results in the weakest of the three hydrogen bonds in the other two 
complexes being the strongest in this complex. In the complex with 24DNBA, this unit 
also includes an acetonitrile molecule which forms weak interactions with the two 
components through C-H…O and C-H…N interactions. In two of the complexes (with 
35DNSA and 26DHBA) hydroxyl groups are present on the benzene ring position 
adjacent to the carboxylate group. In each case the deprotonation results in the formation 
of an intramolecular O-H…O- hydrogen bond between the hydroxyl group and the 
carboxylate oxygen atom on the co-former molecule. This intramolecular interaction is 
stronger in the complex with 35DNSA, with an O…O distance of 2.466(3) Å, compared to 
the two intramolecular interactions in the complex with 26DHBA complex, which have 
O…O distances of 2.589(3) Å and 2.525(3) Å. Figure 7.46 shows the described 
interactions in the asymmetric units of each PX+ complex.  
 
 
Figure 7.46 - Hydrogen bonding interactions in the asymmetric units of each PX
+
 complex.  
 
The zero-dimensional hydrogen bonded units of PX and the co-former molecule interact 
with each other through weak interactions in each complex, but in different arrangements. 
First, in the complex with 35DNSA, the molecules interact in an AABB arrangement with 
the units inverting in orientation to allow them to stack favourably, as shown in  
Figure 7.47. This arrangement is supported by a C-H…O interaction from the 35DNSA 
PX+ 35DNSA- PX+ 24DNBA- PX+ 26DHBA-
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molecule with the S=O group of the PX molecule with a distance of 3.522(3) Å. The PX 
molecules interact through two weak C-H…O interactions, each with a distance of 
3.417(3) Å. Figure 7.48 shows this packing arrangement from the side view.  
 
 
Figure 7.47 - Hydrogen bonding interactions in the PX
+
 35DNSA complex. 
 
 
Figure 7.48 - Hydrogen bonding interactions in the PX
+
 35DNSA complex shown from the side 
view. 
 
Table 7.13 - Hydrogen bonds in PX
+










O(3)#1 0.95(2) 2.45(2) 3.196(2) 135.0(19) 
 C(14)-H(9)
...
O(6) 0.95(2) 2.64(3) 3.283(3) 125.4(18) 
 C(11)-H(6)
...
O(2)#2 0.92(2) 2.56(3) 3.417(3) 155(2) 
 C(11)-H(6)
...
O(1) 0.92(2) 2.32(2) 2.876(3) 118.4(19) 
 C(13)-H(8)
...
O(9)#3 0.94(2) 2.47(3) 3.105(3) 124.6(19) 
 N(1)-H(11)
...
N(2) 0.82(3) 2.26(2) 2.717(3) 116(2) 
 N(1)-H(11)
...
O(5) 0.82(3) 2.39(3) 3.052(3) 138(2) 
 C(16)-H(12)
...
O(7)#4 0.97(3) 2.54(3) 3.476(3) 162(2) 
 O(2)-H(5)
...
O(1) 0.84(3) 1.82(3) 2.588(2) 153(3) 
 N(5)-H(10)
...
O(5) 0.99(3) 1.63(3) 2.608(2) 172(3) 
 N(5)-H(10)
...
O(6) 0.99(3) 2.47(3) 3.161(3) 126(2) 
 O(11)-H(15)
...
O(6) 1.15(4) 1.39(4) 2.466(3) 152(4) 
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,-y+1,-z    #2 -x+1,-y+1,-z+1    #3 x+1,y+1,z     #4 -x,-y+1,-z  
 
Unlike the 35DNSA complex, in the solvated complex of PX with 24DNBA the molecules 
arrange themselves in ABAB chains, as shown in Figure 7.49. The presence of an 
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inversion centre allows the chains to invert and interlock forming a zip-like ribbon lined 
with acetonitrile molecules.  
 
 
Figure 7.49 - Hydrogen bonding interactions in the PX
+
 24DNBA ACN complex viewed down the 
crystallographic a axis. 
 
The overall packing arrangement of molecules in the PX+ 24DNBA ACN complex is 
shown in Figure 7.50. The acetonitrile molecules sit in discrete pores within the structure.  
 
 
Figure 7.50 - Packing arrangement of molecules in the PX
+
 24DNBA ACN complex viewed down 





Table 7.14 - Hydrogen bonds in PX
+










O(1) 0.92(2) 2.23(2) 2.800(3) 119.2(16) 
 C(9)-H(11)
...
O(9)#1 0.99(2) 2.47(2) 3.395(3) 155.1(17) 
 C(19)-H(13)
...
O(3)#2 0.88(3) 2.54(3) 3.376(3) 158.1(19) 
 N(2)-H(9)
...
O(5) 0.90(3) 1.83(3) 2.713(2) 169(2) 
 O(2)-H(19)
...
O(1) 0.93(3) 1.66(3) 2.530(2) 154(3) 
 N(1)-H(20)
...
O(6) 1.02(3) 1.63(3) 2.638(2) 171(3) 
 N(1)-H(20)
...
O(5) 1.02(3) 2.48(3) 3.153(2) 122.8(19) 
 C(23)-H(16)
...
O(7)#2 0.86(4) 2.57(4) 3.257(4) 138(3) 
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,-y+2,-z+2    #2 -x,-y+2,-z+2  
 
In contrast to the previous structures which are both in the triclinic space group, 𝑃1̅, the 
complex of PX with 26DHBA is in the monoclinic space group, P21/n. In this structure the 
unit cell contains four PX+ 26DHBA units and they assemble in ABAB chains which 
interlock with the chains below through weak interactions to form a ribbon of molecules 
(Figure 7.51). In contrast to the previous two structures the units are not inverted due to 
the inversion centre being in a different position. The ribbons of molecules stack in layers, 
as shown in Figure 7.52.  
 
 
Figure 7.51 - Hydrogen bonding interactions in the PX
+
 26DHBA complex viewed down the 




Figure 7.52 - Packing arrangement of molecules in the PX
+
 26DHBA complex viewed down the 
crystallographic a axis. 
 
Interestingly, a complex of PX with the related co-former 2,5-dihydroxybenzoic acid in 
which PXN is present was recently reported196 in which proton transfer has not occurred 
and the length of the hydrogen bond is 2.659(3) Å. This is to be expected since 26DHBA 
is a stronger acid with a lower pKa (1.22) compared to 25DHBA with a pKa of 2.97. 
 
Table 7.15 - Hydrogen bonds in PX
+










O(3)#1 0.98(3) 2.51(3) 3.435(3) 158(2) 
 N(2)-H(10)
...
O(5) 0.91(3) 2.17(3) 3.060(3) 166(3) 
 C(11)-H(5)
...
O(2) 0.97(3) 2.25(3) 2.806(3) 115(2) 
 N(3)-H(9)
...
O(5) 0.88(3) 2.63(3) 3.384(3) 144(3) 
 N(3)-H(9)
...
O(6) 0.88(3) 1.75(3) 2.591(3) 159(3) 
 C(13)-H(7)
...
O(8)#2 0.91(3) 2.59(3) 3.452(3) 159(3) 
 O(8)-H(15)
...
O(5) 0.76(4) 1.88(4) 2.589(3) 155(4) 
 O(7)-H(11)
...
O(6) 0.78(4) 1.81(4) 2.525(3) 151(4) 
 O(1)-H(19)
...
O(2) 1.09(5) 1.53(5) 2.552(3) 152(4) 
Symmetry transformations used to generate equivalent atoms:  
#1 -x+3/2,y+1/2,-z+1/2    #2 x+1/2,-y+1/2,z+1/2  
 
Of the three PX+ complexes discussed here, one shows a layered arrangement of 
molecules in the crystal structure, which was one of the original structural motivations 
(along with the production of disordered solid forms) of this study of PX complexes.  
 
 
7.6 pKa analysis of PX structures 
In a recent study of complexes of PX with benzoic acids by Wales et al.197 a trend 
between the pKa of the co-former molecule and the tautomeric form adopted by the PX 
molecule was identified. The relationship indicates that of the substituted benzoic acid co-
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formers used, those with the lowest and highest pKa values produced complexes in which 
the PX molecule is present in its zwitterionic form. Those compounds with pKa values in 
the middle region featured a non-ionised PX molecule. Table 7.16 show pKa values for 
PX and the co-formers used in this study, as well as a relevant complex from the 
literature.196 The new structures presented here support the findings by Wales et al. in 
that the pKa values of the complexes featuring a neutral PX molecule lie in the middle 
region of the pKa values of all of the co-former molecules and are of a similar value (~3) 
to those reported previously. However, in these complexes the pKa value of co-formers 
which resulted in complexes with a zwitterionic PX molecule lies above those of the 
complexes with the neutral PX tautomer only. Salt forms of PX complexes were not 
discussed previously; however, the co-formers which formed salts in this work have the 
lowest pKa values, as expected based on the ∆pKa rule. The ∆pKa value for all of the salt 
forms reported in this work lies in the intermediate region of the salt-co-crystal continuum, 
between 0 and 3, where it is difficult to predict whether a salt or co-crystal will form. For 
the TA system the value is closer to the region where a neutral complex is likely to form 
which correlates with the experimental outcome. The ∆pKa value for all of the other co-
crystal forms lies below 0 which correlates with the region where a co-crystal is expected 
to form in the salt-co-crystal continuum.  
 
Table 7.16 - pKa1 (base) value for PX, pKa1 (acid) values for co-former molecules used and the 












PX Form ∆pKa 
TA 3.0 ± 0.8 2.13207 PXN Co-crystal 0.12 
35DNBA 2.7 ± 0.9 2.82207 PXN Co-crystal 0.57 
25DHBA 3.0 ± 0.4 2.97208 PXN Co-crystal 0.72 
35DNSA 1.4 ± 0.4 0.70209 PX+ Salt 1.55 
26DHBA 1.8 ± 0.4 1.22207 PX+ Salt 1.03 
24DNBA 1.4 ± 0.4 1.43208 PX+ Salt 0.82 
TA 3.0 ± 0.8 2.13207 PXZ Co-crystal 0.12 
35DHBA 4.2 ± 0.4 4.04208 PXZ Co-crystal 1.79 
34DHBA 4.4 ± 0.4 4.48208 PXZ Co-crystal 2.20 
RES 9.6 ± 0.4 9.32208 PXZ Co-crystal 7.07 









7.7 Thermal analysis of complexes 
PXRD and thermal analysis of the product of evaporative crystallisations were carried out 
for all complexes to further confirm the presence of a new complex, determine the phase 
purity of the product and to investigate its thermal properties. Complexes that display 
interesting thermal behaviour are presented here.  
 
7.7.1 Thermal analysis of disordered PXZ 34DHBA ACN complex  
The complex of PXZ 34DHBA ACN shows interesting thermal behaviour with multiple 
endothermic and exothermic events observed in the DSC and HSM images. Figure 7.53 
shows the HSM images in which the crystals become opaque upon desolvation of the 
acetonitrile from the complex with an onset temperature of 125 °C. This desolvation event 
is also present in the DSC trace (Figure 7.54) in which a broad endothermic event, 
characteristic of a solvent loss event, is observed at 120 - 130 °C. The desolvation event 
in the DSC is followed by an endothermic event characteristic of a melt at around 155 °C 
and an exothermic recrystallisation event at 163 °C. Recrystallisation can be observed in 
the HSM images where at 160 °C small crystallites are observed on the sides of the 





Figure 7.53 - HSM images showing thermal events of the PXZ 34DHBA ACN complex. 
Recrystallisation of small crystallites on the side of the crystal are circled in red. 
 
35 °C 127 °C 
140 °C 
125 °C 




Figure 7.54 - DSC traces of (a) PX, (b) 34DHBA and (c) PXZ 34DHBA ACN complex. 
 
As PX is present in its zwitterionic form in this solvated complex, similar experiments 
were carried out as those with the TA system (Section 7.4.4) to observe whether 
desolvation results in colour change of the complex. A microcrystalline powder of the bulk 
product of evaporative crystallisation was heated past the temperature of desolvation 
(140 °C) at 1 °C min1. However, unlike the PX TA solvates, heating did not result in a 
change in colour and the powder remained yellow. Figure 7.55 shows the PXRD pattern 
of the heated form and is presented with the pattern of the solvated form. New diffraction 
peaks in the pattern suggest upon desolvation the complex does form a different solid 
form, however the lack of colour change suggests the PX molecule remains in its 
zwitterionic form in this case. Extra peaks present in the measured pattern for the 
solvated form, that are not present in the calculated pattern, correlate with those in the 
pattern for the desolvated form which suggests that there may be non-solvated material 
present in the sample from evaporative crystallisation. This is most obvious in the peaks 
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at low angle values. For example, only one peak at 5.5° 2 is present in the calculated 
pattern whereas in both measured patterns an additional peak is observed at around 
6.1° 2 which is more intense in the pattern for the desolvated form. The peak at 5.5° 2 
is more intense in the measured pattern for the solvated form.  
 
 
Figure 7.55 - PXRD patterns of (a) PX 34DHBA ACN and (b) PX 34DHBA ACN after heating to  
140 °C. 
 
7.7.2 Thermal analysis of PX+ 35DNSA complex 
Figure 7.56 shows the PXRD pattern of the bulk material from the evaporative 
crystallisation of PX and 35DNSA along with the calculated pattern from the crystal 
structure of the complex. A good match is observed between the two patterns suggesting 
that the single crystal selected is representative of the bulk material. 
 
Figure 7.56 - PXRD patterns of (a) PX
+
 35DNSA calculated and (b) PX
+




Figure 7.57 shows the DSC trace of the product of the evaporative crystallisation of PX+ 
35DNSA. The complex melts at 235 °C which is followed by an exothermic peak. This 
suggests that upon melting the complex recrystallises into another high temperature form 
which appears visually to be non-crystalline and resembles an oil type form (Figure 7.58).  
 
 
Figure 7.57 - DSC traces (a) 35DNSA, (b) PX and (c) PX
+
 35DNSA complex. 
 
 
Figure 7.58 - HSM images of PX
+
 35DNSA complex. 
 
 
7.7.3 Thermal analysis of PX+ 24DNBA ACN complex 
Figure 7.59 displays the PXRD pattern for the bulk product material from the evaporative 
crystallisation of PX and 24DNBA, along with the calculated pattern from the crystal 
structure of the solvated complex. The measured pattern is of poor quality and therefore it 
is difficult to draw a firm conclusion, however the peaks visible in the pattern demonstrate 
a good positional match with the stronger peaks in the calculated pattern for the PX+ 
24DNBA ACN complex. 




Figure 7.59 - PXRD patterns of (a) PX
+
 24DNBA ACN calculated and (b) PX
+
 24DNBA ACN bulk 
material measured.  
 
Figure 7.60 shows the DSC trace of the solvated complex of PX+ 24DNBA. The DSC 
shows that the acetonitrile solvent is lost from the structure between 85-110 °C. This is 
followed by melting of the desolvated form, at a lower temperature than those of the two 
starting materials.  
 
 
Figure 7.60 - DSC traces of (a) 24DNBA, (b) PX and (c) PX
+




Ten multi-component molecular complexes of PX with planar co-former molecules have 
been presented with respect to their ionisation state and common synthons in their crystal 
structures have been identified. Moreover, in five of these complexes layered 
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architectures are present, and in one of the structures disorder is evident. Layering and 
disorder were the targets of this study towards the optimisation of properties through 
improved designed structural attributes. In all of the PX complexes which show a layered 
packing arrangement, the co-former molecule interacts with the PX molecule through its 
carboxylic acid group, in which two interactions are formed, encouraging the formation of 
the layered structure.  
 
The structures have also been analysed with respect to their pKa values and comparisons 
made with the ΔpKa rule. It was found that the pKa values of the co-formers support the 
findings of Wales et al.,197 in that the co-formers which produced complexes containing 
PXN have pKa values in the middle region of all of the co-formers used in the work. 
However, the pKa value of all the co-formers which resulted in complexes containing PXZ 
is higher than those of co-formers producing PXN complexes. As expected, given the 
ΔpKa rule, the co-formers which resulted in salt forms have the lowest pKa values and 
their resulting complexes have ∆pKa values in the intermediate region of the  
salt-co-crystal continuum. With the exception of PX TA, the ∆pKa value of all of the  
co-crystal forms reported in this work lie in the co-crystal region of the salt-co-crystal 
continuum.  
 
Through this materials discovery study a multi-component molecular complex of PX and 
TA with particularly interesting structural and thermal behaviour was identified; the 
findings on which are summarised in Figure 7.61.  
 
 







Two solvated PX TA co-crystals were identified and their preparation using different 
crystallisation methods was investigated. Solution mediated (slurrying) methods were 
found to be an effective method of producing the solvates in larger quantities. The 
solvates show a layered packing arrangement that, upon desolvation by heating, 
undergoes significant structural rearrangement in the solid state to a non-layered 
structure featuring PXN. The tautomeric transition is further demonstrated by the change 
in colour of the material upon desolvation from yellow to white. The transition was also 
identified as reversible (to a fully crystalline, resolvated form) when the desolvated form is 
exposed to solvent vapours at ambient conditions. Multiple solid-state analytical methods 












Chapter 8  
Disorder levels in 5-chlorouracil  
 
8.1 Introduction and aims 
As noted in Chapter 1, the presence of disorder can affect the solid-state properties of 
molecular materials, which was investigated for planar co-crystalline molecular 
complexes of piroxicam in Chapter 7. Here, disorder is investigated in a single 
component molecular material. 5-chlorouracil (5CL) is a planar molecule analogous to the 
anti-cancer agent 5-fluorouracil. Like several other 5-substituted uracils, 5CL has been 
found to exhibit orientational disorder across the long axis of the molecule in its crystal 
structure, whereby the molecule can lie in two distinct orientations.120,210 These 
correspond to a 180° rotation about the Cl1-C1-C2-O2 axis where O1 can take the 




Figure 8.1 - The structure of 5-chlorouracil with the atoms labelled for (left) an ordered model and 
(right) a disordered model.  Only the atoms for which the type of species is different in the 























A simple CSD search for 5CL yields two structures (Table 8.1). The first structure shows 
disorder, the occupancies of the sites of which are unclear,210,211 while the second 
structure, a lower temperature determination, shows disorder for all the non-hydrogen 
atoms modelled over two sites corresponding to the two orientations with a site 
occupancy ratio of 85:15.210  
 






a 8.450(6) 8.439(1) 
b 6.842(3) 6.841(1) 
c 11.072(16) 9.368(1) 
α 90 90 
β 123.53(19) 104.20(1) 
γ 90 90 
V 533.607 524.327 
Space group P21/c P21/n 
Temp (K) 283-303 150 
Disorder 
One oxygen atom is 
disordered 
The molecule is disordered 




In the P21/n model, the symmetry of the molecule allows for a similar packing 
arrangement to be present in the reported structures of 5CL regardless of the presence of 
the disorder. N-H…O hydrogen bonds form 𝑅2
2(8) dimers with O2 being a hydrogen bond 
acceptor to two NH groups in bifurcated hydrogen bonds with lengths of 2.779(2) Å and 
2.811(2) Å, respectively. There is also a weak C-H…O hydrogen bond between O1 and 
the hydrogen atom H3 on the adjacent molecule. These interactions form a planar ribbon 
arrangement of molecules with the chlorine atoms pointing in opposite directions. Cl1 
forms a Cl…O contact with the O1 atom on the adjacent ribbon of molecules with a bond 
distance of 3.183(1) Å. These interactions link the ribbons of molecules together in a  





Figure 8.2 - Molecular ribbons forming sheets of 5CL molecules. 
 
As the disorder results in the possibility of the molecules being positioned in one of two 
orientations throughout the crystal structure, the implication for the pattern of hydrogen 
bonding within this packing arrangement is significant. The orientations of the molecules 
can be described in relation to one another.210 
 
Within each ribbon the molecules can be arranged in two ways that can be described as 
polar and non-polar (Figure 8.3). When classified as polar all of the C4=O1 carbonyl 
groups point in the same direction within a ribbon. When non-polar, alternate C4=O1 
carbonyls point in opposite directions within a ribbon.  
 
 
Figure 8.3 - Polar and non-polar hydrogen bonding arrangement in ribbons of 5CL. 
 
As discussed above, adjacent ribbons are held together by Cl…O interactions. The 
combination of ribbons of different orientation can be classified as parallel or anti-parallel. 
Polar arrangement Non-polar arrangement 
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Figure 8.4 - Hydrogen bonding in 5CL sheets (a) polar parallel, (b) non-polar parallel, (c) polar 
anti-parallel and (c) non-polar anti-parallel 
 
When looking at the overall packing of the molecules, the sheets of co-planar ribbons 
pack in layers along the (1 0 -3) planes (Figure 8.5).  
(a)       (b)  




Figure 8.5 - Molecular packing of 5CL in layers viewing down the crystallographic b axis. 
 
The orientational disorder in 5CL is similar to the disorder present in 5-ethynyluracil 
(eniluracil). Copley et al. suggested that the disorder in eniluracil could be directly related 
to the crystallisation conditions of that related material.120 As noted above, the presence 
of such disorder in the structure may affect the bulk properties of the substance. For this 
disorder to be exploitable as a solid-state characteristic, its presence needs to be 
understood effectively (and ideally able to be designed into the formation of the crystalline 
solid form). It has also been noted that variation in samples due to disorder resulting from 
different growth conditions can also be readily confused with polymorphism, offering 
another rationale for attempting to control its presence during crystallisation.120,212 
 
In order to probe the possible effect of the growth conditions on the level of disorder in 
5CL, small scale crystallisation experiments were performed. Evaporative crystallisation 
methods at controlled temperatures, along with controlled cooling methods, were used to 
produce single crystals and the disorder present was characterised using single crystal  
X-ray diffraction. An overview of the initial crystal structures produced using these 
methods is presented, followed by subsequent systematic investigations towards the aim 
of establishing further understanding of the disorder in the 5CL system. This 
understanding would aid further studies into controlling this potentially important 
parameter for solid-state physical property optimisation. 
 
 
8.2 Experimental information 
8.2.1 Preparation of single crystals and structural information 
Single crystal X-ray diffraction data were collected using two laboratory diffractometers: 
the Rigaku Oxford Diffraction Gemini Ultra A diffractometer and the Rigaku  
R-AXIS/RAPID diffractometer. All of the structures were solved by direct methods using 
SHELXS-2013137 and refined using SHELXL-2013138 within the WinGX139,140 program.  
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Structure 1 - Ordered 
10 mg of 5CL was dissolved in the minimum amount of water and crystallisation was 
facilitated through evaporation at 30 °C. A suitable single crystal was selected and data 
were collected at 100 K using a Rigaku Oxford Diffraction Gemini Ultra A CCD 
diffractometer with Mo-Kα radiation. Atom H3 was constrained in an idealised position 
based on a riding model. 
 
Structure 2 – 94(1):6(1) occupancy ratio 
Crystals were grown through controlled cooling using the Cambridge Reactor Design 
Polar Bear Plus. 3.8 mg of 5CL was dissolved in 1 ml of water in a 1.5 ml vial and subject 
to a cooling profile of 60 °C to 5 °C at 0.01 °C min1. Data were collected at 298 K using a 
Rigaku Oxford Diffraction Gemini Ultra A CCD diffractometer with Mo-Kα radiation. 
Disordered hydrogen atoms were constrained in an idealised position based on a riding 
model. 
 
Structure 3 - Disorder of equal (50:50) occupancy 
Crystals were grown through controlled cooling using the ReactArray Microvate. 10 mg of 
5CL was weighed into the 2.5 ml vials and filled with a mixed solvent of acetonitrile and 
water in a 1:2 ratio. The temperature was then ramped to 80 °C at 5 °C min1 and held for 
2 hours to ensure complete dissolution. The lids of the vials were removed to allow for 
evaporation during the cooling phase. The temperature was then lowered to 40 °C at a 
rate of 0.1 °C min1. At the end of the experiment the temperature was held at 40 °C prior 
to the selection of a suitable crystal for diffraction. Data were collected at 100 K using the 
Rigaku R-AXIS-RAPID diffractometer with Mo-Kα radiation. The disordered hydrogen 
atom was constrained in an idealised position based on a riding model. 
 
Structure 4 – 62(1):38(1) occupancy ratio 
Crystals were grown from a cooling environment using the ReactArray Microvate. 10 mg 
of 5CL was weighed into the 2.5 ml vials and filled with a mixed solvent of ethanol and 
water in a 1:2 ratio. The temperature was then ramped to 80 °C at 5 °C min1 and held for 
2 hours to ensure complete dissolution. The lids of the vials were removed to allow for 
evaporation to occur during the cooling phase. The temperature was then lowered to  
40 °C at a rate of 0.1 °C min1. At the end of the experiment the temperature was held at  
40 °C until a crystal was selected for diffraction. Data were collected at 100 K using the 
Rigaku R-AXIS RAPID diffractometer with Mo-Kα radiation. All hydrogen atoms were 
constrained in idealised positions based on a riding model. 
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Variable-temperature study (298 and 100 K): Structures 5 and 6 
A second crystal was selected from the same crystallisation experiment as Structure 3. A 
data collection was carried out at 298 K (Structure 5) and immediately followed by 
another data collection at 100 K (Structure 6) on this second single crystal. Data were 
collected using the Rigaku Oxford Diffraction Gemini Ultra A CCD diffractometer with  
Mo-Kα radiation. For both Structures 5 and 6a all hydrogen atoms were constrained in 
idealised positions based on a riding model. For Structure 6b only the disordered 
hydrogen atom was constrained in an idealised position based on a riding model.  
 
Further crystallographic information for structures collected in this study is shown in Table 
8.2. Some of the structures were refined in two crystallographic models; crystallographic 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Crystals selected from the same batch: Structures 7-11 
A saturated solution of 5CL (3.8 mg ml1) was prepared in a 1.5 ml glass vial and 
dissolved in 1.5 ml of water. All crystals (7-11) were selected from the same vial grown by 
cooling from 70 °C to 20 °C at 0.3 °C min1 from water using the Polar Bear Plus 
crystalliser from Cambridge Reactor Design. All data were collected at the same 
temperature (298 K). Single crystal X-ray diffraction data were collected using a Rigaku 
Oxford Diffraction Gemini Ultra A CCD diffractometer with Mo-Kα radiation. Table 8.3 and 
Table 8.4 show the crystallographic information for data obtained in this study. Repeat 
collections were carried out (from the same crystal) for Structure 8 (labelled 8.1, 8.2 and 
8.3). Some of the structures were refined in two crystallographic models; crystallographic 
information is labelled a and b in such cases. The hydrogen atom models used are 
summarised below. 
 
Structure 7 – The disordered hydrogen atoms were constrained in idealised positions 
based on a riding model. 
Structure 8.1 – The disordered hydrogen atoms were constrained in idealised positions 
based on a riding model. 
Structure 8.2 – The disordered hydrogen atoms were constrained in idealised positions 
based on a riding model. 
Structure 8.3 – The disordered hydrogen atoms were constrained in idealised positions 
based on a riding model. 
Structure 9a – All of the hydrogen atoms were constrained in idealised positions based 
on a riding model. 
Structure 9 – The disordered hydrogen atom was constrained in an idealised position 
based on a riding model. 
Structure 10a – All of the hydrogen atoms were constrained in idealised positions based 
on a riding model. 
Structure 10b – the hydrogen atoms were refined freely. 
Structure 11a – All of the hydrogen atoms were constrained in idealised positions based 
on a riding model. 
Structure 11b – The disordered hydrogen atom was constrained in idealised positions 
based on a riding model. 
 
Crystallisation in the presence of Pluronic P123: Structures 12 and 13 
As part of the systematic study of 5CL crystallisations under different conditions, sample 
crystallisations were also carried out in the presence of the polymer additive Pluronic 
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P123 (PP123). The primary aim of the additive experiments was morphology control of 
5CL, which crystallises in a plate-like morphology in the absence of additive (see Chapter 
1 for an account of the importance of morphology control in crystallisation). Cooling 
crystallisations of 5CL in the presence of PP123 were carried out using the Cambridge 
Reactor Design Polar Bear Plus at 1 ml scale. 3.8 mg of 5CL and 25 mg of PP123 were 
dissolved in 1 ml of water and the solution was subject to a linear cooling profile of 60 °C 
to 5 °C at a rate of 0.05 °C min1. Single crystal X-ray diffraction data were collected from 
two selected crystals (12 and 13) using a Rigaku Oxford Diffraction Gemini Ultra A CCD 
diffractometer with Mo-Kα radiation. Further crystallographic information is reported in 
Table 8.5. Both structures were refined in two crystallographic models; crystallographic 
information is labelled a and b for these. 
  
Structure 12a – The disordered hydrogen atoms were constrained in idealised positions 
based on a riding model. 
Structure 12b – The disordered hydrogen atom was constrained in an idealised position 
based on a riding model. 
Structure 13a – All of the hydrogen atoms were constrained in idealised positions based 
on a riding model. 
Structure 13b – The disordered hydrogen atom was constrained in an idealised position 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































8.3 Initial crystal structures 
Structures determined from different crystals selected from different experiments showed 
variable levels of refined orientational disorder across the 5CL molecule (Table 8.2). 
 
8.3.1 Structure 1 – Ordered 
The crystal structure of 5CL that refines as an ordered model crystallises in the 
monoclinic space group, P21/n. The ordered nature of the crystal structure could be 
attributed to the slow conditions used for crystal growth (evaporation from water). Further 
investigation into this structure showed that a low level of disorder could be modelled with 
98:2 ratio of orientations, but some parameters in this refinement were poorly determined 
leading to the conclusion that the structure is more accurately described by the ordered 
model.  
 
8.3.2 Structure 2 – 94(1):6(1) occupancy ratio 
A crystal selected from a crystallisation carried out by slow cooling (0.01 °C min1) also 
gave a refinement with a low level of disorder in the P21/n model (94(1):6(1)). This finding 
supports the conclusion that slow conditions used for growth may enable a crystal 
structure with a more ordered nature whereby the molecules are allowed to assemble in 
the presumably lowest energy configuration.  
 
8.3.3 Structure 3 – Disorder of equal occupancy2 
This data collection gave a refined structure of 5CL with previously unreported unit cell 
dimensions and was solved in the space group, P21/m (Table 8.2). Figure 8.6 illustrates 
the atoms present in the asymmetric unit with the atoms Cl1, C1, C3 and O2 lying on a 
mirror plane. Atoms O1 and H2 are thus disordered with equal occupancy (50:50) while 
atoms N1, H1 and C2 are fully occupied.  
 
Figure 8.6 - The asymmetric unit in the P21/m model of 5CL with the atoms labelled. 
                                               
2
 This structure was subsequently reported in the CSD as a private communication (CLURAC12) 












In the ordered structure (Structure 1, above) the C1-C4 bond length (1.454(2) Å) is longer 
than that of C1=C3 (1.350(2) Å), as expected since C1=C3 is a double bond. However, in 
this structure with disorder of equal occupancy the comparable bond lengths are equal at 
1.399(2) Å, supporting the equal occupancy disorder model. 
 
8.3.4 Structure 4 – 62(1):38(1) occupancy ratio 
This disordered structure was solved in the space group P21/n with the two orientations 
refined to a final occupancy ratio of 62(1):38(1). Table 8.2 shows that the refinement of 
this structure resulted in relatively high values for the refinement parameters. This may 
indicate that the structure may require further modelling to investigate the possibility that 
this structure may in fact represent a 50:50 disorder situation as observed in Structure 3. 
 
8.4 Systematic investigations 
The finding of variable levels of disorder in crystals prepared by different crystallisation 
conditions led to more systematic investigations into a number of parameters that may 
affect the level of refined disorder in these 5CL structures. 
 
8.4.1 Variable temperature X-ray diffraction study  
A study was carried out to determine whether the X-ray diffraction data collection 
temperature affects the disorder occupancy, which may indicate solid state changes in 
the hydrogen bonding pattern as the temperature is lowered. 
 
A data collection was carried out at 298 K (Structure 5), immediately followed by another 
data collection at 100 K (Structure 6) on the same single crystal. Both structures were 
solved in space group P21/n and show orientational disorder. Structures 5 and 6a have 
disorder occupancies of the two orientations of 61(1)% and 59(1)%, respectively. This 
minor discrepancy is not significant, particularly due to the poor quality of refinement in 
Structure 6 in which it was not possible to refine some of the atoms anisotropically. Such 
high values of the refinement parameters led to attempts to resolve the structure in the 
P21/m model, in which an improved refinement was obtained (6b). Attempts to solve the 
dataset obtained at 298 K in the P21/m model were unsuccessful which could reflect the 
quality of the dataset.  
 
The crystal used for these data collections was selected from the same crystallisation 
experiment as that used for the data collection of Structure 3, so it was expected that the 
disorder would be of equal occupancy in both cases. However, the overall refinements in 
the P21/n model are not sufficiently well defined to allow proper discrimination of disorder 
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levels. This finding was the first indication that consistency in disorder modelling may be 
difficult to achieve in these experiments.  
 
All future data collections were performed, wherever possible, at room temperature, since 
the physical properties that are of interest will be measured at room temperature and it is 
difficult to be certain that the temperature has no impact on the disorder.   
 
8.4.2 Homogeneity of disorder occupancy from crystals from the same batch 
The aim of this experiment was to investigate the homogeneity of the level of disorder in 
5CL across multiple crystals selected from the same experimental set-up by carrying out 
full structural determinations for each crystal (Structures 7-11). Data collections were 
carried out for five initial crystals with repeat determinations carried out for one of the 
crystals (Structures 8.1, 8.2, 8.3). Table 8.3 and Table 8.4 show the crystallographic data 
for the collections.  
 
All of the structures were initially solved in the P21/n model where Structures 7 and 8 
showed disorder of 83(1)% and 88(1)%, respectively. The low level of disorder across the 
molecule in Structure 8 allowed the data to be refined effectively in the P21/n model. 
Furthermore, in repeat determinations using the same crystal, the disorder level remained 
constant at 88%. 
 
In contrast, structure solution of Structures 9a, 10a and 11a in the P21/n model produced 
poor refinement parameters and the occupancy level was close to equal in each of the 
structures (50(1)%, 52(2)% and 52(2)%). As a result, the structures were then solved in 
the P21/m model (9b, 10b and 11b) in which improved refinement parameters were 
obtained for each structure. 
  
These results show that there is variability in the disorder level of crystals selected from 
the same vial under the conditions used to produce the crystals. This may be a result of 
each individual crystal having different growth kinetics; the small-scale crystallisation 
system did not have any agitation, for example. It may also reflect the lack of definitive 
indications from the occupancy refinements, as noted above. This finding makes 
determination of the effect of the crystallisation conditions on the overall disorder level 
challenging and sounds a note of caution in this area; each crystal could have a different 
level of disorder and it is not clear that the structural refinements are able fully to 




8.4.3 Effect of a polymer additive on disorder 
As part of the examination of the manner in which different environments may affect 
disorder, the use of additives were also explored. A polymer additive (PP123) was 
dissolved in the aqeuous crystallisation solution. Interestingly, the presence of the 
additive resulted in a significant change in morphology from plates to needles when 
compared to the control crystallisation containing 5CL alone (Figure 8.7). It is worthy of 
note that such a morphology modification was the primary motivation for the additive 
study; during the project, these findings prompted the use of PP123 additive in the 
morphology studies reported in Chapters 4 and 6. The unfavourable morphology resulting 
from additive crystallisations of 5CL (producing needle-like crystals) and the formation of 
very small needle-like crystals in the presence of stirring resulted in this aspect of the 
study not being pursued further. 
 
 
Figure 8.7 - Microscope images of 5CL crystals: (left) plate-like crystals produced in the presence 
of no additive and (right) needle-like crystals produced in the presence of PP123. 
 
Data collections were also obtained for the needle-like crystals produced in the presence 
of the additive in order to assess the possible effect of the additive on the disorder 
occupancy (Table 8.5). As in the previous experiment the crystal structures were initially 
solved in the P21/n model. Structure 12 gave a good refinement in the P21/n model and 
produced a disorder occupancy of 72(1)%. However, the data also provided a good 
refinement in the P21/m model (12b; which constrains the disorder occupancy to a 50:50 
ratio). Again, another crystal selected from the same experiment produced a refinement 
with a different disorder occupancy (Structure 13) of 61(1)% when refined in the P21/n 
model. However, these data produced a better refinement in the (50:50) P21/m model 
(13b) with improved refinement parameters. 
 
This ambiguity in space group assignment makes accurate determination of the disorder 
level challenging, especially when structures can give a good refinement in either model. 
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This suggests that the two cells are not polymorphs, and are as a result of the disorder 
having an impact of the assignment of the space group. Although the two choices of 
space group result in slightly different relative orientations of molecules in the packing, 
and thus different hydrogen bonding schemes in terms of local structure, the two 
possibilities, and the less-regular intermediates between them, are clearly very similar in 
terms of stabilising the overall crystal structure. In structures where there is disorder of 
equal occupancy or close to equal occupancy, the disorder obeys the inherent mirror 
symmetry in the P21/m model more effectively (the mirror plane lies down the same axis 
as the orientational disorder symmetry), and therefore a good refinement can be obtained 
in the P21/m model. In the structures where the disorder occupancies are more uneven, 





Variations in the degree of disorder across different crystals may have implications for the 
physical properties of a substance. In 5CL, the molecule can lie in two orientations and a 
study into the different occupancies of the disorder in different crystals of 5CL has been 
carried out. Crystals of 5CL with different refined disorder occupancies were identified, 
including an ordered structure and a structure with disorder of equal occupancy of both 
molecular orientations. The ordered structure and a structure with a low level of disorder 
(94%) were both produced from samples where crystal growth was allowed to occur at 
slow rates. This finding may be explained by the slow rate of growth allowing for the 
molecules to arrange themselves in the presumably lowest energy configuration. 
However, following this finding, a systematic study into disorder levels of crystals selected 
from the same batch showed that the crystals had different levels of refined disorder.  
 
The study therefore highlighted that the refined level of disorder may be susceptible not 
only to crystallisation conditions, but also to crystal choice. The findings also highlight the 
difficulty in accurate determination of the space group in the presence of the disorder, 
and hence raises a note of caution about lack of reliability of the refined disorder 
occupancies in the 5CL structure. In many cases reasonable structural refinements could 
be carried out in either P21/n or P21/m with some datasets accurately described by both 





In future work it would be beneficial to carry out multiple data collections from crystals 
from the same experiment prepared by slow evaporation or slow cooling where it might 
be expected that there would be less discrepancies in the level of disorder across the 
batch. This could also be carried out for crystals obtained through fast evaporation or 
rapid cooling where uneven disorder levels may be expected. Crystals could also be 
produced in the presence of agitation to provide a more uniform growth environment. 
However, rapid crystallisation and the presence of mixing may reduce the particle size 
making data collection through single crystal X-ray diffraction more challenging. 
Therefore, identification of a bulk method of characterising the disorder may be more 
effective in future studies, especially in light of the fact that any beneficial physical 
property of such materials, such as solubility or compressibility, is likely to be manifest in 
polycrystalline samples. 
 
The inconsistency in the occupancy of disorder across the range of structures collected in 
this work led to the truncation of the study on possible control of disorder in 5CL. 
However, the finding of the effect of the polymer additive on the morphology of 5CL 















Conclusions and future work 
 
9.1 Conclusions 
The work in this thesis presents studies towards optimising the physical and particle 
properties of organic solid forms, particularly with a view to producing particles suited for 
production in continuous crystallisation environments.  
 
Crystal morphology is an important feature affecting the particle properties of a substance 
and therefore relevant to the ease of downstream processes in the fine chemicals 
industries. Various methods can be used to optimise the crystal morphology, one of 
which is the use of soluble additive compounds present in the crystallisation solution. 
Both polymer and structurally similar additive compounds have been shown in this work 
to be effective in modifying the crystal morphology of different target compounds. Their 
possible residual presence in the final crystalline product was also investigated. 
 
The effect of a triblock co-polymer additive, PP123, on the crystal morphology of SA from 
water was studied in detail at different batch scales in the volume range of 1 ml to 350 ml. 
β-SA crystallises from water in a plate-like morphology in the absence of an additive. It 
was found that the morphology-modifying effect of the polymer was dependent on both 
the concentration of SA and of PP123, which were related to the supersaturation ratio of 
the system at nucleation. At low concentrations of SA and additive, favourable block-like 
crystals were produced whereas at high concentrations of SA and additive, less 
favourable, needle-like crystals resulted. A region of concentrations of polymer and SA 
was identified which favoured the desirable block-like morphology, showing that 
conditions can be tuned to achieve this situation. In crystallisations in the presence of the 
additive at both 3 ml and 350 ml scales, the supersaturation ratio at nucleation was 
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highest at the lowest concentration of SA and declined as the SA concentration was 
increased. This may explain why in crystallisations with this low supersaturation ratio the 
effect of the additive was enhanced as more material is available in solution for the 
crystals to grow. Despite the large change in crystal morphology in the presence of very 
small quantities of polymer additive, the solid form of the SA produced was unchanged, 
remaining as the  polymorph. The method of mixing was shown to be crucial in the 
crystal morphology produced. Experiments with magnetic bottom stirring produced very 
small crystals and although morphology changes were observed at 1 ml scale, at larger 
scales the abrasive action of the stirrer bar resulted in significant breakage of the crystals. 
Overhead stirring resulted in less attrition, however, the experiments carried out at 3 ml 
scale with overhead stirring resulted in non-uniform morphologies due to the impeller 
being positioned at the incorrect height for the volume used. When used at 10 ml and  
350 ml scale, with the impeller at the correct height, improved mixing was achieved and 
more uniform particles were produced.  
 
Indexing of the individual crystal faces for each morphology produced and analysis of the 
crystal structure of β-SA was carried out. This, in combination with inspection of the 
morphology of SA produced from additional crystallisations using the individual blocks of 
the triblock co-polymer as additives, allowed a mechanism of the face-specific effect of 
the additive to be devised. Crystals grown in the presence of the additive showed a 
change in their side faces (to (111) and (11̅1)); the change in crystal shape suggested 
that these were the faces whose growth may be inhibited by the additive. Analysis of the 
crystal structure showed that the methyl groups of the SA molecules were positioned on 
the surface of these faces. Furthermore, in the additional crystallisations, the hydrophobic 
block of the polymer (PPG4000) induced a similar effect on the crystal morphology to that 
induced by the triblock co-polymer. Whereas the hydrophilic PEG1000 block did not have 
an effect on the morphology of SA. This suggested that the additive may be interacting 
with the crystal surface through hydrophobic interactions (growth of the hydrophobic 
faces is inhibited by the hydrophobic block of the polymer). The use of PPG4000 as an 
additive also offered the benefit of producing block-like crystals using a broader set of 
crystallisation conditions, enhancing the concentration regions over which this favourable 
outcome is achieved. 
 
As part of the study into the crystallisation of SA from water, other methods for optimising 
the crystal morphology and size were also explored in combination with the use of 
additives. Firstly, direct nucleation control (DNC) experiments were carried out with and 
without the PP123 additive present in solution; these produced large rod and plate-like 
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crystals, respectively. The DNC was effective in improving the size and shape uniformity 
of the crystals. Temperature cycling experiments were also carried out as part of 
collaborative work and interestingly, with no additive present, a unique shape of SA was 
produced. Upon reaching equilibrium, square bipyramidal shaped crystals were formed of 
which the (100) face observed previously was replaced with the (110) and (11̅0) faces.  
 
Another aim of this work was to achieve the implementation of an additive-mediated 
morphology change in a continuous platform; these investigations were carried out using 
the SA and polymer additive system. Two continuous crystallisation platforms were 
investigated: the KRAIC segmented flow crystalliser and the continuous oscillatory baffled 
crystalliser (COBC). Successful transfer of the additive effect was achieved in the COBC 
platform with the favourable block-like morphology reproduced for multiple residence 
times of operation. This is the first reported example of additive-induced morphology 
changes being designed and implemented in continuous crystallisation of small molecule 
systems, and represents a significant achievement towards the aims of the CMAC 
consortium in producing particle control in continuous crystallisation. However, significant 
challenges such as encrustation and sedimentation were encountered in moving this 
system to the continuous environment using this platform which limited the prolonged 
production of the desired crystals. Interestingly, in experiments with the PP123 additive 
present, the severity of the encrustation was less in comparison with experiments with no 
additive present, but back-mixing of crystals into higher temperature straights resulted in 
inconsistent morphologies over successive residence times. The experiments carried out 
in the batch environment showed that the crystal morphology produced in the presence of 
the PP123 polymer was dependent on the temperature of crystal growth. Back-
propagated crystals therefore acted as seeds enabling crystal growth in higher 
temperature straights and the consequent production of elongated crystals. The 
production of the block-like crystals of SA for longer periods of time was achieved using 
the PPG4000 additive due its ability, established in the batch investigations, to produce 
block-like crystals at a range of temperatures (related to the saturation concentration 
range over which the favourable morphology change is achieved). However, problems 
with sedimentation and encrustation remained an issue in the experiments.  
 
Use of the SA system in experiments in the KRAIC segmented flow crystalliser enabled 
significant contributions to the development of the platform, a bespoke device designed, 
constructed and commissioned in the group at the University of Bath. Encrustation within 
the tubing and mixer pieces was overcome by implementation of effective temperature 
control methods. Additionally, a system designed to separate the carrier fluid from the 
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solution prior to filtration was implemented, enabling recovery of the carrier fluid and 
effective filtration of the product. Initial experiments towards achieving additive induced 
morphology in the platform were also carried out. In these initial experiments the PP123 
additive was found to be incompatible with the liquid segmentation; the surfactant 
properties of the polymer enabled emulsification of the two phases and significant loss of 
carrier fluid. In contrast, the PPG4000 additive was compatible with the set-up, however 
its presence in the quantities used in the initial experiments did not result in the desired 
block-like crystals of SA. In the KRAIC the mixing is gentler than the batch environment 
and therefore larger concentrations of the additive may be required to produce the same 
effect. Interestingly, in the experiments with liquid segmentation including those in the 
presence of the PPG4000 additive, the product contained a mixture of α-SA and β-SA. 
The appearance of the α-polymorph of SA may be a result of the absence of a solid 
interface in the unique environment inside the KRAIC.  
 
Substances with structural similarity to the target compound can also be effective as 
additives for optimisation of crystal morphology. The structural similarity of the additive 
may facilitate competition for surface adsorption with the growth units of the target 
compound on specific faces. Such structurally similar additives formed the focus of 
studies into the crystal morphology of the API, isoniazid; this API adopts unfavourable 
morphologies in the absence of additives. The effect of a range of structurally similar and 
size-matched additives, some of which are GRAS compounds, were screened for a 
possible effect on the morphology of IZN from two solvents, water and ethanol. IZN 
crystallises in a needle and plate-like morphology from water and ethanol, respectively. 
However, the modification of the crystal morphology of IZN to more favourable 
morphologies using additives was difficult to achieve and unfortunately the presence of 
the GRAS compounds did not show a favourable effect. Several other additives were, 
however, found to modify the morphology of IZN and further analysis was carried out for 
the additive which showed the most reproducible and enhanced effect (4,4’-bipyridine, 
44BP). The presence of the 44BP additive in evaporative and cooling crystallisations of 
IZN from ethanol resulted in elongated crystals. In comparison with the polymer additive 
used to modify the morphology of SA, higher concentrations of this size-matched additive 
were required to induce an effect on the shape of the IZN crystals. Face indexing and 
analysis of the crystal structure of IZN allowed a possible mechanism for the effect of the 
44BP additive on crystal growth to be constructed. In the presence of the additive, the 
slow growing faces and those with which the additive may be interacting are (01̅2̅) and 
(01̅2). The inhibiting effect of the additive may proceed through the pyridine ring of the 
44BP molecules mimicking the hydrogen bond interaction of the pyridine ring of the IZN 
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molecule with the amine N-H bond of the IZN molecules. The 44BP molecule does not 
possess a hydrogen bond donor group preventing further addition of IZN growth units on 
the crystal surface and thus slowing down crystal growth. The other additives used which 
feature a pyridine ring also feature a hydrogen bond donor group which may have been a 
factor in their limited success as morphology-modifying additives. Prior to the study, it 
was inherently difficult to predict which additives would alter the morphology of IZN and 
the work largely relied on trial-and-error methods. Although none of the additives 
enhanced the crystal morphology of IZN in a favourable manner in terms of solid 
processing, gaining an understanding of the molecular level interactions that may have 
resulted in changes in morphology can aid the design of future “tailor-made” additives for 
a more desirable effect on the crystal shape.   
 
Due to their structural similarity one of the challenges of using such additives is the risk of 
their incorporation into the crystal lattice. Polymer additives are less likely to be 
incorporated due to their larger size but may be present on the surface of the crystals. 
For both studies of SA and IZN, a range of analytical techniques were used to investigate 
the purity of the final crystalline product. The additives were not detected in the final solid 
product by any of the analytical methods used suggesting that they are not present in the 
product or are present in quantities below the detection limit of the instruments used. For 
the SA system, a qualitative method involving recrystallisation was devised to determine 
the presence of polymer in the product and the effectiveness of washing the crystals in 
removing the additive. Recrystallisation of a product previously crystallised from solution 
containing the highest concentration of PP123 additive (rod-like crystals) resulted in 
block-like crystals. This suggests that a small quantity of the additive may be present on 
the surface of the crystals. However, slurrying of the crystals in a non-polar solvent was 
effective in removing the remaining additive; plate-like crystals were produced when the 
dry sample was recrystallised after this washing procedure. 
 
The properties of a substance can also be affected by its structural attributes. In  
Chapter 7, multi-component crystallisation was used to produce novel solid forms of the 
API, piroxicam. The aim of the work was to induce layered or disordered solid forms using 
co-former molecules selected based on their planar and symmetrical nature. Ten 
molecular complexes were produced of which five showed layered crystal structures, one 
of which had disorder present. In all of the structures which featured a layered packing 
arrangement, the co-former molecule forms interactions with the PX molecule through a 
carboxylic acid group, enabling the formation of two hydrogen bonds and encouraging the 
formation of a layered architecture. Through the study a series of solvates of a co-crystal 
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with layered structures were identified which showed interesting structural and thermal 
properties. Upon desolvation the PX molecule undergoes a tautomeric transition in the 
solid state which produces a colour change from yellow to white of which was found to be 
reversible through exposure to solvent vapour. Thermal, structural and spectroscopic 
analysis enabled the transition to be studied in detail. Through the rearrangement of the 
molecules in the crystal structure upon desolvation, the layered architecture is not 
retained in the structure of the desolvated form.     
 
Another structural attribute that may affect the properties of a substance is the presence 
of molecular disorder. Chapter 8 describes an investigation into orientational disorder in 
5CL whereby different levels of disorder could be refined from different crystals. The initial 
aims of the study were to investigate the effect of the crystallisation conditions on the 
level of disorder, with a view to exerting control over this effect. However, the level of 
disorder was not found to be uniform across crystals selected from the same experiment, 
which resulted in challenges in attributing the crystallisation conditions to the level of 
disorder in the crystals. A lack of reliability in the refined level of disorder was also evident 
due to the inherent difficulty in assignment of the space group. In several cases 
reasonable structural refinements could be achieved in either P21/n or P21/m. 
 
 
9.2 Future work 
Looking to the future a number of themes arise. The effect of the PP123 polymer additive 
on the crystal morphology of SA was studied in detail, however a number of other 
parameters could be investigated. A more detailed investigation into the effect of different 
cooling rates on the morphology of SA in the presence of polymer additives as well as the 
effect of the stirring speed would enhance the understanding of the additive effect under 
different conditions. Detection of the nucleation temperature in such experiments would 
provide further understanding of the effect of the supersaturation on the crystal 
morphology. A Design of Experiments approach would be advantageous, enabling the 
conditions required to produce the most optimised morphology to be identified. It was 
also shown in this work that the polymer additive used could be applied to modify the 
morphology of another dicarboxylic acid. Developments would further target 
crystallisation of other dicarboxylic acids, allowing for comparisons to be made between 
the morphologies produced in the presence of the polymer additive. Another area of 
future significance to the work presented is the measurement and comparison of the 




Significant future work remains in terms of transfer of the SA system to the continuous 
environment. In order to make the production of the block-like crystals of SA in the 
presence of the polymer additives in the COBC sustainable, optimisation of the mixing 
conditions within the platform is required to prevent the severity of back-mixing and 
sedimentation. The implementation of seeding within the COBC would also be 
advantageous in prevention of nucleation on the walls of the crystalliser. This may enable 
access to improved particle size distributions and operation for prolonged periods. In 
terms of crystallisation in segmented flow, it is clear that the solid recovery requires 
optimisation for both experiments with and without additives present. Although the 
presence of the PP123 polymer was incompatible with the liquid segmented flow set-up, 
the use of the PPG4000 additive proved to be promising in the initial experiment. In future 
experiments, increasing the concentration of the PPG4000 additive may enable more 
effective production of the desired block-like crystals of SA. Crystallisations of SA in the 
presence of polymer additives could also be carried out in other continuous crystallisation 
platforms such as an MSMPR set-up. 
 
In the study of the effect of the PP123 additive on the crystal morphology of SA, the most 
desirable morphology was tuned by altering the concentrations of the two components. A 
more detailed investigation into the effect of the structurally similar additives shown to 
impact the morphology of IZN may identify conditions required to access improved 
morphology for the API material. For example, the presence of the 44BP additive 
produced elongated crystals of IZN in the concentration tested; use of the additive in 
slightly lower concentrations may induce a less extreme effect and less elongated 
crystals. Furthermore, the knowledge gained from indexing the crystal faces may help to 
design future additives to induce an effect on the crystal morphology. Additional studies 
involving face indexing of other systems where reproducible morphology changes were 
observed, such as the use of urea as an additive, would therefore be beneficial. 
 
A series of molecular complexes of PX were identified in this work, some of which were 
produced in larger quantities through crystallisation techniques other than evaporation. 
Production of the other complexes of interest through these methods may enable 
production of enough substance to measure and compare their physical properties and 
make correlations with the structural attributes observed.   
 
To date, a method of characterising the occupancy of disorder without the requirement for 
single crystals has not yet been determined. This is significant in terms of scale-up since 
the product of is often a crystalline powder. Since studies of 5CL showed that the level of 
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disorder is inconsistent in crystals selected from the same experiment, a method of 
probing the disorder in the bulk is necessary in order to exploit this structural attribute for 
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Appendix A4 (Chapter 4) 
 
A4.1 1H NMR analysis 
 
 
Figure A4.1 – The structure of succinic acid with the hydrogen atoms labelled. 
 
SA sample crystallised with PP123 additive: 1H NMR (500MHz, D2O) δ ppm 2.64 (4H, 
s, Ha), 4.75 (s, H2O). 
SA sample crystallised without PP123 additive: 1H NMR (500MHz, D2O) δ ppm 2.64 





A4.2 MALDI-TOF MS 
 
 
Figure A4.2 - MALDI-TOF MS analysis of SA sample crystallised in the presence of 0.5% PP123 













Figure A4.5 - MALDI-TOF MS analysis of PP123 polymer (0.05 mg ml-1).   
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Appendix A6 (Chapter 6) 
 
A6.1 Tables of experiments carried out 
 

















Nicotinic acid 100:1, 1:1 10:1 10:1 10:1 N/A 
Isonicotinic acid 100:1, 1:1 10:1 10:1 10:1 10:1 
Nicotinamide 100:1, 1:1 10:1 10:1 10:1 N/A 
Isonicotinamide 100:1, 1:1 10:1 10:1 10:1 N/A 
2-picolinic acid 100:1, 1:1 10:1 10:1 10:1 10:1 
Pyrazine carboxamide 100:1, 1:1 10:1 10:1 10:1 N/A 
PEG 100:1, 1:1 10:1 10:1 10:1 N/A 
PPG 100:1, 1:1 10:1 10:1 10:1 N/A 
PP123 100:1, 1:1 10:1 10:1 10:1 N/A 
PF127 100:1, 1:1 10:1 10:1 10:1 N/A 
Biuret 10:1, 1:1 10:1 10:1 10:1 10:1 
Urea 10:1, 1:1 10:1 10:1 10:1 N/A 
Resorcinol 10:1, 1:1 10:1 10:1 10:1 N/A 
Imidazole 10:1, 1:1 10:1 10:1 10:1 N/A 
Benzoic acid 10:1, 1:1 10:1 10:1 10:1 N/A 
Oxalic acid 10:1, 1:1 10:1 10:1 10:1 N/A 
Malic acid 10:1, 1:1 10:1 10:1 10:1 N/A 
2,4-dinitrobenzoic acid 10:1, 1:1 10:1 10:1 10:1 10:1 
3-methylbenzoic acid 10:1, 1:1 10:1 10:1 10:1 N/A 
4-fluorobenzoic acid 10:1, 1:1 10:1 10:1 10:1 N/A 
4-hydroxybenzoic acid 10:1 10:1 10:1 10:1 N/A 
2,2'-bipyridyl  10:1, 1:1 10:1 10:1 10:1 N/A 
4,4'-bipyridyl 10:1, 1:1 10:1 10:1 10:1 10:1 


















Nicotinic acid 100:1, 1:1 10:1 
Isonicotinic acid 100:1, 1:1 10:1 
Nicotinamide 100:1, 1:1 10:1 
Isonicotinamide 100:1, 1:1 10:1 
2-picolinic acid 100:1, 1:1 10:1 
Pyrazine carboxamide 100:1, 1:1 10:1 
PEG 100:1, 1:1 10:1 
PPG 100:1, 1:1 10:1 
PP123 100:1, 1:1 10:1 
PF127 100:1, 1:1 10:1 
Biuret 10:1, 1:1 10:1 
Urea 10:1, 1:1 10:1 
Resorcinol 10:1, 1:1 10:1 
Imidazole 10:1, 1:1 10:1 
Oxalic acid 10:1, 1:1 10:1 
Malic acid 10:1, 1:1 10:1 
2,4-dinitrobenzoic acid 10:1, 1:1 10:1 
4-hydroxybenzoic acid 10:1, 1:1 10:1 
2,2'-bipyridyl  10:1, 1:1 10:1 
4,4'-bipyridyl 10:1, 1:1 10:1 
2-aminopyridine 10:1, 1:1 10:1 
 
 







Nicotinic acid 100:1, 1:1 100:1, 1:1 100:1, 1:1 
Isonicotinic acid 100:1, 1:1 100:1, 1:1 100:1, 1:1 
Nicotinamide 100:1, 1:1 100:1, 1:1 100:1, 1:1 
Isonicotinamide 100:1, 1:1 100:1, 1:1 100:1, 1:1 
2-picolinic acid 100:1, 1:1 100:1, 1:1 100:1, 1:1 
Pyrazine carboxamide 100:1, 1:1 100:1, 1:1 100:1, 1:1 
PEG 100:1, 1:1 100:1, 1:1 100:1, 1:1 
PPG 100:1, 1:1 100:1, 1:1 100:1, 1:1 
PP123 100:1, 1:1 100:1, 1:1 100:1, 1:1 




A6.2 1H NMR analysis 
 
 
Figure A6.1 – The structures of (left) isoniazid and (right) 4,4'-bipyridyl with the hydrogen atoms 
labelled. 
 
IZN: 1H NMR (500MHz, D2O) δ ppm 4.75 (s, H2O), 7.64 (1H, d, Hb), 8.63 (1H, d, Ha).  
 
44BP: 1H NMR (500MHz, CDCl3) δ ppm 1.63 (s, H2O), 7.27 (s, CHCl3), 7.55 (1H, d of d, 
Hd), 8.76 (1H, d of d, Hc).  
 
IZN crystallised from ethanol by evaporative crystallisation: 1H NMR (500MHz, D2O) 
δ ppm 4.75 (s, H2O), 7.67(1H, d, Hb), 8.65 (1H, d, Ha).  
 
IZN crystallised from ethanol in the presence of 44BP via evaporative 





A6.3  Powder X-ray diffraction 
Evaporative crystallisation of IZN from ethanol 
 
Figure A6.2 - PXRD patterns of isoniazid crystallised evaporatively from ethanol in the presence of 
(a) no additive, (b) 4-fluorobenzoic acid, (c) 4-hydroxybenzoic acid, (d) imidazole, (e) benzoic acid 
and (f) resorcinol, all in a 10:1 molar ratio.  
 
 
Cooling crystallisation of IZN from ethanol 
 
Figure A6.3 - PXRD patterns of isoniazid crystallised in a cooling environment from ethanol in the 
presence of (a) no additive, (b) isonicotinic acid, (c) nicotinic acid, (d) 2-picolinic acid and (e) 





Figure A6.4 – PXRD patterns of isoniazid crystallised in a cooling environment from ethanol in the 
presence of (a) no additive, (b) biuret, (c) 2-picolinic acid and (d) isonicotinic acid, all in a 10:1 
molar ratio at 10 ml scale with overhead stirring. 
 
 
Evaporative crystallisation of IZN from water 
 
Figure A6.5 - PXRD patterns of isoniazid crystallised evaporatively from water in the presence of 





Figure A6.6 - PXRD patterns of isoniazid crystallised evaporatively from water in the presence of 
(a) no additive, (b) urea, (c) resorcinol and (d) 4-hydroxybenzoic acid, all in a 10:1 molar ratio. 
 
 
Cooling crystallisation of IZN from water 
 
Figure A6.7 - PXRD patterns of isoniazid crystallised in a cooling environment from water in the 
presence of (a) no additive, (b) imidazole, (c) urea and (d) 2,2-bipyridyl, all in a 10:1 ratio at 1 ml 
scale. 
 
 
 
 
